col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

731 Results       Page 1

American Society of Hematology: Blood
  original article Date Title Authors   All Authors
1 [GO] 2023―Dec―02 Efficacy and Safety of Tixagevimab-Cilgavimab (Evusheld or AZD7442) As Pre-Exposure Prophylaxis for COVID-19 Among Allogeneic Hematopoietic Stem Cell Transplant Recipients Quan Do, Waled Bahaj, Natasha Chandler, Ju-Hsien Chao, Robert V.B. Emmons, Mohamed Hegazi
2 [GO] 2023―Dec―02 Assessing the Impact of the Covid-19 Pandemic on Outcomes of Patient Admitted with Sickle Cell Disease Jay Vakil, Vaishali Deenadayalan, Hafeez Shaka, Maryam Zia
3 [GO] 2023―Dec―02 Characteristics of Coronavirus Disease in Allogeneic Hematopoietic Stem Cell Transplantation during the Omicron Wave: A Single-Center Study Panpan Zhu, Luxin Yang, Lizhen Liu, Xiaoyu Lai, Jimin Shi, Yanmin Zhao, et al. (+6)
4 [GO] 2023―Dec―02 Sars-Cov-2 and Chronic Myeloid Leukemia: A Systematic Review Elrazi Ali, Anas Al-sadi, Qusai Al-maharmeh, Amulya Bellamkonda, Madhumati Kalavar, Kalpana Panigrahi, Mohamed A Yassin
5 [GO] 2023―Dec―01 Transient Anti-Interferon Auto Antibodies in the Airway Are Associated with Recovery in Mild COVID-19 Benjamin R Babcock, Astrid Kosters, Nadia R Roan, Sulggi Lee, Eliver E.B. Ghosn
6 [GO] 2023―Dec―01 Incidence and Risk Factors for Thrombosis in Cancer Patients with COVID-19 Alexander J. Didier, Andrew Campbell, Swamroop V Nandwani, Alan Fahoury, Camelia Arsene
7 [GO] 2023―Dec―01 Nationwide Analysis of Characteristics and Outcomes of Patients with Heparin Induced Thrombocytopenia Admitted for Treatment of COVID-19 Mohammad Ammad Ud Din, Hania Liaqat, Moazzam Shahzad, Ali Jaan, Muhammad Osama, Muhammad Farooq, Michael V. Jaglal
8 [GO] 2023―Dec―01 Factor V Inhibitor in COVID-19 an Unusual Presentation Hawra Shawayli, Jassim Ahmed Khan, Deena Mudawi, Shehab Mohamed, Amna Gameil, Dekra AlFaridi, Feryal Abbas
9 [GO] 2023―Dec―01 Extended Thromboprophylaxis in Patients Hospitalized with COVID-19 at Time of Discharge from the Hospital Is Not Associated with an Improvement in Quality of Life: Results from the Activ 4c Clinical Trial Lisa Baumann Kreuziger, Taeim Kwon, Lana Wahid, Raj S. Kasthuri, Andrei L. Kindzelski, M. Margaret Knudson, et al. (+12)
10 [GO] 2023―Dec―01 Clinical Characteristics of COVID-19 Coagulopathy, Experiences in a New York City Safety Net Hospital Parima Saxena, Riddhi Chauhan, Prashil Dave, Dedipya Bhamidipati, Nazeera Ghanie, Edwin Chiu, John Muthu
11 [GO] 2023―Dec―01 A Retrospective Analysis of COVID-19 Coagulopathy in Hospitalized and Intensive Care Patients with Sickle Cell Disease Parima Saxena, Riddhi Chauhan, Prashil Dave, Dedipya Bhamidipati, Edwin Chiu, John Muthu
12 [GO] 2023―Dec―01 Clonal Hematopoiesis Is Associated with Severe COVID-19 Enhancing Inflammatory Responses in Myeloid Cells Ryunosuke Saiki, Ryuya Edahiro, Kyuto Sonehara, Qingbo S Wang, Ho Namkoong, Takanori Hasegawa, et al. (+21)
13 [GO] 2023―Dec―01 Impact of COVID-19 Epidemics on Paediatric and Adult Patients with Haemophilia Treated in a Haemophilia Therapeutic Centre Shuxia Zhang, Xiaofan Li, Feng'e Yang
14 [GO] 2023―Dec―01 Decoding the Historical TALE: COVID-19 Impact on Hematological Malignancy Patients - Insights from 2020 to 2022 Francesco Marchesi, Jon Salmanton-García, Francesca Farina, Barbora Weinbergerova, Federico Itri, Julio Dávila-Valls, et al. (+13)
15 [GO] 2023―Dec―01 COVID-19 in Adults with Sickle Cell Disease Stephanie H. Guarino, Rick Caplan, Bayo Gbadebo, Claudine Jurkovitz
16 [GO] 2023―Dec―01 Clinical Outcome of Covid-19 in Haematologic Malignancy Patients with a Fourth Dose of Anti-Sars-Cov-2 Vaccine: A Final Epicovideha Report Meinolf Karthaus, Jon Salmanton-García, Francesco Marchesi, Andreas Glenthoej, Yavuz M Bilgin, Jens Van Praet, et al. (+3)
17 [GO] 2023―Dec―01 Impact of COVID-19 in Patients with Chronic Lymphocytic Leukemia Treated with Venetoclax: A Possible Role of the Association to Anti-CD20 Antibody? a Multicentre Seifem Study Francesco Autore, Andrea Visentin, Marina Deodato, Candida Vitale, Eugenio Galli, Alberto Fresa, et al. (+17)
18 [GO] 2023―Dec―01 Impact of COVID-19 in Thalassemia Patients Undergoing Hematopoietic Stem Cell Transplant Recipients Shao Jingxuan, Rongrong Liu, Yongrong Lai, Xinmei Wei, Ning Zhang, Cuifeng Huang, et al. (+5)
19 [GO] 2023―Dec―01 Prevalence and Impact of COVID-19 in Young Women of Reproductive Age [18-44 Years] Hospitalized with Pulmonary Embolism in the US in 2020 Using National Inpatient Sample Dataset, in-Hospital Mortality, Racial Disparity and Predictors of Mortality Ummul Z Asfeen, Kanishka Uttam Chandani, Kalaivani Babu, Maithri Vallabhaneni, Pratiksha Shankarlal Nathani, Beenish Najam, et al. (+6)
20 [GO] 2023―Dec―01 A Nationwide Analysis of the Outcomes Among Hospitalized Patients with Heparin Induced Thrombocytopenia and Concomitant COVID-19 Infection Arshi Syal, Yajur Arya, Bruce Adrian Casipit, Claudia Dourado, Ryan J Mayo, Gordon Heller
21 [GO] 2023―Dec―01 A Nationwide Analysis of Risks and Outcomes in Hospitalized Patients with Immune Thrombocytopenia and COVID-19 Infection Rushin Patel, Darshil Patel, Zalak Patel, Mrunal Patel, Akshit Chitkara, Chieh Yang
22 [GO] 2023―Dec―01 Risk and Protective Factors for COVID-19 Infection Among Pregnant Women with Sickle Cell Trait Kim Abbegail Tan Aldecoa, Camelia Arsene, Tiffany Chng, Garett Cherry, Nabila Chowdhury, Ryan Clark, et al. (+13)
23 [GO] 2023―Dec―01 Multi-Center Study of COVID-19 Infection in Elderly Patients with Lymphoma: On Behalf of Jiangsu Cooperative Lymphoma Group (JCLG) Wenyu Shi, Xiao Lu, Xiaoping Zhang, Haiying Hua, Jie Zhang, Yuqing Miao, et al. (+23)
24 [GO] 2023―Dec―01 Low Mortality from COVID-19 Infection in Patients with B-Cell Lymphoma after Bispecific CD20xCD3 Therapy Emil Ramsø Kyvsgaard, Anna Caroline Hasselbalch Riley, Michael Roost Clausen, Mads Harsløf, Line Dam Heftdal, Carsten Utoft Niemann, et al. (+3)
25 [GO] 2023―Dec―01 TLR1-10 Protein Expression in Circulating Human White Blood Cells during Bacterial and COVID-19 Infections Laurent Mauvieux
26 [GO] 2023―Dec―01 Long COVID-19 Infections and Organizing Pneumonia in a Series of Patients with Indolent Lymphoma Treated with Rituximab David Savage, Marin Xavier, James Mason, Jacqueline Chang, Steven Escobar
27 [GO] 2023―Dec―01 Pre-Graft Vaccination or Infection Do Not Provide More Protection Against COVID-19 Infections in Post-Graft Vaccinated Recipients of Allogeneic Stem Cell Transplantation Valentin Letailleur, Amandine Le Bourgeois, Thierry Guillaume, Alice Garnier, Pierre Peterlin, Maxime Jullien, et al. (+3)
28 [GO] 2023―Dec―01 Incidence and Management of COVID-19 Infections in Vaccinated Patients with CLL Chaitra S Ujjani, Ted Gooley, Tanya Siddiqi, Deborah M. Stephens, Catherine Broome, Stephen E Spurgeon, et al. (+17)
29 [GO] 2023―Dec―01 Risk Factors for Severe Infection and Unfavorable Outcomes in Hematologic Malignancy Patients with COVID-19 Inflection during the Omicron Era: A Chinese Single-Center Retrospective Study Li Ye, Ye Yang, Xuewu Zhang, Lu Wang, Li Zhu, Xia Li, et al. (+20)
30 [GO] 2023―Dec―01 Secondary Polycythemia Associated with COVID-19 Is Associated with Higher Mortality but Does Not Seem to Affect Thrombotic Risk Marko Lucijanic, Ivan Krecak, Ena Soric, Anica Sabljic, Tamara Vasilj, David Cicic, et al. (+6)
31 [GO] 2023―Dec―01 Timing of Vaccination Impacts Serological Response to COVID-19 Myeloma Patients after BCMA-Targeted CAR T Oliver Van Oekelen, Morgan Van Kesteren, Adolfo Aleman, Ariel Kogan Zajdman, Lucia Y Chen, Tarek H. Mouhieddine, et al. (+21)
32 [GO] 2023―Dec―01 Trends in Heparin-Induced Thrombocytopenia in the Pre-Pandemic and Peak-Pandemic Era, and Impact of COVID-19 on Mortality; An Analysis Via the National Inpatient Sample Salini Ajitha, Saisree Reddy Adla Jala, Renuka Verma, Suma Sri Chennapragada, Arcita Hanjani Pramudita, Mehndi Dandwani, et al. (+9)
33 [GO] 2023―Dec―01 Association of Vaccination and Current Immunotherapy with COVID-19 Outcome in Patients with Follicular Lymphoma: A Retrospective Study Mengyuan He, Xiangxiang Zhou, Yingyue Liu, Yiqing Cai, Linquan Zhan, Xin Wang
34 [GO] 2023―Dec―01 Evaluating the Effectiveness of COVID-19 Vaccines in Adults with Sickle Cell Disease during the Omicron Period of COVID-19 Pandemic Kim Abbegail Tan Aldecoa, Camelia Arsene, Tiffany Chng, Garett Cherry, Nabila Chowdhury, Ryan Clark, et al. (+14)
35 [GO] 2023―Dec―01 Ruxolitinib or Interferon-α Treatment As a Protective Strategy for Patients with Philadelphia-Negative Myeloproliferative Neoplasms (MPN) during the COVID-19 Pandemic Zicheng Gao, Zherou He, Xuan Zhou, Ziyu Wen, Hong Chen, Qiang Wang, et al. (+5)
36 [GO] 2023―Dec―01 National Mortality Outcomes of Acute Chest Syndrome Hospitalization during the COVID-19 Pandemic Ayobami Olafimihan, Ekrem Turk, Stanley Ozogbo, Maria Cristina Cuartas-Mesa, Praise Fawehinmi, Hafeez Shaka
37 [GO] 2023―Dec―01 The Outcome of the First-Line Therapy of Patients with Follicular Lymphoma during COVID-19 Pandemic. a Real-World Data from the Polish Lymphoma Research Group (PLRG) Ewa Paszkiewicz-Kozik, Monika Palka, Malgorzata Debowska, Marcin Szymanski, Agnieszka Konska, Elzbieta Kalicinska, et al. (+28)
38 [GO] 2023―Dec―01 Indolent Lymphoma Care Delivery and Outcomes during the COVID-19 Pandemic in Ontario, Canada Inna Gong, Anca Prica, Zharmaine Ante, Andrew Calzavara, Monika Krzyzanowska, Simron Singh, et al. (+3)
39 [GO] 2023―Dec―01 Telehealth Use Among Adults with Sickle Cell Disease before and during the COVID-19 Pandemic in the United States Hyeun Ah Kang, Xueye Yan, Robert C Mignacca
40 [GO] 2023―Dec―01 Impact of COVID-19 Pandemic on Overall Survival in Acute Myeloid Leukemia: A Comprehensive Cancer Center Experience of 627 Patients Juhi Gor, Ian Bouligny, Thuy Ho, Graeme Murray, Keri Maher
41 [GO] 2023―Dec―01 Omission of Anti-CD20 Antibody in Chronic Lymphocytic Leukemia during COVID-19 Pandemic: Twelve Month Course of Venetoclax Is a Safe and Effective Alternative Regimen Aarib M Shahab, Saadia Yunus
42 [GO] 2023―Dec―01 Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio for an Early Detection of Venous Thromboembolism in COVID-19 Patients Hussein Khalil Gharib, Susanna Szpunar, Ashsih Bhargava, Zyad Kafri
43 [GO] 2023―Dec―01 Impact of TTP on COVID-19 Patients Assessing Treatment Outcomes and Healthcare Expenditure Farhan Khalid, Ali Jaan, Junaid Anwar, Uzair Chatha, Muhammad A. Khalid, Doantrang Du, Faiz Anwer
44 [GO] 2023―Dec―01 Prevalence and Disparities of Cardiovascular Events and Outcomes of COVID-19 Patients Hospitalized with Multiple Myeloma: A National Inpatient Sample Analysis, 2020 Zainab Muslehuddin, Fazal Khan, Vaishnavi Arote, Mahboob Younus Shaik, Mariam Ashfaque, Shilpa Reddy, et al. (+4)
45 [GO] 2023―Dec―01 Characterizing Hematological Changes and Morphological Abnormalities in Hospitalized COVID-19 Patients of Hispanic Descent Rodrigo Paredes De La Fuente, Pamela Contreras Chavez, Ximena Jordan Bruno, Rubelio Cornejo, Billy Sanchez-Jacinto, Sharon Estrada, et al. (+4)
46 [GO] 2023―Dec―01 Mortality and Comorbidities of Covid-19 Patients with Immune Thrombocytopenic Purpura - a Review of the National Database 2019-2020 Husam El Sharu, Maria Jamil, Sukhvir Singh, Sara Cowles, Darla K. Liles, Joshua Zweigle
47 [GO] 2023―Dec―01 Predictors of Immune Thrombocytopenic Purpura in COVID-19 Positive Elderly Admitted in the Pre-Vaccination Era of the Pandemic; An Analysis Via the 2020 National Inpatient Sample Saisree Reddy Adla Jala, Sailaja Sanikommu, Suma Sri Chennapragada, Balkiranjit Kaur Dhillon, Shruti Aggarwal, Saloni Savani, et al. (+9)
48 [GO] 2023―Dec―01 COVID-19 Related Mortality Does Not Correlate with Vaccine Availability in Leukemia Patients: 2020-2023 Analysis in the United States Tony Varughese, Maciej Kabat, Eli Zolotov, Jamie Koprivnikar
49 [GO] 2023―Dec―01 Risk of Severe Sars-Cov-2 Infections in COVID-19 Vaccinated Individuals with Hematologic Malignancies (SAVE HEM): A Nationwide Cohort Study in the Netherlands Quincy Hofsink, Sabine Haggenburg, Birgit I. Lissenberg-Witte, Abraham Goorhuis, Mette D. Hazenberg, Caroline E. Rutten, et al. (+11)
50 [GO] 2023―Dec―01 Antigen-Specific T-Cell Repertoire Responses Following COVID-19 Vaccination Are Intact in Majority of Patients with B-Cell Lymphoid Malignancies on Active Therapy Shipra Goel, Elizabeth A. Griffiths, Brahm Segal, Michael Nemeth, Matthew J Cortese, Francisco J. Hernandez-Ilizaliturri, et al. (+4)
51 [GO] 2023―Dec―01 Sars-Cov-2 Antibody and T-Cell Responses in Patients with Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia after Four COVID-19 Vaccinations Alexandra Pike, Natalie Fox, Claire E McKinley, Louise M Arnold, Mark Harland, Deborah Clarke, et al. (+19)
52 [GO] 2023―Dec―01 COVID-19 Vaccine Acceptance/Hesitancy and Influence on Infection in Patients with Multiple Myeloma: A National-Wide Multicenter Survey in China Huiwen He, Ziping Li, Shuangjiao Liu, Wenming Chen, Wanling Sun, Baolai Hua, et al. (+2)
53 [GO] 2023―Dec―01 SCD and COVID-19 Vaccines: What Do Pediatric Patients Want to Know? Lisa M Shook, Amy Lang, Allison A. King, Kim Smith-Whitley, Alexis A. Thompson, Christina M Barriteau, et al. (+5)
54 [GO] 2023―Dec―01 The Use of Caplacizumab in COVID-19-Related TTP Anisha Rajavel, Jai Behgal, Praneeth Reddy Keesari, Muhammad Niazi, Yevgeniy Skaradinskiy
55 [GO] 2023―Dec―01 Incidence of Venous Thromboembolism in Pediatric Cancer Patients with COVID-19: MD Anderson Cancer Center Experience Shaikha Alqahtani, Faryal Munir, Lucas Ramsey, Olga Starostina, David McCall, Nidra Rodriguez
56 [GO] 2023―Dec―01 Estimating the Burden of Venous and Arterial Thrombotic Events in Hospitalized Adults with COVID-19; A National Multicenter Cohort Study Rushad Patell, Dana E. Angelini, Stacy R Ellsworth, Paul Lewis, James C Lee, Edith A. Nutescu, et al. (+12)
57 [GO] 2023―Dec―01 Changes in the Fibrinolytic System of Patients Infected with Severe Acute Respiratory Syndrome Coronavirus 2 Tarek M Owaidah, Esraa Abudouleh, Ahmed al Qahtani, Amal Al Hazzani, Kadiga Khorfan
58 [GO] 2023―Dec―01 Cellular Mechanisms Associated with Suboptimal Immune Responses to Sars-Cov-2 Bivalent Booster Vaccination in Patients with Multiple Myeloma Adolfo Aleman, Morgan Van Kesteren, Ariel Kogan Zajdman, Komal Srivastava, Lucia Y Chen, Bhaskar Upadhyaya, et al. (+13)
59 [GO] 2023―Dec―01 Exosomal Vesicles: A Therapeutic Strategy Against Severe Sars-Cov-2 in Multiple Myeloma Patients Yan Leyfman, Muskan Joshi, Gayathri P. Menon, Alexandra Van de Kieft, Chandler Howard Park
60 [GO] 2023―Dec―01 Loss of Platelet 12-Lipoxygenase Aggravates the Severity of Sars-Cov-2 Infection Ana Claudia Andrade, Emile Lacasse, Isabelle Dubuc, Leslie Gudimard, Florian Puhm, Celso Queiroz, et al. (+7)
61 [GO] 2023―Dec―01 Differential Host Response Contributing to Incidence of Arterial and Venous Thromboembolism at Index Hospitalization for Sars-Cov-2 Infection across Wuhan, Delta, Omicron and Omicron BA.x Variants Zeina Kayali, Gustavo Garcia, Karen Hamad, Wilhelmine Wiese-Rometsch, Ke Ning
62 [GO] 2023―Dec―01 Hemogram Derived Clinical Traits Evinced Differential Contribution to Explained Variance of Mortality Risk Model at Index Hospitalization for Sars-Cov-2 Infection across Wuhan/D614G, Delta, Omicron and Omicron BA.x Variants Gustavo Garcia, Maha Hameed, Zeina Kayali, Karen Hamad, Wilhelmine Wiese-Rometsch, Precious Idogun, Anjan J. Patel
63 [GO] 2023―Dec―01 Efficacy of Monoclonal Antibody Tixagevimab/Cilgavimab for Prevention of Sars-Cov-2 Infection Among Cancer Patients : Double Blined Randomized Placebo Controlled Trail (ProvMAB trial) Manassamon Navinpipat, Aimwipa Sasakul, Chayapa Thookhamme, Piyarat Limpawittayakul, Chumut Phanthunane, Taweegrit Siripongboonsitti, et al. (+2)
64 [GO] 2023―Dec―01 Sars-Cov-2 Infection Does Not Lead to Progression of Monoclonal Gammopathy of Undetermined Significance: Results from the Population-Based Istopmm Screening Study Robert Palmason, Sara Ekberg, Elias Eythorsson, Sæmundur Rögnvaldsson, Sigrun Thorsteinsdottir, Michael Crowther, et al. (+26)
65 [GO] 2023―Dec―01 Spatiotemporal Impact of Sars-Cov-2 Infection on the Transcriptome of Bone Marrow Megakaryocytes Isabelle Allaeys, Mickael Leclercq, Julia Tilburg, Andrew Stone, Maude Fleury, Emile Lacasse, et al. (+4)
66 [GO] 2023―Dec―01 Targeting Glutamine Dependence through GLS1 Inhibition Suppress Multiple Myeloma and Phenomenon of Sars-Cov-2 Infectious Disease Seiichi Okabe, Yuko Tanaka, Akihiko Gotoh
67 [GO] 2023―Dec―01 The Efficacy and Safety of Tixagevimab/Cilgavimab (AZD7442) Against Sars-Cov-2 Omicron BA.5 for Patients with Hematologic Malignancies Yoo Jin Lee, Jae-Cheol Jo, Youjin Kim, Hyunki Kim
68 [GO] 2023―Dec―01 Effect of Ursodeoxycholic Acid for Sars-Cov-2 Prevention in Hematological Malignancies: An Observational Real-World Study Hongye Gao, Jiali Wang, Xinhui Zheng, Yigeng Cao, Erlie Jiang
69 [GO] 2023―Dec―01 Incidence, Risk Factors and Clinical Impact of Sars-Cov-2 Prolonged Viral Shedding in Patients Diagnosed with Hematologic Malignancies Moraima Jimenez, Víctor Navarro Garces, Irene Medina, Cristina Andres, Monica Martinez-Gallo, Daniel Medina, et al. (+14)
70 [GO] 2023―Dec―01 Sars-Cov-2 Spike Protein Triggers Inflammasome-Mediated Tissue Factor Activity Nikhil Ranjan, Molly Kuzma, Xiang-Zuo Pan, Michael Cole, Robert A. Brodsky, Gloria F. Gerber
71 [GO] 2023―Dec―01 Survival Advantage Associated with Heterozygous Factor V Leiden Mutation in Sars-Cov-2-Infected K18-hACE2 Mice Roberto Aiolfi, Jose A. Fernandez, Hiroshi Deguchi, Xiao Xu, Jeanine Ahmed, Miriam Hauer-Jensen, et al. (+4)
72 [GO] 2023―Dec―01 The Role of Coagulation Gene Polymorphisms in Sars-CoV2 Infection in the Bergamo Area Marina Marchetti, Chiara Villa, Sara Gamba, Donatella Conconi, Cinzia Giaccherini, Laura Russo, et al. (+8)
73 [GO] 2023―Dec―01 Sars-CoV2 ORF7a Protein Stimulates Synthesis and Secretion of Endothelial Von Willebrand Factor Quan Zhang, Xiaohu Huang, Szumam Liu, Noritaka Yada, Zhe Han, X. Long Zheng
74 [GO] 2023―Dec―01 Effective Targeting of Evolutions in Concerns Underpinning COVID Vaccine Hesitancy in Patients with Sickle Cell Disease across the Lifespan of the COVID19 Pandemic Sarah Helen Oram, Shwe Ei, Rohan Shankarghatta, Ananth Sathyanath, Benji Hilary, Tullie Yeghen, et al. (+3)
75 [GO] 2023―Dec―01 Patterns of Outpatient IVIG Use before and during the COVID Pandemic in Patients with Multiple Myeloma Jonathan Lambird, John T Mckay, Meng-Yun Lin, Lindsey Abdelfattah, Manisha Bhutani, Barry Paul, et al. (+4)
76 [GO] 2023―Aug―03 Pagano L, Salmanton-García J, Marchesi F, et al. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey. Blood. 2022;140(26):2773-2787.
77 [GO] 2023―Aug―03 Immediate COVID-19 treatment in CLL Carsten Utoft Niemann
78 [GO] 2023―Jun―27 Blood Group A Enhances SARS-CoV-2 Infection Shang-Chuen Wu, Connie M Arthur, Hau-MIng Jan, Wilfredo F Garcia-Beltran, Kashyap R Patel, Matthew Rathgeber, et al. (+12)
79 [GO] 2023―Apr―06 B-cell prolymphocytic leukemia after COVID-19 infection Brunangelo Falini, Stefano Lazzi
80 [GO] 2023―Jan―12 COVID-19 prophylaxis: half-full or half-empty glass? Lydia Scarfò, Antonio Cuneo
81 [GO] 2022―Dec―29 COVID-19 and blood cancer in the vaccination era Lisa K. Hicks, Abi Vijenthira
82 [GO] 2022―Dec―22 SARS-CoV-2 vaccination in CLL: how often is enough? Sibylle C. Mellinghoff, Oliver A. Cornely
83 [GO] 2022―Dec―09 The Histone Methyltransferase MLL1/KMT2A in Monocytes Drives Coronavirus-Associated Coagulopathy and Inflammation Sriganesh B Sharma, William James Melvin, Christopher O Audu, Monica Bame, Nicole M Rhoads, Weisheng Wu, et al. (+9)
84 [GO] 2022―Nov―29 Acquired Hemophilia Following COVID-19 and Influenza Vaccination: A Systematic Review Kanak Parmar, Shivam Singh, Lukman Tijani, David A. Garcia
85 [GO] 2022―Nov―29 Inflammatory and Coagulation Biomarkers in Patients with Sars-COV2 Infection Receiving COVID-19 Convalescent Plasma: The Bergamo Registry Marina Marchetti, Angela Maria Palladino, Carmen J Tartari, Laura Russo, Cinzia Giaccherini, Sara Gamba, et al. (+7)
86 [GO] 2022―Nov―29 The Complement System Mediates COVID-19 Endothelial Cell Injury, Modifying Cell Permeability Arlette Bohorquez, NIyousha Rostam, Carolina Ortiz-Sandoval, Claire Howard, Walter H.A. Kahr, Christopher J. Campbell, Christoph Licht
87 [GO] 2022―Nov―29 Sex Hormone Levels, Biomarkers of Hypercoagulability and Endothelial Cell Activation Are Determinants of Severity of COVID-19 in Women and Men. the Roadmap-COVID-19 Prospective Study Patrick Van Dreden, Salahdin Khelifi Otmane, Grigorios T. Gerotziafas, Matthieu Grusse, Aurélie Rousseau, Lila Louadj, Michele Sabbah
88 [GO] 2022―Nov―29 Response to COVID-19 Infection and Vaccination in the CLL Population: A Large Single-Center Experience Alexander Coltoff, Andrew H. Lipsky, Todd L. Rosenblat, Jennifer E. Amengual, Mark L Heaney, Joseph G. Jurcic, Nicole Lamanna
89 [GO] 2022―Nov―29 Risk Factors and Outcome of COVID-19 Infection in Haematological Patients : A Multicenter Retrospective Analysis in Malaysia Sui Keat, Ai Sim Goh, Carol Chew Yuen Goh, Hong Siew Tan, Tee Chuan Ong, Sen Mui Tan, et al. (+12)
90 [GO] 2022―Nov―29 Discordant Cellular and Humoral Responses to a 3-Dose COVID-19 mRNA Vaccination Schedule in Patients with Hematologic Malignancies Cilia R. Pothast, Quincy Hofsink, Sabine Haggenburg, Bhoekhan S. Michel, Nienke J.E. Haverkate, Romy C. Dijkland, et al. (+26)
91 [GO] 2022―Nov―29 Handling of Allogeneic HPC Grafts in European Transplant Centers during the COVID-19 Pandemic - a Survey from the Infectious Diseases and Cellular Therapy & Immunobiology Working Parties of the EBMT Nina Worel, Per T Ljungman, Isabel Sánchez-Ortega, Jorinde D Hoogenboom, Nina S Knelange, Inge CM Verheggen, et al. (+6)
92 [GO] 2022―Nov―29 Patients Experience with Telemedicine during COVID-19 Pandemic in a Tertiary Cancer Center in Qatar Israa Elhakeem, Phool Iqbal, Abdulqadir Jeprel Nashwan, Muhammad Abubakar, Arslan Tahir Jawad, Mousa A AlHiyari, et al. (+5)
93 [GO] 2022―Nov―29 Assessing Immune Response to 3rd Dose of COVID-19 Vaccine Series in Patients Undergoing Cancer Treatment at University Medical Center- New Orleans Anh Q. Nguyen, Amber J Trauth, Aneesha Ananthula, Katharine Thomas, Shyam Mani, Monique Germain, et al. (+3)
94 [GO] 2022―Nov―29 Analysis of Immunological and Clinical Response to Vaccination Against Sars-COV-2 in Patients with Chronic Myeloid Leukemia Alejandro ZURDO Castronuño, Miriam Solera Sainero, Magdalena Corona, Monserrat Torres, Guiomar Casado-Fernandez, Fernando Ramos-García, et al. (+10)
95 [GO] 2022―Nov―29 Risk of Immune Thrombocytopenia Relapse and Onset Related to Sars-Cov-2 Infection and Vaccination Giuseppe Auteri, Camilla Mazzoni, Mattia Biondo, Simona Paglia, Marta Venturi, Andrea Davide Romagnoli, et al. (+4)
96 [GO] 2022―Nov―29 Risk of Thrombosis in Myeloproliferative Neoplasms after Sars-Cov-2 Vaccination Oscar Borsani, Virginia Valeria Ferretti, Ilaria Carola Casetti, Daniele Vanni, Chiara Trotti, Martina Boldini, et al. (+4)
97 [GO] 2022―Nov―29 Markedly Reduced FVIII Recovery Associated with Anti-FVIII Peg Antibodies after BNT162b2 Sars-Cov-2 Vaccination Carla Valsecchi, Roberta Gualtierotti, Sara Arcudi, Alessandro Ciavarella, Lucia Schiavone, Cristina Novembrino, et al. (+3)
98 [GO] 2022―Nov―29 Booster and Btki Interruption Improve Response to Sars-Cov-2 Vaccine in Patients with CLL Emily Bryer, Shira Paul, Jonathan Chen, Christopher Pleyer, Adrian Wiestner, Clare Sun
99 [GO] 2022―Nov―29 Efficacy of Preexposure Prophylaxis with Monoclonal-Antibody AZD7442 (tixagevimab-cilgavimab) Against Sars-Cov-2 Variants in Patients with CLL Ohad Benjamini, Tamar Tadmor, Abraham Avigdor, Rotem Gershon, Limor Klike, Nofar Atari, et al. (+3)
100 [GO] 2022―Nov―28 Thrombomodulin Resistance May be Involved in the Prothrombotic State of COVID-19 Adrián Montaño, Ana Marco, Francisco José López-Jaime, Ihosvany Fernandez-Bello, Faustino García-Candel, Miguel Blanquer Blanquer, et al. (+2)
101 [GO] 2022―Nov―28 Elevated Plasma Levels of Von Willebrand Factor and Syndecan-1 Predict 60-Day Mortality in Patients with Severe and Critical COVID-19 Quan Zhang, Zhan Ye, Antonia Bignotti, X. Long Zheng
102 [GO] 2022―Nov―28 Sars-Cov-2 Fails to Infect Mesenchymal Stromal Cells (MSCs) - Pre-Clinical Investigations in Support of Therapeutic Use of MSCs for Severe COVID-19 Lisa-Marie Pfeffermann, Denisa Bojkova, Joshua Kandler, Sabine Huenecke, Melanie Bremm, Natascha Piede, et al. (+5)
103 [GO] 2022―Nov―28 The Duration of Coronavirus Disease 2019 (COVID-19) Clearance in Patients with Hematological Malignancies Can be Stratified By the Number of Chemotherapy Treatment and Severity of COVID-19 Masashi Nishikubo, Yoshimitsu Shimomura, Yuya Nagai, Tadakazu Kondo, Takayuki Ishikawa
104 [GO] 2022―Nov―28 Anticoagulation and Antiplatelet Strategies in Non-Critically Ill Patients with Covid-19 Zoe McQuilten, Balasubramanian Venkatesh, Vivekanand Jha, Jason Roberts, Susan Morpeth, James Totterdell, et al. (+94)
105 [GO] 2022―Nov―28 Characterisation of Platelet Sensitivity in Severe COVID-19 Rocel C. Saputil, Joanne L. Dunster, Neline Kriek, Yunchuan Ding, Michelle M.H. Tan, Emma Thorley, et al. (+7)
106 [GO] 2022―Nov―28 Phase I Clinical Trial to Evaluate the Safety of Baricitinib to Prevent Respiratory Insufficiency Progression in Oncohematological Patients Affected with COVID-19 - BARCOVID19 Study Gabriela Sanz-Linares, Alberto Mussetti, Adaia Albasanz-Puig, Iñaki Salvador-Corre, Anna Sureda, Carlota Gudiol, et al. (+12)
107 [GO] 2022―Nov―28 No Difference in Venous Thromboembolism Outcomes after COVID-19 and Influenza Vaccinations Damon E. Houghton, David M Scott, Waldemar E. Wysokinski, Rajiv K. Pruthi, Meera Sridharan, Leslie Padrnos, et al. (+6)
108 [GO] 2022―Nov―28 Hemostatic Biomarkers Predict Risk of Thromboembolism (TE), Severe COVID-19 and Mortality: A Report from the National Cancer Institute COVID-19 in Cancer Patients Study (NCCAPS) Alok A Khorana, Ana Best, Andrea Denicoff, Melissa Bowman, Marwa Shekfeh, Larry V. Rubinstein, et al. (+4)
109 [GO] 2022―Nov―28 Quantification of Neutrophil Extracellular Traps (NETs) in Pediatric Patients with COVID-19 and Multisystem Inflammatory Syndrome (MIS-C) through Plasma and Peripheral Smear Analysis Rachelle Thompson, Megan Zoltowski, Derick Lim, Caroline Diorio, Elizabeth Margolskee, Michele Paessler, et al. (+6)
110 [GO] 2022―Nov―28 COVID-19 Immune Response in Hematologic Malignancies: Analysis of COVID-19 Anti-Spike Antibodies in Previously Infected and Uninfected Patients Alex Niu, Victor H Ramirez, Bronwyn Gunn, Melyssa Bratton, Sarah Foster, James Robinson, et al. (+10)
111 [GO] 2022―Nov―28 COVID-19 Associated 60-Day Acute VTE Events in Hospitalized Patients Can be Predicted By D-Dimer and Prior VTE but Not By Reticulated Platelets Bilal Ashraf, Haekyung Jeon-slaughter, Nicholas C.J. Lee, Taha Bat, Sung-Hee Choi, Weina Chen, et al. (+2)
112 [GO] 2022―Nov―28 COVID-19 Associated Atypical Hemolytic Uremic Syndrome Muhammad Shan Ul Abedin, Emma Galarza, Samavia Munir
113 [GO] 2022―Nov―28 Increased COVID-19 Breakthrough Infection Risk after Sars-Cov-2 Vaccine Boosting in Patients with Plasma Cell Disorders: A Large Nationwide Veterans Affairs Study Nathanael R Fillmore, Jennifer La, Julie Tsu-Yu Wu, Westyn Branch-Elliman, Paul Monach, Mary Brophy, et al. (+2)
114 [GO] 2022―Nov―28 Outcomes of Thromboembolism in COVID-19 Cancer Patients Vs Non-Cancer Patients Can Jones, Kristina Menchaca, Catherine Ostos, Jeffery Durbin, Kai Chen, Shachar Peles
115 [GO] 2022―Nov―28 Contribution of Neutrophil Extracellular Traps (NETs) and Platelet Activation to COVID-19 Clinical Course and Inhibitory Effect of Anticoagulants and Platelets on NETs Release José Diogo Oliveira, Letícia Queiroz da Silva, Camila de Oliveira Vaz, Bruna Cardoso Jacintho, Ana Paula Rosa dos Santos, Gabriela Lisiane Tripiquia Vechiatto Mesquita, et al. (+5)
116 [GO] 2022―Nov―28 Duvelisib for Critically-Ill Patients with COVID-19 Disease: An Investigator-Initiated, Randomized, Placebo-Controlled Double-Blind Pilot Trial Scott R. Goldsmith, Fahrettin Covut, Mark A. Fiala, Elizabeth Bradtke, Ayan Gasanli, Brandon Christen, et al. (+8)
117 [GO] 2022―Nov―28 Impact of the COVID-19 Epidemic on Patients with Myeloproliferative Neoplasia: The French Prospective Observational Study Covim Laurence Legros, Françoise Boyer perrard, Dana Ranta, Lydia Roy, Mario Ojeda-Uribe, Stephane Giraudier, et al. (+21)
118 [GO] 2022―Nov―28 Shifts in Multiple Myeloma Care Utilization of Veterans in the COVID-19 Era: Interrupted Time Series Analysis of Veterans Health Administration Data Christopher T Su, Jason Chen, Jeremy Sussman
119 [GO] 2022―Nov―28 The Use of Convalescent Plasma Therapy on COVID-19 Filipino Patients: A Tertiary Center Experience Manuel Reyes Velasco, Jesus Alvarez Relos, Rosalio P. Torres, Maria Regina Valencia Pelobello-De Leon, Teresita Dumagay, Jimmy Reyes Lafavilla, et al. (+3)
120 [GO] 2022―Nov―28 Ongoing Risk of Unrelated Donors Testing Positive for COVID-19 Following Medical Clearance and Impact on Operations: A Report from the National Marrow Donor Program Heather E Stefanski, Jennifer Novakovich, Jennifer Newman, Christian Snyder, Meghann Cody, Jason Oakes, et al. (+4)
121 [GO] 2022―Nov―28 COVID-19 in Adults with Sickle Cell Disease: Data from Cerner Real-World Database Stephanie H Guarino, Bayo Gbadebo, Richard Caplan, Kevin Ndura, Claudine Jurkovitz
122 [GO] 2022―Nov―28 The Outcomes of Covid-19 in Patients with CLL during the Omicron Sub-Variants Surge Yotam Bronstein, Shai Levi, Yair Herishanu
123 [GO] 2022―Nov―28 Mortality of COVID-19 in Patients with Hematological Malignancies Versus Solid Tumors: A Systematic Literature Review and Meta-Analysis Charan Thej Reddy Vegivinti, Tejo Niharika Musunuru, Sahas Reddy Jitta, Mansi Mehta, Jeevan Shivkumar, Rahul Kumar Thakur, et al. (+9)
124 [GO] 2022―Nov―28 Do Monoclonal Antibody Therapies Improve 'Real-World' Outcomes of COVID-19 in Patients with Lymphoid Malignancies? the UT Southwestern Experience Aishwarya Sannareddy, Heather Reves, Kefyalew Jaleta, Ramyakumari .Ramiahsankarasubramanian, Hetalkumari Patel, Madhusudhanan Narasimhan, et al. (+11)
125 [GO] 2022―Nov―28 Predictors of Hospitalizations and Death from COVID-19 in Patients with Multiple Myeloma Chakra P Chaulagain, Maroun Bou Zerdan, Jack Khouri, Beth M. Faiman, Faiz Anwer, Chieh-Lin Fu, Jason Valent
126 [GO] 2022―Nov―28 Detailed Analysis of the Impact of Clonal Hematopoiesis on the Risk of Severe COVID-19 Infection Ryunosuke Saiki, Ho Namkoong, Ryuya Edahiro, Kyuto Sonehara, Qingbo S Wang, Takanori Hasegawa, et al. (+20)
127 [GO] 2022―Nov―28 Intracerebral Hemorrhage in Patients with COVID-19 Infection Naomi Mayman, Laura Stein, Mandip Dhamoon, John Liang, Alexandra Reynolds, Katherine A. Hawkins
128 [GO] 2022―Nov―28 Accuracy and Prediction of D-Dimers for Pulmonary Embolism in Patients with COVID-19 Infection Damon E. Houghton, Ewa Wysokinska, Ana I. Casanegra, Leslie Padrnos, Surbhi Shah, Waldemar E. Wysokinski, et al. (+3)
129 [GO] 2022―Nov―28 Hemophagocytic Lymphohystiocytosis in a Patient with Post-Acute COVID-19 Infection Mohamed Zakee Mohamed Jiffry, Mohammad Aimal Ahmed-khan, Jonathan Alejandro Vargas, Teena Thomas, Susanna Josey
130 [GO] 2022―Nov―28 Meta-Analysis on Impact of Rituximab in Patients with Hematological Malignancies with Covid-19 Infection Charan Thej Reddy Vegivinti, Tejo Niharika Musunuru, Rahul Kumar Thakur, Venkata Kiranmayi Kakumani, Ansh Krishnachandra Mehta, Eleftheria Atalla, et al. (+5)
131 [GO] 2022―Nov―28 Patients with Monoclonal Gammopathy Have a High Rate of Second Symptomatic COVID-19 Infection Even after a Prior COVID-19 Infection and Vaccination Saurabh Zanwar, Matthew Ho, Francis K. Buadi, Sikander Ailawadhi, Jeremy T. Larsen, P. Leif Bergsagel, et al. (+24)
132 [GO] 2022―Nov―28 COVID-19 Infection in Children with Down Syndrome and Hematologic Malignancies Blake Foxworthy, Elizabeth C Davis, Ana C. Xavier, Julienne Brackett, David Dickens, Alissa R. Kahn, et al. (+9)
133 [GO] 2022―Nov―28 Real World Outcomes of Therapeutic Anticoagulation Use in Moderate COVID-19 Infection in Hospitalised Patients Katherine J. Creeper, Katie White, Karen Breen, Beverley J. Hunt
134 [GO] 2022―Nov―28 Oral Antiviral Therapy and Monoclonal Antibody for the Treatment of COVID-19 Infection in Outpatients Receiving Anti-Cancer Treatment for Hematological Malignancies: A Multicenter Prospective Study Exploring Efficacy, Safety and Predictors of COVID-19 Lung Failure Carla Minoia, Davide Bavaro, Giacomo Loseto, Crescenza Pasciolla, Lucia Diella, Carmen Pelligrino, et al. (+10)
135 [GO] 2022―Nov―28 An Ex Vivo Monocyte Stimulation Test Predicts Severity of COVID-19 Infection in Patients with Chronic Lymphocytic Leukemia (CLL) Gordon Ruan, Xiaosheng Wu, Kimberly Gwin, Michelle K. Manske, Jithma P. Abeykoon, Taylor L. Witter, et al. (+6)
136 [GO] 2022―Nov―28 Prediction of Mortality Following Cytokine Storm in Patients with Hematological Malignancies and COVID-19 Infections Rishab Prakash, James Long, Paul Edelkamp, Mark Knafl, Sairah Ahmed, Fareed Khawaja, et al. (+7)
137 [GO] 2022―Nov―28 Incidence and Severity of COVID-19 Infections in a Cohort of 211 Allotransplanted Patients after One or Two Boosters during the Omicron Wave in France Valentin Letailleur, Amandine Le Bourgeois, Thierry Guillaume, Pierre Peterlin, Alice Garnier, Maxime Jullien, et al. (+3)
138 [GO] 2022―Nov―28 Outcomes of Breakthrough COVID-19 Infections in Patients with Hematologic Malignancies Kelly S. Chien, Christine B. Peterson, Elliana Young, Dai Chihara, Elisabet E. Manasanch, Jeremy L. Ramdial, Philip A. Thompson
139 [GO] 2022―Nov―28 Breakthrough COVID-19 Infections in Patients with Hematologic Malignancies during the Omicron (B.1.1.529) Surge: Data from the Patient-Reported Leukemia & Lymphoma Society National Registry Sneha T Reddy, Larry A Saltzman, Louis J DeGennaro, Gwen L Nichols, Janaela Scott, Jonathon W Senefeld, et al. (+2)
140 [GO] 2022―Nov―28 COVID-19 Is Associated with an Increased Risk of Venous Thromboembolism, but Not Arterial Ischemic Stroke in Hospitalized Children: A Multicenter Observational Study Riten Kumar, Nan Chen, Laura Lehman, Wendy B. London
141 [GO] 2022―Nov―28 Netosis and the Formation of Neutrophil Extracellular Traps (NETs) in Patients with Severe and Critical COVID-19 May Contribute to Disease Progression and Thrombosis Noritaka Yada, Quan Zhang, Antonia Bignotti, Liang Zheng, Zhan Ye, X. Long Zheng
142 [GO] 2022―Nov―28 Risk Factors Associated with in-Hospital COVID-19 Mortality in a Public Hospital in Brazil Ana Carla Franklin Braga, Juliana Borges Coelho, Angélica Maria Rodrigues França, Alessa Cléa Rebouças Holanda, Filipe Bittencourt Paz de Sousa, Sâmya Di Paula Alves Ferreira Sampaio, et al. (+3)
143 [GO] 2022―Nov―28 Antibody Response to COVID-19 mRNA Vaccine in Patients with Multiple Myeloma and Waldenstrom's Macroglobulinemia after Primary Immunization and Booster: Reactivity to the Sars-Cov-2 WT Virus, Delta and Omicron Variants Evangelos Terpos, Margherita Rosati, Jenifer Bear, Robert Burns, Ioannis Ntanasis-Stathopoulos, Santhi Devasundaram, et al. (+5)
144 [GO] 2022―Nov―28 Impact of COVID-19 on Treatment Patterns and Management of Multiple Myeloma: Insights from the Connect® MM Registry Joshua Richter, Sikander Ailawadhi, Hans C. Lee, James W. Hardin, Howard R. Terebelo, Rafat Abonour, et al. (+12)
145 [GO] 2022―Nov―28 COVID-19 Outcomes at a Comprehensive Sickle Cell Center: A Two-Year Report Fuad El Rassi, Ross M. Fasano, Morgan L. McLemore
146 [GO] 2022―Nov―28 Clinical Impact of Sars-Cov-2 Vaccination in COVID-19 Outcomes in Patients Diagnosed with Hematologic Malignancies: Real-World Evidence of Two Years of Pandemic Moraima Jiménez, Sandra Novoa Jáuregui, Candela Fernández-Naval, Marc Bosch Schips, Sofía Muzio, Víctor Navarro Garcés, et al. (+19)
147 [GO] 2022―Nov―28 Domiciliary Nursing Management for Patients Affected By Multiple Myeloma during Covid-19 Pandemia in the Viterbo Home Care Unit: Data Analysis from March 2020 to March 2022 Elisa Emanueli Cippitelli, Vincenza Innocenti, Gioia De Angelis, Silvia Bertelli, Roberta Talucci, Roberta Perazzini, et al. (+16)
148 [GO] 2022―Nov―28 Racial Disparities in Newly Diagnosed Hematological Malignancies in the United States during the COVID-19 Pandemic, January 2020 to March 2021 Sudip Bhandari, Jitesh Chawla, Prerna Jain, Alpana Kaushiva, Charles Lagor, Lincy S. Lal, et al. (+2)
149 [GO] 2022―Nov―28 Impacts of the COVID-19 Pandemic on Assessment of M-Protein and Free Light Chain Levels in Patients with Multiple Myeloma James Roose, Yichen Lu, Amy E Pierre, Ahmed Sawas, Gregory S Calip
150 [GO] 2022―Nov―28 Impact of Coronavirus (COVID-19) Pandemic on Maintenance Therapy for Follicular Lymphoma (FL) and Mantle Cell Lymphoma (MCL) Angel Serna, Angela Sanchez, Laia Lopez, Juan-Manuel Sancho, Eva Gonzalez Barca, Alberto Lopez-Garcia, et al. (+13)
151 [GO] 2022―Nov―28 Impact of the COVID-19 Pandemic on the Incidence Registry of Hematological Neoplasms in the Region of Madrid (Spain). Preliminary Report of 2014-2021 Adrian Alegre, Luis Juarez-Salcedo, Víctor Jiménez-Yuste, Julio Garcia-Suarez, José Luis Díez-Martín, Joaquín Martínez-López, et al. (+17)
152 [GO] 2022―Nov―28 Impact of the COVID-19 Pandemic on the Prevalence of Nosocomial Infections in Patients Hospitalized in the Clinical Department of Hematology in Cracow, Poland Maria Rozploch, Agnieszka Giza, Magdalena Kaminska, Wiktor Nowak, Tomasz Sacha
153 [GO] 2022―Nov―28 Substantial Alteration of Allogeneic Stem Cell Grafts Imposed By COVID-19 Pandemic Related Recommendations Igor Novitzky-Basso, Megan Nelles, Mats Remberger, Mileidys Alvarez, Amina Mohamed, Emily Fu, et al. (+25)
154 [GO] 2022―Nov―28 Impact of COVID-19 Pandemic Waves on Outcomes of Patients with Previously Untreated Advanced Follicular Lymphoma Enrolled in the Urban Ambispective Study in Italy Antonio Pinto, Emanuele Guardalben, Marica Battista, Giulia Chiara Gazzoli, Michele Merli, Annalisa Chiarenza, et al. (+14)
155 [GO] 2022―Nov―28 Increased Incidence Rate of Post-Transplant Lymphoproliferative Disorders (PTLD) Following the COVID-19 Pandemic: A Single Center Experience Bassil Said, Tahmeena Ahmed, Christina Y. Lee
156 [GO] 2022―Nov―28 Lessons Learned from COVID-19 Pandemic: Outcomes after Sars-Cov-2 Infection in Hematopoietic Cell Transplant and Cell Therapy Recipients Muhammad Umair Mushtaq, Joe S Al-Ramahi, Kevin S Li, Moazzam Shahzad, Sibgha Gull Chaudhary, Ramesh Balusu, et al. (+7)
157 [GO] 2022―Nov―28 Frequency of Thrombosis in Covid-19 Patients Compared to Non-Covid-19 Sepsis Patients Admitted to the Intensive Care Unit Sherri Huang, Ashley Perry, Carlos Sanchez Parra, Adriana Gonzalez Torriente, Haider Ghumman, Shaun Charkowick, et al. (+5)
158 [GO] 2022―Nov―28 Differential Fibrinolysis Profile in COVID-19 Patients Dependent on Immunosuppressive Treatment Regimen: A Nested Case-Control Study Magdolna Nagy, Joep Schellens, Anne-Marije Hulshof, Frank van Rosmalen, Rene van Oerle, Thijs T.W. van Herpt, et al. (+7)
159 [GO] 2022―Nov―28 Hematologic Outcomes of COVID-19 Patients with and without G6PD Deficiency: A Comparative Study Mohamed A Yassin, Kamran Mushtaq, Abdulqadir Jeprel Nashwan, Fateen Ata, Fatima M Iqbal, Ahmed A Karawia, et al. (+10)
160 [GO] 2022―Nov―28 PI3Kδ/γ Inhibitor Duvelisib Modulates Inflammatory Profile in Severe COVID-19 Patients: Results from a Randomized Placebo-Controlled Phase 2 Study Hanwen Zhang, Shuhua Wang, Manali Rupji, Chenxi Wu, Sanjay Chandrasekaran, Christopher R. Funk, et al. (+18)
161 [GO] 2022―Nov―28 Use of Hormonal Therapy Increases the Risk of Venous Thrombosis in COVID-19 Patients; Results of 1071 Patient Cohort Corinne Marie Lavasseur, Rick Mathews, Hannah Stowe McMurry, Shira Peress, Jean M.G. Sabile, Ileisa Oleson, et al. (+3)
162 [GO] 2022―Nov―28 Molecular Systems Network Predicts Sars-Cov-2 NSP3 and Orf6 Role in COVID-19 Related Thrombotic Events Mushtaq Hussain, Fakiha Siddiqui, Syed Muhammad Omer, Anusha Amanullah, Nusrat Jabeen, Bulent Kantarcioglu, Jawed Fareed
163 [GO] 2022―Nov―28 Prediction of Outcome in Hospitalized Patients with COVID-19: Development of a COVID-19 Scoring Prognostic Model Ganesh Raman, Bilal Ashraf, Yusuf Demir, Corey Kershaw, Sreekanth Cheruku, Murat Atis, et al. (+6)
164 [GO] 2022―Nov―28 Gamma' Fibrinogen Levels As a Biomarker of COVID-19 Severity Lucy Z Kornblith, Bindhya Sadhanandhan, Sreepriya Arun, Rebecca Long, Alicia J Johnson, Jamie Noll, et al. (+3)
165 [GO] 2022―Nov―28 COVID-19 Severity and Survival over Time in Vaccinated Patients with Hematologic Malignancies Joaquin Martinez Lopez, Javier De La Cruz, Rodrigo Gil-Manso, Celina Benavente Cuesta, Lauren Benito, jose Angel Hernandez, et al. (+13)
166 [GO] 2022―Nov―28 Persisting Endothelial Cell Activation and Hypercoagulability after Recovering from COVID-19: The Roadmap-Post COVID-19 Study Patrick Van Dreden, Evangelos Terpos, Marianna Politou, Meletios A. Dimopoulos, Matthieu Grusse, Grigorios T. Gerotziafas
167 [GO] 2022―Nov―28 Sickle Cell Disease Patients Mount Adequate Humoral but Reduced Cellular Responses to COVID-19 Vaccination Cilia R. Pothast, Quincy Hofsink, Sabine Haggenburg, Michel Bhoekhan, Nienke J.E. Haverkate, Romy C. Dijkland, et al. (+26)
168 [GO] 2022―Nov―28 A Case Series of Immune Flare and Lupus Anticoagulant Following COVID-19 Vaccination Medha Reddy Cherabuddi, Zaid Al-Saheli, Vijaya Donthireddy
169 [GO] 2022―Nov―28 Self-Reported Experiences of Adult Hematopoietic Cell Transplantation Survivors with COVID-19 Vaccination and Infection Emily C. Liang, Lynn E. Onstad, Paul A. Carpenter, Steven A. Pergam, Stephanie J. Lee, Catherine Liu
170 [GO] 2022―Nov―28 COVID-19 Vaccination Associated Severe Immune Thrombocytopenic Purpura Said Sharawi, Vivek Yadala, Jennifer Dotson
171 [GO] 2022―Nov―28 COVID-19 Vaccination in Children and Young Adults with Pre-Existing Immune Thrombocytopenia (ITP): Preliminary Data from the Platelet Disorder Support Association (PDSA) Patient Registry Jennifer MacWhirter - DiRaimo, Caroline Kruse, Alexandra Kruse, James B. Bussel
172 [GO] 2022―Nov―28 Immune Response to Covid-19 Vaccination in Patients with Chronic Lymphocytic Leukaemia (CLL): An Experience from Two Italian Centres Idanna Innocenti, Roberta Murru, Giulia Benintende, Andrea Galitzia, Antonio Mosca, Luca Barabino, et al. (+7)
173 [GO] 2022―Nov―28 Humoral Response to the Third-Dose COVID-19 Vaccination in Patients with Hematological Malignancy Daisuke Ikeda, Toshiki Terao, Ami Fukumoto, Ayumi Kuzume, Yuya Kamura, Rikako Tabata, et al. (+7)
174 [GO] 2022―Nov―28 Evaluation of Antibody and T Cell Responses to COVID-19 Vaccination in Patients with Lymphoid Malignancies Receiving B Cell-Depleting Agents Shipra Goel, Brahm Segal, Elizabeth A. Griffiths, Francisco Hernandez-Ilizaliturri, Pallawi Torka, Matthew J Cortese, et al. (+3)
175 [GO] 2022―Nov―28 Clinical Effectiveness and Long-Term Serologic Responses of COVID-19 Vaccination in Patients with Multiple Myeloma and Waldenström Macroglobulinemia Andrew R. Branagan, Matthew M Lei, Clifton C Mo, Andrew J. Yee, Elizabeth K. O'Donnell, Jorge J. Castillo, et al. (+20)
176 [GO] 2022―Nov―28 Variable Immune Response Following BNT162b2 mRNA COVID-19 Vaccination in Pediatric Patients with Hematological Malignancies Under Treatment Juliëtte Schmidt, Peter M. Hoogerbrugge, Caroline Lindemans, Stefan Nierkens, Robert S. Van Binnendijk, Louis J Bont, Wim J.E. Tissing
177 [GO] 2022―Nov―28 COVID-19 Vaccination Outcomes in Children, Adolescents, and Young Adults with Acute Lymphoblastic Leukemia Rebecca S Parker, Justin Le, Miguel Villa, Maurice R.G. O'Gorman, Jennifer Dien-Bard, Seon-Jae Yoon, et al. (+5)
178 [GO] 2022―Nov―28 Increasing COVID-19 Vaccination Rates Amongst Children with Sickle Cell Disease: A Quality Improvement Project Adam P Yan, Natasha M. Archer, Dianne Arnold, Eileen Hansbury, Matthew M. Heeney, Dave Johnson, et al. (+4)
179 [GO] 2022―Nov―28 COVID-19 Vaccination Status and Disease Burden in Patients with Sickle Cell Disease Jin Han, Xu Zhang, Robert E. Molokie, Franklin Njoku, Faiz Ahmed Hussain, Marwah Farooqui, et al. (+3)
180 [GO] 2022―Nov―28 Evaluation of Anti-PF4 Positivity and Platelet Activation after COVID-19 Vaccination with Ad26.COV2.S in Brazil Joanna Bokel, Daniela P. Mendes-de-Almeida, Remy Martins-Gonçalves, Eduarda Grinsztejn, Brenda Hoagland, Sandra Wagner, et al. (+9)
181 [GO] 2022―Nov―28 Differences in Humoral and Cellular Response to COVID-19 Vaccine Against Different Variants over Time in Chronic Lymphocytic Leukemia Matteo Passerini, Tamar Ratishvili, Neil E. Kay, Zelalem Temesgen, Thomas E. Witzig, Richard Kennedy, Sameer A. Parikh
182 [GO] 2022―Nov―28 Immunogenicity of Covid-19 Vaccine Among Multiple Myeloma Patients Post Autologous Stem Cell Transplant Nishanth Thalambedu, Yetunde Ogunsesan, Jaskirat Sethi, Munawwar Hussain, Lakshmi Yarlagadda, Sravani Gundarlapalli, et al. (+10)
183 [GO] 2022―Nov―28 Sars-Cov-2 T-Cell Responses after One or Two COVID-19 Vaccine Boosters in Allogeneic Transplant Recipients Beatrice Clemenceau, Amandine Le Bourgeois, Thierry Guillaume, Marianne Coste-Burel, Pierre Peterlin, Alice Garnier, et al. (+4)
184 [GO] 2022―Nov―28 Booster Effect of a Third mRNA-Based COVID-19 Vaccine Dose in Patients with Myeloid Malignancies Akio Mori, Masahiro Onozawa, Mirei Kobayashi, Shihori Tsukamoto, Hajime Senjo, Takashi Ishio, et al. (+7)
185 [GO] 2022―Nov―28 Booster Dose of mRNA-Based COVID-19 Vaccine Induces a Humoral and Cellular Response in Patients Recently Treated with Anti-CD20 Monoclonal Antibodies Masashi Nishikubo, Yoshimitsu Shimomura, Ryusuke Yamamoto, Hayato Maruoka, Seiko Nasu, Tomomi Nishioka, et al. (+13)
186 [GO] 2022―Nov―28 Immune Thrombocytopenia Purpura Relapse in Patients Who Received mRNA COVID-19 Vaccines Hana Qasim, Alaa Rahhal, Awni Alshurafa, Abdelkarim Alammora, Khaled Alsa'ed, Ahmed Alsayed, et al. (+4)
187 [GO] 2022―Nov―28 A Prospective Study Evaluating the Serological Profile of the Novel Coronavirus (COVID-19) Vaccines in Cancer Patients Aditi Singh, Hemang Patel, Ahmed Abdalla, Talal Bazzi, Mohamed Issa, Hussein Gharib, et al. (+9)
188 [GO] 2022―Nov―28 Concomitant Use of Sutimlimab and COVID-19 Vaccines in Patients with Cold Agglutinin Disease from the Phase 3 Cardinal and Cadenza Studies Bruno Fattizzo, Alexander Roeth, Catherine M. Broome, Umer Khan, Frank Shafer, Matias Cordoba, Wilma Barcellini
189 [GO] 2022―Nov―28 Analysis of COVID-19-Associated Proteins Identifies TANK-Binding Kinase 1 As an Immunotherapeutic Target in Multiple Myeloma Arghya Ray, Ting DU, Krishan Chauhan, Dharminder Chauhan, Kenneth C. Anderson
190 [GO] 2022―Nov―28 The Development of an Ontology Platform to Detect Serine Protease Involvement in COVID-19-Induced Co-Morbid BALT Lymphoma Yan Leyfman, Samarth Sandeep, Kirk McGregor, Chandler Howard Park
191 [GO] 2022―Nov―28 Thrombotic and Bleeding Complications in Patients with Chronic Lymphocytic Leukemia and Severe COVID-19: A Study of Eric, the European Research Initiative on CLL Darko Antic, Natasa Milic, Thomas Chatzikonstantinou, Lydia Scarfò, Vladimir Otasevic, Nina Rajovic, et al. (+95)
192 [GO] 2022―Nov―28 A Risk Model for CML Patients with COVID-19: Importance of Molecular Response in the Context of Age, Comorbidities and Country Income Jerald P. Radich, Chung Hoow Kok, Ekaterina Yu. Chelysheva, Jorge E. Cortes, Qian Jiang, Michael Mauro, et al. (+9)
193 [GO] 2022―Nov―28 Real World Favourable Experience of Haematopoietic Stem Cell Transplantation during Acute Coronavirus Disease 2019 in a Highly-Vaccinated Asian Population Christopher Tham, Yeh Ching Linn, Lawrence Ng, Jeffrey Quek, Aloysius YL Ho, Francesca Lim, et al. (+8)
194 [GO] 2022―Nov―28 A Phase II Randomized Multi-Center Study to Evaluate the Safety and Efficacy of Infusion of Memory T Cells As Adoptive Therapy in Coronavirus Pneumonia and/or Lymphopenia (RELEASE NCT04578210) Antonio Perez, Cristina Ferreras, Clara Hernandez, Alejandro Martín-Quirós, Karima Al-Akioui, Marta Mora-Rillo, et al. (+17)
195 [GO] 2022―Nov―28 Immunological Response to Sars-Cov-2 after Infection and/or Vaccination Among Chronic Myeloid Leukemia Patients - a Prospective Study Marisol Miranda, Ravindra Kolhe, Danielle Bradshaw, Jaspreet Farmaha, Kimya Jones, Harmanpreet Singh, et al. (+3)
196 [GO] 2022―Nov―28 Portraying Immunity to Sars-Cov-2 after mRNA-Vaccination in Patients with Multiple Myeloma Julius Christoph Enssle, Alina Moter, Julia Campe, Alec Gessner, Ika Weijia Yu, Sebastian Wolf, et al. (+13)
197 [GO] 2022―Nov―28 T Cell Receptor Repertoire Profiling Reveals Breadth of Cellular Responses Against Sars-Cov-2 after Natural Infection and Vaccination in Allogeneic Hematopoietic Stem Cell Transplant Recipients Anne-Claire Mamez, Amandine Pradier, Caroline Stephan, Federica Giannotti, Stavroula Masouridi-Levrat, Sarah Morin, et al. (+9)
198 [GO] 2022―Nov―28 High-Sensitivity Analysis of Normal B-Cell Subsets in MBL and Untreated CLL Identifies Patients with Sub-Optimal Sars-Cov-2 Antibody Responses Andrew C. Rawstron, James Senior, Nichola Webster, Vicky Martin, Ruth M. de Tute, Talha Munir, Peter Hillmen
199 [GO] 2022―Nov―28 Secreted Sars-Cov-2 Encoded ORF8 Protein Stimulates Pro-Inflammatory Cytokines and Predicts Severe Clinical Outcome Michelle K. Manske, Xiaosheng Wu, Gordon Ruan, Taylor L. Witter, Kimberly Gwin, Kevin E. Nowakowski, et al. (+9)
200 [GO] 2022―Nov―28 Does IVIG Use Reduce the Risk of Contracting Sars-Cov-2 in Patients with Immune Thrombocytopenia: Data from the Platelet Disorder Support Association (PDSA) Patient Registry Jennifer MacWhirter - DiRaimo, Caroline Kruse, Alexandra Kruse, James B. Bussel
201 [GO] 2022―Nov―28 Prevalence of Sars-Cov-2 in Stem Cell Donors from Anthony Nolan UK Stem Cell Registry: Sars-Cov-2 Testing Programme, Impact on Stem Cell Collections and Managing Risk Going Forward Angharad Pryce, Ruta Maniusyte, Paul Johnson, Laura Hitchinson, Ann O'leary, Antonio Pagliuca, et al. (+3)
202 [GO] 2022―Nov―28 Use of Convalescent/ Post-Vaccination Plasma in Immunosuppressed Patients with Persistent Sars-Cov-2 Infection Alexandra Pedraza, Paola Charry, Jordi Fornells, Mar De Pablo-Miró, Ares Guardia, Katia Guinetti, et al. (+6)
203 [GO] 2022―Nov―28 Blood Group A Enhances SARS-CoV-2 Infection Shang-Chuen Wu, Connie M. Arthur, Hau-Ming Jan, Wilfredo F Garcia-Beltran, Kashyap R. Patel, Matthew F. Rathgeber, et al. (+12)
204 [GO] 2022―Nov―28 Impact on Tumour Treatment and Outcome of Sars-Cov-2 Infection in 91 Patients with Primary CNS Lymphoma: A Real-Life Study of the International PCNSL Collaborative Group Teresa Calimeri, Sara Steffanoni, Alice Laurenge, Christopher P. Fox, Carole Soussain, Christian Grommes, et al. (+22)
205 [GO] 2022―Nov―28 Sex-Specific Differences in the Pathogenesis, Endothelial Dysfunction, and Hypercoagulability of Sars-Cov-2 Infection in K18-hACE2 Mice Roberto Aiolfi, Hiroshi Deguchi, Jose F. Fernández, Jeanine Ahmed, Miriam Hauer-Jensen, Juan Carlos de la Torre, Laurent O. Mosnier
206 [GO] 2022―Nov―28 Extracellular Vesicles As Markers of Inflammation and Hypercoagulability during the First Month of Sars-COV-2 Infection in Outpatients and Hospitalized Patients Bárbara Gomes Barion, Tania Rubia Rocha, Ho Yeh-Li, Paula Ribeiro Villaça, Bruna M Mazetto, Erica Okasaki, et al. (+4)
207 [GO] 2022―Nov―28 Blood and Marrow Transplantation (BMT) within Four Weeks of Sars-Cov-2 Infection Is Associated with Increased Risk of Mortality: A National COVID Cohort Collaborative Study Meera Mohan, Nathaniel Verhagen, Aditya Shreenivas, Sabarinath Radhakrishnan, Binod Dhakal, Saurabh Chhabra, et al. (+6)
208 [GO] 2022―Nov―28 Pathogenicity of Sars-Cov-2 Spike Protein Variants Correlates with Coagulation and Complement Assays Gloria Gerber, Xiang-Zuo Pan, Nikhil Ranjan, Anna Warmack, Robert Brodsky
209 [GO] 2022―Nov―28 Cellular Immune Composition in Multiple Myeloma Patients Associated with Variable Humoral Responses to Sars-Cov-2 Vaccination Ariel Kogan Zajdman, Adolfo Aleman, Bhaskar Upadhyaya, Katherine F. Beach, Kseniya Serebryakova, Sarita Agte, et al. (+11)
210 [GO] 2022―Nov―28 Immunologic Responses to Sars-Cov-2 Vaccination in Myeloproliferative Neoplasm Patients: Durability, Booster Responses, and Associations with Infections Joan How, Kathleen M.E. Gallagher, Yiwen Liu, Katelin Katsis, Eva Elder, Donna S. Neuberg, et al. (+3)
211 [GO] 2022―Nov―28 Safety and Efficacy of SARS-CoV-2 Vaccination in Patients with Immune Thrombocytopaenia: a Multi-Centre Review Sara Stefani, Rocel C. Saputil, Michelle MH Tan, Noora Buti, Deena Paul, Naghma Rizvi, et al. (+12)
212 [GO] 2022―Nov―28 Dysregulated Humoral and Cellular Response to Sars-Cov-2 Vaccination in Patients with MGUS and SMM Yoshinobu Konishi, Romanos Sklavenitis-Pistofidis, Michelle P. Aranha, Ting Wu, Hong Yue, Elizabeth D. Lightbody, et al. (+17)
213 [GO] 2022―Nov―28 Sars-Cov-2 Vaccination in Pre-Existing and De Novo ITP: A Single Center Experience with Long-Term Follow-up Marina Beltrami Moreira, James B. Bussel, Eun-Ju Lee
214 [GO] 2022―Nov―28 Sars-Cov-2 Vaccination Response Monitoring in Lymphoma and Multiple Myeloma Patients Following Standard Versus High-Dose Chemotherapy and Autologous Stem Cell Transplantation Uros Markovic, Giulio Antonio Milone, Daniela Carco, Valeria Iachelli, Nunziatina Laura Parrinello, Paola Scire, et al. (+5)
215 [GO] 2022―Nov―28 Sars-Cov-2 Vaccinations Do Not Lead to Progression of Monoclonal Gammopathy of Undetermined Significance: Results from the Population-Based Istopmm Screening Study Robert Palmason, Elias Eythorsson, Sæmundur Rögnvaldsson, Sigrun Thorsteinsdottir, Sara Ekberg, Michael Crowther, et al. (+26)
216 [GO] 2022―Nov―28 The Impact of B-Cell-Directed Therapy on Sars-Cov-2 Vaccine Efficacy in CLL: 1-Year Follow up Chaitra S. Ujjani, Christina Poh, Brian Tu, Sydney Lee, Stacy Selke, Haiying Zhu, et al. (+13)
217 [GO] 2022―Nov―28 Sars-Cov-2 Vaccine-Induced Cellular and Humoral Immunity in Patients after CD19.CAR-T Cell Therapy Hannah Reimann, Anita Natalie Kremer, Viktoria Blumenberg, Katja Schmidt, Michael Aigner, Andreas Kremer, et al. (+8)
218 [GO] 2022―Nov―28 Serological Response after Two Doses of Sars-Cov-2 Vaccines in CML Patients - a Prospective Study of a Brazilian Center Ana Carolina Mourão Toreli, Leonardo Fechio, Adriana Silva Santos Duarte, Audrey Basso, Gislaine B O Duarte, Samuel de Souza Medina, et al. (+7)
219 [GO] 2022―Nov―28 Sars-Cov-2-Specific CD4+ and CD8+ T Cell Responses Can Originate from Cross-Reactive CMV-Specific T Cells Cilia R. Pothast, Romy C. Dijkland, Melissa Thaler, Renate S. Hagedoorn, Michel G.D. Kester, Anne K. Wouters, et al. (+5)
220 [GO] 2022―Nov―28 Differences in Clinical Course and Management of Sars-CoV2 Infection in Patients with Chronic Lymphocytic Leukemia between the Sequential Pandemic Phases: An Eric Study Andrea Visentin, Lydia Scarfò, Thomas Chatzikonstantinou, Anargyros Kapetanakis, Christos Demosthenous, Georgios Karakatsoulis, et al. (+93)
221 [GO] 2022―Nov―28 Outcomes and Management of Sars-CoV2 Omicron Variant in Recipients of Hematopoietic Cell Transplantation (HCT) and CAR-T Therapy Maria Stefania Infante, Susan DeWolf, Roni Tamari, Parastoo B. Dahi, Yeon Joo Lee, Ioannis Politikos, et al. (+8)
222 [GO] 2022―Nov―28 Patients with B Cell Malignancy That Lacked Immune Response to Sars-Covid-2 Vaccination Mount Antibody Response Following Actual Sars-Covid-2 Infection: Potential to Improve Vaccination Strategy Hamza Hassan, June Corrigan, Nathanael R Fillmore, Jennifer La, Nhan V Do, Mary Brophy, Nikhil C Munshi
223 [GO] 2022―Nov―28 The Trend of Respiratory Virus Infection in Allogeneic Bone Marrow Transplant Recipients during the COVID Pandemic Guneet Kaleka, John Sharp, Kailyn Kim, Pryce Gaynor, Gary J. Schiller, Wanxing Chai-Ho
224 [GO] 2022―Nov―28 A Successful Patient Blood Management System Implemented during the COVID Pandemic Based on Daily Blood Inventory Levels in a Single Large Oncology Institution Fleur M. Aung, Adriana M. Knopfelmacher Couchonal, Jeff Beno, Alana Newman, Jolyn Taylor, Mark W. Clemens, et al. (+3)
225 [GO] 2022―Nov―28 Real Pandemic World Results of Personalized Prophylaxis of Bleeds in Polish Children and Adolescents with Severe Hemophilia a Tomasz Urasinski, Klaudia Paczoska, Wanda Badowska, Halina Bobrowska, Lucja Dakowicz, Grzegorz Dobaczewski, et al. (+15)
226 [GO] 2022―Nov―28 Acute Myeloid Leukemia during the COVID Pandemic: Impact and the Indian Experience Chepsy C Philip, Sushil Selvarajan, Lingaraj Nayak, Hasmukh Jain, Uday Prakash Kulkarni, Prasanna Samuel, et al. (+24)
227 [GO] 2022―Nov―28 Profiling of Heparin-Induced Thrombocytopenia Antibodies in Thai People Who Received ChAdOx1 Ncov-19 Vaccination Nonthakorn Hantrakun, Peampost Sinsakolwat, Adisak Tantiworawit, Ekarat Rattarittamrong, Thanawat Rattanathammethee, Sasinee Hantrakool, et al. (+5)
228 [GO] 2022―Nov―18 High frequency of low-count monoclonal B-cell lymphocytosis in hospitalized COVID-19 patients Guillermo Oliva-Ariza, Blanca Fuentes-Herrero, Cristina Carbonell, Quentin AL Lecrevisse, Alba Pérez-Pons, Alba Torres-Valle, et al. (+26)
229 [GO] 2022―Nov―04 Efficacy of tixagevimab-cilgavimab in preventing SARS-CoV-2 for patients with B-cell malignancies James A Davis, Katelynn Granger, Kiera Roubal, Deidra Smith, Kelly J Gaffney, Mary McGann, et al. (+6)
230 [GO] 2022―Oct―07 Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversion Yandong Shen, Jane A Freeman, Juliette Holland, Kartik Naidu, Ann Solterbeck, Nenna Van Bilsen, et al. (+12)
231 [GO] 2022―Sep―23 Hybrid immunity in immunocompromised patients with CLL after SARS-CoV-2 infection followed by booster mRNA vaccination Blixt Lisa, Yu Gao, David Wullimann, Hanna Murén Ingelman-Sundberg, Sandra Muschiol, Katie Healy, et al. (+11)
232 [GO] 2022―Sep―22 Berzuini A, Bianco C, Paccapelo C, et al. Red cell-bound antibodies and transfusion requirements in hospitalized patients with COVID-19. Blood. 2020;136(6):766-768.
233 [GO] 2022―Sep―20 Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from EPICOVIDEHA survey Livio Pagano, Jon Salmanton-García, Francesco Marchesi, Ola Blennow, Maria Gomes da Silva, Andreas Glenthøj, et al. (+73)
234 [GO] 2022―Sep―12 Risk Factors for Severe Infection and Mortality in COVID-19 and Monoclonal Gammopathy of Undetermined Significance Matthew Ho, Saurabh Zanwar, Francis K Buadi, Sikander Ailawadhi, Jeremy T Larsen, P Leif Bergsagel, et al. (+24)
235 [GO] 2022―Sep―12 Clonal Hematopoiesis of Indeterminate Potential and Risk of Death from COVID-19 Peter Grant Miller, Geoffrey Fell, Brody Foy, Allison Scherer, Christopher J. Gibson, Adam S. Sperling, et al. (+15)
236 [GO] 2022―Aug―25 Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-Thalassemia: additional dose role Rita Carsetti, Chiara Agrati, Valeria Maria Pinto, Barbara Gianesin, Maria Rita Gamberini, Monica Fortini, et al. (+17)
237 [GO] 2022―Aug―04 CLL and COVID-19: light at the end of the tunnel? Lydia Scarfò, Yair Herishanu
238 [GO] 2022―Jul―15 Clonal Hematopoiesis Is Not Significantly Associated with Covid-19 Disease Severity Yifan Zhou, Ruba N Shalhoub, Stephanie N Rogers, Shiqin Yu, Muxin Gu, Margarete Alice Fabre, et al. (+37)
239 [GO] 2022―Jul―14 Buckling up against COVID-19 after CAR T-cell therapy Jeffery J. Auletta
240 [GO] 2022―Jul―01 How I Treat and Prevent COVID-19 in Patients with Hematologic Malignancies and Recipients of Cellular Therapies Firas El Chaer, Jeffery J Auletta, Roy F Chemaly
241 [GO] 2022―Jun―03 Introduction to a Review Series on COVID-19 Thomas L. Ortel, Nancy Berliner
242 [GO] 2022―Jun―02 Anticoagulation in Hospitalized Patients with COVID-19 Lisa Baumann Kreuziger, Michelle Sholzberg, Mary Cushman
243 [GO] 2022―May―23 Increased COVID-19 Breakthrough Infection Risk in Patients with Plasma Cell Disorders Jennifer La, Julie Tsu-Yu Wu, Westyn Branch-Elliman, Linden Huhmann, Summer S Han, Mary T. Brophy, et al. (+4)
244 [GO] 2022―May―19 Patients with CLL have lower risk of death from COVID-19 in the omicron era Carsten Utoft Niemann, Caspar da Cunha-Bang, Marie Helleberg, Sisse R Ostrowski, Christian Brieghel
245 [GO] 2022―May―11 COVID-19 in patients with hematologic malignancy Petra Langerbeins, Michael Hallek
246 [GO] 2022―May―10 Vaccine-induced T cells against Sars-Cov-2 and its Omicron variant in B cell-depleted lymphoma patients after CART Djordje Atanackovic, Tim Luetkens, Destiny Omili, Thierry Iraguha, Forat Lutfi, Nancy M Hardy, et al. (+17)
247 [GO] 2022―Apr―30 Thrombocytopenia and splenic platelet directed immune responses after intravenous ChAdOx1 nCov-19 administration Leo Nicolai, Alexander Leunig, Kami Pekayvaz, Max Esefeld, Afra Anjum, Justina Rath, et al. (+19)
248 [GO] 2022―Apr―22 Clinical features of thrombosis and bleeding in COVID-19 Mari Thomas, Marie Scully
249 [GO] 2022―Apr―21 De novo and relapsed immune thrombocytopenia after COVID-19 vaccines: results of French safety monitoring Guillaume Moulis, Etienne Crickx, Laure Thomas, Nathalie Massy, Matthieu Mahévas, Marie-Blanche Valnet-Rabier, et al. (+5)
250 [GO] 2022―Mar―28 Neutralization of SARS-CoV-2 Omicron after vaccination of myelodysplastic syndromes and acute myeloid leukemia patients Lorenza Bellusci, Gabrielle Grubbs, Pragya Srivastava, Michael J Nemeth, Elizabeth A Griffiths, Hana Golding, Surender Khurana
251 [GO] 2022―Mar―10 Danger ahead: COVID-19 infections after vaccination Lee M. Greenberger, Gwen L. Nichols
252 [GO] 2022―Mar―10 Immune-mediated thrombotic thrombocytopenic purpura following COVID-19 vaccination Adrien Picod, Jean-Michel Rebibou, Antoine Dossier, Bérengère Cador, David Ribes, Claire Vasco-Moynet, et al. (+12)
253 [GO] 2022―Mar―09 Cerebral venous thrombosis due to vaccine-induced immune thrombotic thrombocytopenia after a second ChAdOx1 nCoV-19 dose Katarzyna Krzywicka, Anita van de Munckhof, Julian Zimmerman, Felix J. Bode, Giovanni Frisullo, Theodoros Karapanayiotides, et al. (+8)
254 [GO] 2022―Mar―08 SARS-CoV-2 Vaccination and Immune Thrombotic Thrombocytopenic Purpura Hridaya Shah, Ann Soo Kim, Senthil Sukumar, Marshall A. Mazepa, Ruhail Kohli, Evan M. Braunstein, et al. (+3)
255 [GO] 2022―Mar―03 Cellular therapies for the treatment and prevention of SARS-CoV-2 infection Susan Conway, Michael D. Keller, Catherine M. Bollard
256 [GO] 2022―Jan―05 Vasculopathy in COVID-19 Robert Flaumenhaft, Keiichi Enjyoji, Alec A Schmaier
257 [GO] 2022―Jan―05 Booster BNT162b2 Optimizes SARS-CoV-2 Humoral Response in Myeloma Patients; the Negative Effect of anti-BCMA therapy Evangelos Terpos, Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis, Sentiljana Gumeni, Panagiotis Malandrakis, et al. (+6)
258 [GO] 2021―Dec―14 Anti-CD38 therapy impairs SARS-CoV-2 vaccine response against Alpha and Delta variants in Multiple Myeloma patients Soledad Henriquez, Jérémie Zerbit, Timothée Bruel, Amani Ouedrani, Delphine Planas, Paul Deschamps, et al. (+15)
259 [GO] 2021―Dec―03 Efficacy of a Third BNT162b2 mRNA COVID-19 Vaccine Dose in Patients with CLL who Failed Standard Two-dose Vaccination Yair Herishanu, Galia Rahav, Shai Levi, Andrei Braester, Gilad Itchaki, Osnat Bairey, et al. (+6)
260 [GO] 2021―Nov―25 Concurrent COVID-19 and babesiosis in an older, splenectomized patient Jeremy W. Jacobs, Alexa J. Siddon
261 [GO] 2021―Nov―24 The Correlation between Racial/Ethnic Groups, Thrombosis, and Mortality in Hospitalized Patients with COVID-19 Maya Rodriguez, Wen Dai, Hayley Lund, Kristen Osinski, Ziyu Zhang, Silvia Munoz-Price, et al. (+2)
262 [GO] 2021―Nov―24 Circulating Levels of Ang/Tie2 and VEGF-a Pathway Mediators Are Associated with Clinical Severity, Endothelial Barrier Disruption and Coagulation Activation in COVID-19 Carla Roberta Peachazepi de Moraes, Ivanio Teixeira de Borba Junior, Franciele de Lima, Mayck Silva Barbosa, Stephany Cares Huber, Andre C. Palma, et al. (+13)
263 [GO] 2021―Nov―24 High Plasma Apolipoprotein(a) Concentration and Low Plasmin Tpa Enzymatic Activity in Hospitalized Patients with COVID-19 Ziyu Zhang, Wen Dai, Wen Zhu, Maya Rodriguez, Mary Rau, Hayley Lund, et al. (+4)
264 [GO] 2021―Nov―24 The Compass-COVID19-ICU Study: Identification of Factors to Predict the Risk of Intubation and Mortality in Patients with Severe COVID-19 Patrick Van Dreden, Douglas D Fraser, Guillaume Voiriot, Aurélie Rousseau, Ismail Elalamy, Ioannis Prassas, et al. (+4)
265 [GO] 2021―Nov―24 A Comparative Outcome Analysis of COVID-19 and Influenza Infection in Patients with Hematological Malignancies Susanne Ghandili, Christian Niederwieser, Katja Weisel, Carsten Bokemeyer, Walter Fiedler, Franziska Modemann
266 [GO] 2021―Nov―24 Comparison of Thrombotic Complications in Critically Ill Patients between COVID-19 and Mers-COV Abdulrahman Al Raizah, Khalid Aldosari, Mohamed Alnahdi, Naila Shaheen, Mosaad Almegren, Mohammed Al Shuaibi, Turki Alshuaibi
267 [GO] 2021―Nov―24 Humoral Immunity and Adverse Events after Vaccination Against COVID-19 By a Vector Based Vaccine Sputnik V in Patients with Chronic Myeloid Leukemia Ekaterina Yu. Chelysheva, Anna Petrova, Oleg A. Shukhov, Margarita Gurianova, Anastasiya Bykova, Irina Nemchenko, et al. (+3)
268 [GO] 2021―Nov―24 Evaluation of the Relationship between Clonal Hematopoiesis and Severe COVID-19 Disease in Rhesus Macaques Taehoon Shin, Yifan Zhou, So Gun Hong, John-Paul Todd, Shayne Andrew, Barbara Flynn, et al. (+9)
269 [GO] 2021―Nov―24 COVID-19 in Children Following Hematopoietic Cell Transplantation: A Multinational Study of the European Bone Marrow Transplantation Society (EBMT) and the Spanish Group of Hematopoietic Stem Cell Transplantation (GETH) Diana Averbuch, Rafael De La Camara, Selim Corbacioglu, Malgorzata Mikulska, Jose Luis Piñana Sanchez, Gloria Tridello, et al. (+15)
270 [GO] 2021―Nov―24 COVID-19 in Hospitalized Patients with Sickle Cell Disease Stephanie Guarino, Sophie M. Lanzkron
271 [GO] 2021―Nov―24 COVID-19 in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS): An Observational Retrospective Study Nicola Sgherza, Paola Curci, Rita Rizzi, Silvio Tafuri, Pasquale Stefanizzi, Vanda Strafella, et al. (+7)
272 [GO] 2021―Nov―24 Second Versus First Wave of COVID-19 in Patients with MPN Tiziano Barbui, Alessandra Iurlo, Arianna Masciulli, Alessandra Carobbio, Arianna Ghirardi, Greta Carioli, et al. (+48)
273 [GO] 2021―Nov―24 COVID-19 in Pediatric Hematopoietic Cell Transplant Recipients: A CIBMTR Study Neel S. Bhatt, Akshay Sharma, Andrew St. Martin, Michael Martens, Marcie L. Riches, Christopher E Dandoy, Jeffery J. Auletta
274 [GO] 2021―Nov―24 ACUTE Lymphoblastic Leukemia (ALL) and COVID-19 Infection. a Campus ALL Report Sabina Chiaretti, Massimiliano Bonifacio, Roberta Agrippino, Mario Annunziata, Anna Candoni, Cerrano Marco, et al. (+32)
275 [GO] 2021―Nov―24 Neither COVID-19, Nor Cryopreservation, Prevented Allogeneic Product Infusion: A Report from the National Marrow Donor Program Heather E. Stefanski, Jeni Newman, Jennifer Novakovich, Jacklyn Barten, Jason Oakes, Meghann Cody, et al. (+4)
276 [GO] 2021―Nov―24 COVID-19 Outcomes Among Participants in the NHLBI Myelodysplastic Syndromes (MDS) Natural History Study Eric Padron, Donnie Hebert, Steven D. Gore, Nancy Gillis, Rami S. Komrokji, Wael Saber, et al. (+11)
277 [GO] 2021―Nov―24 Platform Incorporating Patient Navigation, Preparative Guidelines, and Hospital at Home May Improve COVID-19 Outcomes for Patients with Myeloid Malignancies Brittany Knick Ragon, Tamara K. Moyo, Ashley Sumrall, Ifeyinwa (IFY) Osunkwo, Kris Blackley, Laura Kabrich, et al. (+20)
278 [GO] 2021―Nov―24 Nursing Management of Frail Patients with Hematologic Malignancies during COVID-19 Pandemia in the Viterbo Domiciliary Care Unit: Data Analysis from March 2020 to March 2021 Silvia Ciambella, Vincenza Innocenti, Elisa Emanueli Cippitelli, Silvia Bertelli, Roberta Talucci, Valentina Panichi, et al. (+14)
279 [GO] 2021―Nov―24 Association of Race, Ethnicity, Age and Socioeconomic Status with Access to Virtual Visits within the Brigham & Women's Hospital Division of Hematology during the COVID-19 Pandemic Miriam Kwarteng-Siaw, Lauren E. Merz, Siyang Ren, Donna S. Neuberg, Maureen Achebe, Jorge A. Rodriguez, Arielle L. Langer
280 [GO] 2021―Nov―24 Clinical Characteristics and Outcomes of Patients with Newly Diagnosed De Novo Acute Myeloid Leukemia (AML) during the COVID-19 Pandemic Hari S. Raman, Yael Flamand, Marlise R. Luskin, Daniel J. DeAngelo, Richard M. Stone, Jacqueline S. Garcia, et al. (+6)
281 [GO] 2021―Nov―24 Pediatric Sickle Cell Disease and the COVID-19 Pandemic: A Year in Review at Children's National Hospital Olufunke Y. Martin, Deepika S. Darbari, Stefanie Margulies, Robert Sheppard Nickel, Alexis Leonard, Barbara Speller-Brown, et al. (+5)
282 [GO] 2021―Nov―24 Possible Divergent Local and Peripheral Immunological Effects of Low-Dose Mesencure, an Enhanced Mesenchymal Cell Therapy, May Contribute to Its Success in Treating Severe Covid-19 Patients Tomer Bronshtein, Dror Ben David, Atara Novak, Vered Kivity, Shai Meretzki, Tony Hayek, et al. (+2)
283 [GO] 2021―Nov―24 Characteristics and Outcomes of COVID-19 Patients with Mature B-Cell Non-Hodgkin Lymphomas (mB-Cell NHL): A US Nationwide Electronic Health Record (EHR) Database Study Xiaomeng Yue, David Hallett, Yangyang Liu, Reethi Iyengar, Elisa Basa, Huiying Yang
284 [GO] 2021―Nov―24 Risk Stratification for Acute Arterial and Venous Thromboembolism using CHA 2DS 2-VASc Score in Hospitalized COVID-19 Patients: A Multicenter Study Yi Lee, Qasim Jehangir, Pin Li, Chun-Hui Lin, Anupam A Sule, Geetha Krishnamoorthy, et al. (+6)
285 [GO] 2021―Nov―24 Clonal Hematopoiesis of Indeterminate Potential Is Associated with Increased Age-Independent Morbidity and Mortality in Patients with COVID-19- the Beyond DNA COVID-19 Project Marissa Li, Terra Lasho, Moritz Binder, Wazim Mohammed Ismail, Susan M. Geyer, Jenna Fernandez, et al. (+6)
286 [GO] 2021―Nov―24 Risks for Hospitalization and Death Among Patients with Blood Disorders from the ASH RC COVID-19 Registry for Hematology Lisa K. Hicks, Robert A. Redd, Kenneth C. Anderson, Pinkal Desai, Brendan Dolan, Aaron D Goldberg, et al. (+10)
287 [GO] 2021―Nov―24 Clinical Outcomes in Critically-Ill Patients with COVID-19 Treated with Therapeutic Dose of Anticoagulants for Suspected Thromboembolism Phyu Thin Naing, Hadya Elshakh, Lauren Elreda, Joon Ha Woo, Michael Karass, John Prudenti, Alan Wu
288 [GO] 2021―Nov―24 Incidence and Predictors of Sars-Cov-2 Antibody Responses Following COVID-19 Vaccination in Allogeneic Stem Cell Transplant Recipients Janna C. Minehart, Christopher Catania, Linda Perry, Mary Ellen Martin, Jacqueline Smith, Shannon R. McCurdy, et al. (+9)
289 [GO] 2021―Nov―24 Antibody and T-Cell Responses to COVID-19 Vaccination in Myeloproliferative Neoplasm Patients Joan How, Kathleen M.E. Gallagher, Yiwen Liu, Ashley DeMato, Katelin Katsis, Rebecca Larson, et al. (+4)
290 [GO] 2021―Nov―24 Do Splenectomized Immune Thrombocytopenia (ITP) Patients Have Increased Risks for Platelet Decreases Following COVID-19 Vaccination? Jennifer MacWhirter - DiRaimo, Caroline Kruse, James B Bussel, Alexandra Kruse
291 [GO] 2021―Nov―24 Response to COVID-19 Vaccines in Patients Receiving Intensified Post-ASCT Therapy with Daratumumab, Lenalidomide, Bortezomib (Dara-VR) Due to Ultra-High Risk (UHiR) Newly Diagnosed Myeloma (NDMM) or Primary Plasma Cell Leukemia (pPCL): Exploratory Analysis of the UK Optimum/Muknine Trial Matthew W Jenner, Andrew Hall, Sian E Faustini, Alexandra Pitchford, Ruth M. de Tute, Sadie Roberts, et al. (+12)
292 [GO] 2021―Nov―24 Should be a Third Dose of BNT162b2 mRNA COVID-19-Vaccine Administered in Patients with Myelofibrosis Under Ruxolitinib? Giovanni Caocci, Olga Mulas, Daniela Mantovani, Alessandro Costa, Andrea Galizia, Luca Barabino, et al. (+3)
293 [GO] 2021―Nov―24 Implementation and Preliminary Effectiveness of mHealth Apps for Improving Sickle Cell Disease Care during COVID-19: A Mixed-Methods Evaluation Sherif M. Badawy, Lisa DiMartino, Donald Brambilla, Ana Baumann, Ebony Burns, Theresa Demartino, et al. (+7)
294 [GO] 2021―Nov―24 Use of Monoclonal Antibody Therapy in Hematologic Patients with Mild-to-Moderate COVID-19: A Retrospective Single-Center Experience Idoroenyi Amanam, Janny M. Yao, Alfredo Puing, Ni-Chun Tsai, Diana Samuels, Dat Ngo, et al. (+18)
295 [GO] 2021―Nov―24 Monoclonal Gammopathy of Undetermined Significance and COVID-19: Results from the Population-Based Iceland Screens Treats or Prevents Multiple Myeloma Study (iStopMM) Sæmundur Rögnvaldsson, Elias Eythorsson, Sigrun Thorsteinsdottir, Brynjar Vidarsson, Pall Torfi Onundarson, Bjarni Agnar Agnarsson, et al. (+22)
296 [GO] 2021―Nov―24 Treatment and in-Hospital Overall Survival in Hematological Patients with Grade 4 Neutropenia and Coronavirus Infection Ksenia V. Kaluzhskaya, Yuri Yu. Polyakov, Elena A. Baryakh, Eduard G. Gemdzhian, Elena N. Misyurina, Evgenia I. Zhelnova, et al. (+7)
297 [GO] 2021―Nov―24 Manufacture and Immunological Characterization of GMP-Compliant Functional Sars-COV-2 Cytotoxic T Lymphocytes (CTLs) Utilizing the Clinimacs ® Cytokine Capture System Yaya Chu, Jordan Milner, Margaret Lamb, Elena Maryamchik, Olivia Rigot, Janet Ayello, et al. (+15)
298 [GO] 2021―Nov―24 Characterization of the Humoral and Cellular Immune Response Against the Natural Infection By Sars-Cov-2 in Oncohematological Patients with Post-COVID19 Autologous Transplantation Adrián Sánchez-Tornero, Lorena Vigon, Guiomar Casado-Fernandez, Javier Garcia-Pérez, Elena Mateos, Magdalena Corona De Lapuerta, et al. (+8)
299 [GO] 2021―Nov―24 Sars-Cov-2 Infection Associated with Aplastic Anemia and Pure Red Cell Aplasia Nicholas C.J. Lee, Bhavisha A. Patel, Taha Bat, Ibrahim F. Ibrahim, Madhuri Vusirikala, Mingyi Chen, et al. (+4)
300 [GO] 2021―Nov―24 SARS-CoV-2 Ion Channel ORF3a Enables TMEM16F-Dependent Phosphatidylserine Externalization to Augment Procoagulant Activity of the Tenase and Prothrombinase Complexes Jacob G Ludington, Shabbir A Ansari, Alec A Schmaier, Keiichi Enjyoji, Benjamin E Nilsson-Payant, Yaron Bram, et al. (+5)
301 [GO] 2021―Nov―24 Immunogenicity of Sars-Cov-2 mRNA 1273 Vaccine in Patients with Lymphoid Malignancies Ning Dong, Akriti G Jain, Elaine S Tan, Somedeb Ball, Junmin Whiting, Sameh Gaballa, et al. (+10)
302 [GO] 2021―Nov―24 Antibody Response to 2-Dose Sars-Cov-2 mRNA Vaccine in Allogeneic Hematopoietic Cell Transplant Recipients Alexis Maillard, Rabah Redjoul, Marion Klemencie, Hélène Labussière, Amandine Le Bourgeois, Maud d'Aveni, et al. (+10)
303 [GO] 2021―Nov―24 Antibody Response after One and/or Two Doses of BNT162b2 Anti- Sars-Cov-2 mRNA Vaccine in Patients Treated By CAR T-Cells Therapy Thomas Gastinne, Amandine Le Bourgeois, Marianne Coste-Burel, Thierry Guillaume, Pierre Peterlin, Alice Garnier, et al. (+14)
304 [GO] 2021―Nov―24 Sars-Cov-2 T-Cell Response in Allogeneic Hematopoietic Stem Cell Recipients Following Two Doses of BNT162b2 Vaccine Beatrice Clemenceau, Thierry Guillaume, Marianne Coste-Burel, Pierre Peterlin, Alice Garnier, Amandine Le Bourgeois, et al. (+17)
305 [GO] 2021―Nov―24 Safety and Tolerability of Sars-Cov-2 Vaccination and Natural History of Infection Among Patients with Castleman Disease Sheila K Pierson, Russell Perkins, Frits van Rhee, Corey Casper, David C Fajgenbaum
306 [GO] 2021―Nov―24 Humoral and T Cell Immune Responses to Sars-Cov-2 Vaccination in Hematopoietic Cell Transplant Recipients Eleni Gavriilaki, Anastasia Papadopoulou, Tasoula Touloumenidou, Fani Stavridou, Evdoxia Koravou, Maria Giannaki, et al. (+10)
307 [GO] 2021―Nov―24 Sars-Cov-2 Vaccination in Patients with Paroxysmal Nocturnal Hemoglobinuria: An Italian Multicenter Survey Juri Alessandro Giannotta, Bruno Fattizzo, Corrado Girmenia, Claudia Ielo, Elisabetta Metafuni, Adele Visentin, et al. (+7)
308 [GO] 2021―Nov―24 Inadequate Sars-Cov-2 Vaccine Effectiveness in Patients with Multiple Myeloma: A Large Nationwide Veterans Affairs Study Nathanael R Fillmore, Jennifer La, Julie Tsu-Yu Wu, Westyn Branch-Elliman, Linden Huhmann, Summer S Han, et al. (+6)
309 [GO] 2021―Nov―24 Assessment of Serology after Sars-Cov-2 Vaccine in Allogeneic HCT Recipients Melissa Baker, Maria Cortes, Jaeil Ahn, Michele L. Donato, Sukhdeep Kaur, Hyung C. Suh, et al. (+5)
310 [GO] 2021―Nov―24 Time Since Last Anti-CD20 Treatment Is a Major Determinant of Sars-Cov-2 Vaccine Response in a Large Cohort of Patients with B-Cell Lymphoma Tanaya Shree, Vishnu Shankar, Debra K. Czerwinski, Gladys Rodriguez, Sara Beygi, Joseph G Schroers-Martin, et al. (+10)
311 [GO] 2021―Nov―24 Safety and Efficacy of Sars-Cov-2 Vaccines in Hodgkin Lymphoma Patients Receiving PD-1 Inhibitors Jakub Svoboda, Hatcher J Ballard, Carrie I Ho, Mitchell E. Hughes, Elise A Chong, Adam Duca, et al. (+7)
312 [GO] 2021―Nov―24 Responses to Sars-Cov-2 Vaccines in Patients with Myelodysplastic Syndrome and Acute Myeloid Leukemia Akriti G Jain, Ning C. Dong, Somedeb Ball, Elaine S Tan, Junmin Whiting, Rami S. Komrokji, et al. (+7)
313 [GO] 2021―Nov―24 Venetoclax with Azacitidine or Low Dose Cytarabine As an Alternative to Intensive Chemotherapy in Fit Adults during the COVID19 Pandemic: Real World Data from the UK National Health Service Jad Othman, Mariam Amer, Ruebina Amofa, Laura Anderson, Michael J Austin, Alex Bashford, et al. (+47)
314 [GO] 2021―Nov―24 Antibody Response after 2 and 3 doses of SARS-CoV-2 mRNA Vaccine in Allogeneic Hematopoietic Cell Transplant Recipients Alexis Maillard, Rabah Redjoul, Marion Klemencie, Helene Labussiere-Wallet, Amandine Le Bourgeois, Maud D'Aveni, et al. (+13)
315 [GO] 2021―Nov―23 ERN-EuroBloodNet European Registry of Patients Affected by Red Blood Cell Disorders and COVID-19 Pablo Velasco, Filomena Longo, Andrea Piolatto, Eduardo J. Bardón-Cancho, Beatriz Ponce-Salas, Pagona Flevari, et al. (+44)
316 [GO] 2021―Nov―23 Immature Platelets and Disease Severity in Patients Hospitalized with Acute COVID-19 Who Are Vaccinated Against COVID-19 Nicholas C.J. Lee, Haekyung Jeon-Slaughter, Ibrahim F. Ibrahim, Taha Bat, Sung-Hee Choi
317 [GO] 2021―Nov―23 Retrospective Study Evaluating Effect of Voxelotor Treatment on Acute Care Utilization during the Peak of COVID-19 Shivani Rao, Nicole K. Yun, James L. Coggan, Peter Wu, Teresa O'Brien, Katherine Barnett, et al. (+8)
318 [GO] 2021―Nov―23 Lymphocyte Ratios Progressively Worsen in Non-Survivors of COVID-19 Adekunle Emmanuel Alagbe, Gisele Audrei Pedroso, Beatriz Benedetti de Oliveira, Edivilson de Costa, Gisélia Aparecida Freire Maia, Bruna Facanali Piellusch, et al. (+7)
319 [GO] 2021―Nov―23 Characterization of the Early Humoral and Cellular Response Developed in Oncohematological Patients Post-Vaccination with One Dose Against COVID-19 Magdalena Corona De Lapuerta, Sara Rodriguez-Mora, Guiomar Casado-Fernandez, Javier Garcia-Pérez, Lorena Vigon, María Aranzazú Murciano-Antón, et al. (+9)
320 [GO] 2021―Nov―23 Neutrophil Metabolic Rewiring in Severe and Mild COVID-19 Yafeng Li, Jessica S Hook, Qing Ding, Stephen Chung, Jessica Moreland, Michalis Agathocleous
321 [GO] 2021―Nov―23 Extended Thromboprophylaxis in Patients with COVID-19 Wei Zhao, Pin Li, Scott Kaatz, Katie Latack, Lonni Schultz, Laila Poisson
322 [GO] 2021―Nov―23 Sars-Cov-2 Infection Promotes Endothelial Dysfunction and Thrombosis in a Mouse Model of COVID-19 Roberto Aiolfi, Jeanine Ahmed, Juan Carlos de la Torre, John H. Griffin, Laurent O. Mosnier
323 [GO] 2021―Nov―23 Increased Risk of Thrombosis in Patients with Myeloproliferative Neoplasms Compared with the General Population Hospitalized with COVID-19 Orly Leiva, Umberto Campia, Julia Snyder, Briana Barns, Samantha Rizzo, Candrika Khairani, et al. (+8)
324 [GO] 2021―Nov―23 Success and Satisfaction with Virtual Hematology Curriculum Implemented in Response to COVID-19 Ali Noel Gunesch, Kristen McClellan, Gabrielle Meyers, Evan Shereck
325 [GO] 2021―Nov―23 Optimal Anticoagulant Dosing in Patients with COVID-19, a Retrospective Review Alessandra Carrillo, Shil Punatar, Sushma Pavaluri, Madeline Jentink, Dixita Patel, Joseph Braun, et al. (+5)
326 [GO] 2021―Nov―23 Poor Outcome of Patients with COVID-19 after CAR T-Cell Therapy for B-Cell Malignancies: Results from a Multicenter Study on Behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group Anne Mea Spanjaart, Per Ljungman, Rafael De La Camara, Gloria Tridello, Valentín Ortiz-Maldonado, Alvaro Urbano-Ispizua, et al. (+28)
327 [GO] 2021―Nov―23 COVID-19 Among Patients with Hematological Malignancies: Experience from a Tertiary Center Showing Lower Than Expected Mortality and Establishing the Safety of in-Hospital Patient Care during the Pandemic Shlomzion Aumann, Uria Tsubary, Sarah Israel, Dina Ben Yehuda, David Lavie, Neta Goldschmidt, et al. (+10)
328 [GO] 2021―Nov―23 Social Media Validation for Pre-Screened Ontologies As a Driver for Biomolecular Interaction Significance in COVID-19 and Hematological Malignancies Yan Leyfman, Samarth Sandeep, Peter Rizk, Carlo Khoury, Chandler Howard Park
329 [GO] 2021―Nov―23 Association between Insufficient Interleukin-6 (IL-6) Inhibition and Worsening Outcomes in COVID-19 and Idiopathic Multicentric Castleman Disease (iMCD), and a Mathematical Model to Predict Optimal Dosing to Completely Block IL-6 Activity Jean-Francois Rossi, Hao-Chun Chiang, Zhao-Yang Lu, Kalle Levon, Frits van Rhee, Karan Kanhai, et al. (+2)
330 [GO] 2021―Nov―23 COVID-19 and Sickle Cell Disease in the Province of Q: Morbidity and Mortality Rates Derived from the Provincial Registry Mathias Castonguay, Nawar Dakhallah, Marie-Laure Colaiacovo, Camille Jimenez-Cortes, Justin Desroches, Anne-Marie Claveau, et al. (+13)
331 [GO] 2021―Nov―23 COVID-19 Antibody Detection and Assay Performance Using Red Cell Agglutination Willy A. Flegel, Kshitij Srivastava, Valeria De Giorgi, Michael R Holbrook, Nicolai V Bovin, Stephen M Henry, Kamille West
332 [GO] 2021―Nov―23 Proteomic Profiles in Patients with Thrombosis Due to COVID-19 Are Distinct from Non-COVID-19 Thrombosis Daria V Madeeva, Kelly Borges, Marcus Shallow, Prerak V Juthani, Stephen Y Wang, Akash Gupta, et al. (+3)
333 [GO] 2021―Nov―23 Inherited Thrombophilias Are Associated with an Increased Risk of COVID-19 Associated Venous Thromboembolism: A Prospective Population-Based Cohort Study Hannah P Stevens, Rodrigo Canovas, Karlheinz Peter, Huyen Tran, Zane Kaplan, James David McFadyen
334 [GO] 2021―Nov―23 Comparison of D-Dimer Level on Mild, Moderate and Severe COVID-19 at Immanuel Hospital Bandung City October 1 st - December 31 st, 2020 Hary Gustian, Regina Anjani Budi Pratiwi, Rini Riantie
335 [GO] 2021―Nov―23 Four-Fold Increased Mortality from Sars-Cov-2 Infection in Patients with Hematologic Versus Non-Hematologic Malignancies Treated at the Largest Tertiary COVID-19 Center in Chicago/Rush University Medical Center (March 1, 2020-December 31,2020) Nicole K. Yun, Praneeth Chebrolu, Paul R. Yarnold, Joshua Thomas, James L. Coggan, Anmol Baranwal, et al. (+3)
336 [GO] 2021―Nov―23 Severity of Covid-19 Clinical Outcomes and Mortality in Multiple Myeloma Patients over Year 1 of the Pandemic Joaquín Martínez-López, Maria-Victoria Mateos, Nieves López-Muñoz, Maria Alicia Senin Magan, Maria Dunia De Miguel, Ana López de la Guía, et al. (+21)
337 [GO] 2021―Nov―23 Oxygenation and Inflammatory Markers after Early Covid-19 Convalescent Plasma: A Comparison of Survivors and Non-Survivors Valentina Baez Sosa, Ahmad M Nassar, Nikitha Vobugari, Anjali S Ghodasara, Cathy Conry-Cantilena, Glenn Wortmann, et al. (+6)
338 [GO] 2021―Nov―23 Global Waldenström's Macroglobulinemia Patient-Derived Data Registry, Whimsical, Highlights Real-World Treatment Outcomes and COVID-19 Data Ibrahim Tohidi-Esfahani, Andrew Warden, Elena Malunis, Peter Liburdi deNardis, Michelle Postek, Shirley D'Sa, et al. (+7)
339 [GO] 2021―Nov―23 COVID-19 Diagnosis and Its Impact on Thrombotic Risk in a Cohort of Patients Simultaneously Hospitalized Due to Acute Respiratory Distress Syndrome Andréa Coy-Canguçu, Gisele Aparecida Locachevic, João Carlos Silva Mariolano, Kaio Henrique De Oliveira Soares, José Diogo Oliveira, Camila de Oliveira Vaz, et al. (+5)
340 [GO] 2021―Nov―23 A Rare Case of Mild COVID-19 Disease Associated with Type 1 Cryoglobulinemia and Thrombotic Thrombocytopenic Purpura Syed Mujtaba Naqvi, Carrisa Schwartz, Rachel Whittaker, Ghayth Hammad, Rishi Agarwal
341 [GO] 2021―Nov―23 Targeting the Endothelium in the Treatment of COVID-19 Early Clinical Stages: Results of a Randomized Placebo-Controlled Trial Alejandro Gonzalez-Ochoa
342 [GO] 2021―Nov―23 Patients with Multiple Myeloma and Prior COVID-19 Have Superior Antibody Responses Against Sars-Cov-2 Compared with Fully Vaccinated Myeloma Patients with the BNT162b2 Vaccine Maria Gavriatopoulou, Evangelos Terpos, Panagiotis Malandrakis, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis, Sentiljana Gumeni, et al. (+9)
343 [GO] 2021―Nov―23 A Multicompartment Mathematical Model Based on Host Immunity for Dissecting COVID-19 Heterogeneity Jianghua Wu, Heng Mei, Jianwei Li, Jingpeng Zhang, Lu Tang, Mengyi Du, et al. (+2)
344 [GO] 2021―Nov―23 Does Fibrin Structure Contribute to the Increased Risk of Thrombosis in COVID-19 ICU Patients? Judith Juliana De Vries, Chantal Visser, Lotte Geers, Johan A. Slotman, Henrik Endeman, Marieke J.H.A. Kruip, et al. (+2)
345 [GO] 2021―Nov―23 COVID-19 in Children, Adolescents and Young Adults with Hematological Malignancies Rebecca S Parker, Jemily Malvar, Andrew Doan, Paibel Aguayo-Hiraldo, Chintan Parekh
346 [GO] 2021―Nov―23 Humoral Response to mRNA Vaccines BNT162b2 and mRNA-1273 COVID-19 in Chronic Lymphocytic Leukemia Patients Cristina Bagacean, Rémi Letestu, Chadi Al Nawakil, Ségolène Brichler, Vincent Lévy, Nanthara Sritharan, et al. (+21)
347 [GO] 2021―Nov―23 Clinical Outcomes of COVID-19 in Hematological Malignancies in Jordan : Tertiary Cancer Center Experience Hazim Ababneh, Fadwa Alqadi, Mohammad ma'Akoseh, Khalid Halahleh, Layan abo Abed, Mohammad Akkawi, Kamal Al-Rabi
348 [GO] 2021―Nov―23 Outcomes of COVID-19 in Hematopoietic Stem-Cell Transplant Recipients: A Single Institution Observational Study Sami Dwabe, Lakshmi Savitala-Damerla, Jack Rodman, Abdullah Ladha, Eric Tam, Houda Alachkar, et al. (+3)
349 [GO] 2021―Nov―23 COVID-19 in Multiple Myeloma Patients: Frequencies and Risk Factors for Hospitalization, Ventilatory Support, Intensive Care Admission and Mortality -Cooperative Registry from Grupo Brasileiro De Mieloma Multiplo (GBRAM) Marcia Garnica, Edvan De Queiroz Crusoe, Glaciano Ribeiro, Rosane Bittencourt, Roberto José Pessoa Magalhães, Karla Richter Zanella, et al. (+7)
350 [GO] 2021―Nov―23 Results of a Single Center Survey on Vaccination Against COVID-19 in Patients with Chronic Myeloid Leukemia Ekaterina Yu. Chelysheva, Anna Petrova, Oleg A. Shukhov, Margarita Gurianova, Anastasiya Bykova, Irina Nemchenko, et al. (+3)
351 [GO] 2021―Nov―23 COVID-19 in Patients with Chronic Myeloid Leukemia: Poor Outcomes for Patients with Comorbidities, Older Age, Advanced Phase Disease, and Those from Low-Income Countries: An Update of the Candid Study Katia B Pagnano, Chung Hoow Kok, Michael J. Mauro, Jorge E. Cortes, Nicola Evans, Qian Jiang, et al. (+7)
352 [GO] 2021―Nov―23 Updated Analysis Confirms Sustained Poor Prognosis of COVID-19 in Patients with Lymphoma in Latin America: A Cohort of 160 Patients from Gell Guilherme Fleury Perini, Luis Villela, Brady E Beltran, Denisse Castro, Victoria Otero, Mariana Kalmus, et al. (+36)
353 [GO] 2021―Nov―23 Final Results of CHRONOS19 Observational Study in Patients with Hematologic Disease and COVID-19 in Russia Olga A. Gavrilina, Kristina A. Zakurdaeva, Anastasia N. Vasileva, Sergei Dubov, Vitaly S. Dubov, Vladimir I. Vorobyev, et al. (+19)
354 [GO] 2021―Nov―23 COVID-19 Incidence in Asymptomatic Cancer Patients Undergoing Chemotherapy Claudia Monteiro, Cecília Gomes, Leticia Marani, Leandro Colli, Rodrigo T. Calado, Lorena Figueiredo-Pontes
355 [GO] 2021―Nov―23 Randomized, Multi-Center, Double-Blinded, Placebo Controlled Safety and Early Efficacy Trial of Cryopreserved Cord Blood Derived T-Regulatory Cell Infusions (CK0802) in the Treatment of COVID-19 Induced ARDS. (RESOLVE Trial) Douglas E Gladstone, Christopher Howard, Mi-Ae Lyu, Jason Mock, Darryl Adams, Kevin Gibbs, et al. (+11)
356 [GO] 2021―Nov―23 Spontaneous Heparin-Induced Thrombocytopenia and COVID-19 Infection Suneetha Amara
357 [GO] 2021―Nov―23 Clinical Outcomes of COVID-19 Infection Among Children with Cancer: A Single-Center Experience Esra Akkoyun, Jesus Sotelo, Giselle Cherry, Maria Bisceglia, Tamra Slone, Victor Aquino, Paul Sue
358 [GO] 2021―Nov―23 COVID-19 Infection and Outcomes at a Comprehensive Sickle Cell Center Fuad El Rassi, Abeer N. Abouyabis, Ross M. Fasano, Morgan L. McLemore
359 [GO] 2021―Nov―23 Covid-19 Infection in Hematological Malignancies: Registry Data from India Arihant Jain, Lingaraj Nayak, Uday Prakash Kulkarni, Nikita Mehra, Uday Yanamandra, Smita Kayal, et al. (+20)
360 [GO] 2021―Nov―23 Low Incidence of COVID-19 Infection in Patients with Acute Myeloid Leukemia Undergoing Reduced Intensity/Venetoclax Based Treatment: Initial Results of the PACE Prospective Clinical Study from the UK Trials Acceleration Program (Justin) Ching Ting Loke, Charlotte Gaskell, Sonia Fox, Rachel Fletcher, Catherine Thomas, Louise Hopkins, et al. (+32)
361 [GO] 2021―Nov―23 COVID-19 Infection in Vaccinated Adult Patients with Hematological Malignancies. Preliminary Results from Epicovideha (Epidemiology of COVID-19 infection in patients with hematological malignancies: A European Haematology Association Survey) Francesco Marchesi, Jon Salmanton-García, Alberto Lopez-Garcia, Giulia Dragonetti, Uluhan Sili, Andreas Glenthoej, et al. (+12)
362 [GO] 2021―Nov―23 COVID-19 Infection of HSCT Recipients Is Associated with High Mortality but No Detectable Cytokine Storm at Presentation Giovanna Lucchini, Elena Cozma, Aimee Jackson, Kimberly Gilmour, Rachel Elizabeth Protheroe, Eleni Tholouli, et al. (+17)
363 [GO] 2021―Nov―23 In Covid-19 Infection, Plasma Extracellular Vesicle Tissue Factor Activity Does Not Correlate with D-Dimer Levels Thomas J. Girard, Irem Eldem, Kenneth E Remy, Monty Mazer, Jorge Di Paola
364 [GO] 2021―Nov―23 Acquired Aplastic Anemia in Immunocompetent Pediatric Patients with Asymptomatic COVID-19 Infection: A Case Series Jordan E. Fritch, Taylor Losole, Lindsey Leyden, Jiri Bedrnicek, Deborah A. Perry, Melissa A. Acquazzino, Chital Raulji
365 [GO] 2021―Nov―23 Sickle Cell Disease and COVID-19 Infection: A Single-Center Experience Sindhu Devarashetty, Kimberly Le Blanc, Udhayvir Singh Grewal, Jacqueline Walton, Tabitha Jones, Runhua Shi, et al. (+3)
366 [GO] 2021―Nov―23 Clinical Predictors of Outcome in Adult Patients with Acute Leukemias and Myelodysplastic Syndrome and COVID-19 Infection: Report from the American Society of Hematology Research Collaborative (ASH RC) Data Hub Pinkal Desai, Aaron D Goldberg, Kenneth C. Anderson, Varun Narendra, Donna S. Neuberg, Vivek Radhakrishnan, et al. (+10)
367 [GO] 2021―Nov―23 Allogeneic and Autologous Hematopoietic Transplants Can be Safely Performed after COVID-19 Infections Jeremy L. Ramdial, Rima M. Saliba, Amin M. Alousi, Gabriela Rondon, Julianne Chen, Celina Ledesma, et al. (+3)
368 [GO] 2021―Nov―23 Blood Type Does Not Affect Morbidity or Mortality in COVID-19 Infections, As Assessed By a Clinical Severity Scoring System Katharine E Thomas, Erin Marie Dauchy, Amber Karamanis, Andrew G. Chapple, Michelle M Loch
369 [GO] 2021―Nov―23 COVID-19 Is Associated with Endothelial Dysfunction and Enhanced Plasma Thrombin Generation Despite Pharmacological Thromboprophylaxis Sarah Kelliher, Luisa Weiss, Sarah Cullivan, Ellen O' Rourke, Claire Murphy, Shane Toolan, et al. (+12)
370 [GO] 2021―Nov―23 Complete Blood Count Parameters Outperform Putative Inflammatory Markers in Predicting COVID-19 Mortality: A Multimodal Machine Learning Model Precious Idogun, John Sia, Mindy Ward, Dillan Patel, Wilhelmine Wiese-Rometsch, Anjan J. Patel
371 [GO] 2021―Nov―23 Antibody and T-Cell Responses to Covid-19 mRNA Vaccines in Patients with B-Cell Lymphomas and Chronic Lymphocytic Leukemia (CLL) Emily C. Ayers, Jeffrey Wilson, Glenda Canderan, Behnam Keshavarz, Judith Woodfolk, Craig A. Portell, Michael E. Williams
372 [GO] 2021―Nov―23 The Impact of COVID-19 on Acute Myeloid Leukemia (AML) Treatment Patterns in the United States: Retrospective Analysis of an Electronic Medical Records (EMR) Database Clara Chen, David Rotter, Zephirin Kiendrebeogo, Ravi Potluri
373 [GO] 2021―Nov―23 A Multi-Center Retrospective Review of COVID-19 Outcomes in Patients with Lymphoid Malignancy Yun Choi, Jessica Caro, Xiaochun Li, Arshed Al-Obeidi, Sharyn Lynn Kurtz, Austin I. Kim, et al. (+16)
374 [GO] 2021―Nov―23 Safety of Daratumumab Combined with Bortezomib, Cyclophosphamide and Dexamethasone for the Treatment of Patients with Multiple Myeloma Presenting with Extramedullary Disease during the COVID-19 Pandemic Meral Beksac, Tulin Tuglular, Ali Unal, Michele Cavo, Francesca Gay, Eirini Katodritou, et al. (+7)
375 [GO] 2021―Nov―23 Cryopreservation of Allogeneic Hematopoietic Cell Grafts Did Not Adversely Affect Early Post-Transplant Survival during the First Six Months of the COVID-19 Pandemic Steven Devine, Michelle Kuxhausen, Stephen R. Spellman, Caitrin Fretham, Kwang Woo Ahn, Heather E. Stefanski, et al. (+3)
376 [GO] 2021―Nov―23 Utilizing HealthTree ® Cure Hub's Real-World Data to Assess Treatment Management of Patients with Multiple Myeloma during the COVID-19 Pandemic Nathan W. Sweeney, Jennifer M. Ahlstrom
377 [GO] 2021―Nov―23 Impact of Crizanlizumab on Acute Medical Care Utilization in the Height of the COVID-19 Pandemic Shivani Rao, Nicole K. Yun, James L. Coggan, Peter Wu, Teresa O'Brien, Katherine Barnett, et al. (+8)
378 [GO] 2021―Nov―23 Chronic Lymphocytic Leukemia (CLL) Patients Quality of Life (QoL): A Cross-Sectional Analysis of the Italian Experience in the Choice Study during the First Wave of the COVID-19 Pandemic Alessandra Tedeschi, Idanna Innocenti, Francesco Albano, Alessandro Gozzetti, Luciano Levato, Marika Porrazzo, et al. (+7)
379 [GO] 2021―Nov―23 Successful Treatment of Acute Myeloid Leukemia with CPX-351 in 2 Patients in the United Kingdom during the COVID-19 Pandemic Sreetharan Munisamy, Satarupa Choudhuri
380 [GO] 2021―Nov―23 Drepadom - Establishment of Home Care Services and Hospitalizations for Sickle Cell Disease Patients As Standard Care Since the Covid-19 Pandemic Yanís Pelinski, Cindy Mescam, Christian Kassasseya, Gonzalo De Luna, Henri Guillet, Clara Noizat, et al. (+10)
381 [GO] 2021―Nov―23 Potential Benefits of a 6-Week Exercise and Mindfulness-Based Telehealth Training for HCT Survivors to Meet the Challenges of the COVID-19 Pandemic - a Feasibility Study David Ma, David Kliman, Kate Fennessy, Nikki Molan
382 [GO] 2021―Nov―23 Clinical Profile and Outcome of COVID Positive Hematology Patients during the COVID-19 Pandemic - an Analytical Cross Sectional Study from a Tertiary Care Centre in India Faisal Kassim, Chirag Sunil Lalwani, Hamsini Movva, Sani Kodathumuriyil Sunny, Merlin Moni, Remya Sudevan, et al. (+5)
383 [GO] 2021―Nov―23 A Survey Conducted during COVID-19 Pandemic Among Brazilian Chronic Myeloid Leukemia and Philadelphia-Negative Myeloproliferative Neoplasms Patients Leonardo Fechio, Ana Vitória Ferreira Mota, Jaisson Bortolini, Gislaine B O Duarte, Marcia Delamain, Samuel S Medina, et al. (+5)
384 [GO] 2021―Nov―23 Virtual Care during the COVID-19 Pandemic Among Patients with Hematologic Malignancies - a Princess Margaret Cancer Centre Experience Adam Suleman, Abi Vijenthira, Tran Trong, Alejandro Berlin, Anca Prica, Danielle Rodin
385 [GO] 2021―Nov―23 Racial Disparities in Telemedicine Uptake during the COVID-19 Pandemic Among Patients with Hematologic Malignancies in the United States Natalia Neparidze, Krystal W. Lau, Xiaoliang Wang, Amy J. Davidoff, Scott F. Huntington, Omer Hassan Jamy, et al. (+8)
386 [GO] 2021―Nov―23 Effect of COVID-19 Pandemic Control Measures on Diagnoses of Hematologic Cancer Among CMS Population in 2020 Dave Smart, Wendy Moore, Karina Hjort, Karen Keating, Bob Holt, Raymond Henderson, et al. (+4)
387 [GO] 2021―Nov―23 COVID-19 Pandemic Impact on Chronic Lymphocytic Leukemia (CLL) Patients' Preferences Towards Therapies: The Italian Experience (CHOICE Study) Stefano Molica, Luca Laurenti, Paolo Ghia, Marta Coscia, Antonio Cuneo, Gianluca Gaidano, et al. (+9)
388 [GO] 2021―Nov―23 Impact of the COVID-19 Pandemic on Acute Care Visits for Patients with Sickle Cell Disease Dennis Orkoulas-Razis, Nicholas Bishop, Ellen Dupont, Maria R. Baer, Richard Gentry Wilkerson, Jennie Y. Law
389 [GO] 2021―Nov―23 Effects of the COVID-19 Pandemic on Caregivers of Young Children with Sickle Cell Disease Enrolled in the Engage-HU Trial Anna M Hood, Aimee K Hildenbrand, Joanna Rebitski, Jasmine Stallworth, Yolanda Johnson, Stacey Gomes, et al. (+17)
390 [GO] 2021―Nov―23 Impact of COVID-19 Pandemic on Global Unrelated Stem Cell Donations in 2020 - Report from World Marrow Donor Association Monique Jöris, Stefanie Bernas, Alexander H. Schmidt, Jay Feinberg, Nicoletta Sacchi, Heidi Elmoazzen, et al. (+14)
391 [GO] 2021―Nov―23 Impact of the COVID-19 Pandemic on in-Person Visit Rates Among Patients with Hematologic Malignancies in the United States Gaurav Goyal, Krystal W. Lau, Xiaoliang Wang, Amy J. Davidoff, Scott F. Huntington, Omer Hassan Jamy, et al. (+8)
392 [GO] 2021―Nov―23 Impact of the COVID-19 Pandemic on Primary Care Access for Patients with Hematologic Malignancies Ying Ling, Kelvin Chan, Aditi Patrikar, Ning Liu, Aisha Lofters, Colleen Fox, et al. (+2)
393 [GO] 2021―Nov―23 The Impact of the COVID-19 Pandemic on Quality of Life in Danish Patients with Multiple Myeloma; Results from an Ongoing Longitudinal National Survey Louise Redder, Sören Möller, Anna Thit Johnsen, Mary Jarden, Christen lykkegaard Andersen, Henrik Frederiksen, et al. (+9)
394 [GO] 2021―Nov―23 Impact of the Covid-19 Pandemic on Quality of Life of Patients with CML Hubert Wysoglad, Elzbieta Szczepanek, Ositadima Chukwu, Weronika Lebowa, Wiktor Nowak, Tomasz Sacha
395 [GO] 2021―Nov―23 The Impact of the COVID-19 Pandemic on the Diagnosis and Management of Patients with Classical Hodgkin Lymphoma: A Single-Center Experience Selin Kucukyurt, Kübra Şahin, Umut Yılmaz, Abdülkadir Erçalışkan, Tuba Özkan Tekin, Damla Ortaboz, et al. (+6)
396 [GO] 2021―Nov―23 Changes in Multiple Myeloma Treatment Patterns during the Early COVID-19 Pandemic Period Natalia Neparidze, Rong Wang, Amer M. Zeidan, Nikolai Podoltsev, Rory M. Shallis, Xiaomei Ma, et al. (+2)
397 [GO] 2021―Nov―23 Gilteritinib for Relapsed Acute Myeloid Leukaemia with FLT3 Mutation during the COVID-19 Pandemic: Real World Experience from the UK National Health Service Jad Othman, Usman Afzal, Ruebina Amofa, Michael J Austin, Alex Bashford, Edward Belsham, et al. (+36)
398 [GO] 2021―Nov―23 The Impact of Degree of Anticoagulation on Thrombotic and Other Complications in Hospitalized COVID-19 Patients Rena Zheng, Alexandra Solomon, Madeline DiLorenzo, Iniya Rajendran, Joseph Park, Vrushali Dhongade, et al. (+6)
399 [GO] 2021―Nov―23 Assessment of Macrophage Inflammatory Biomarkers and Neutrophil Extracellular Traps Associated Proteins in COVID-19 Patients Laura Lopez de Frutos, Irene Serrano-Gonzalo, Barbara Menendez-Jandula, Esther Franco-Garcia, Carlos Lahoz, Paz Latre, et al. (+2)
400 [GO] 2021―Nov―23 Ethnic Variation in Hospitalized COVID-19 Patients and Correlation with Coagulopathy, Thrombosis, Prognosis and 30 Day Mortality Outcomes in California's Central Valley Charity A Huang, Omar Mahmood, Paul Mills, Mehdia Amini, Sundeep Bekal, Jason Doornenbal, et al. (+3)
401 [GO] 2021―Nov―23 Red Blood Cells from COVID-19 Patients Show Evidence of Increased Oxidative Stress and Increased Lactate Influx Philip Murphy, Edel Mullen, Stephen Bergin, Geraldine Healy, Michelle Lavin, John Quinn, Siobhan Glavey
402 [GO] 2021―Nov―23 Thrombotic Events in COVID-19 Patients Undergoing Convalescent Plasma Therapy: A Systematic Review Philip Yu, Faran Khalid, Allen Li, Marissa Laureano, Mark Crowther
403 [GO] 2021―Nov―23 Whole Blood Adhesion to VCAM-1 and P-Selectin and RBC Mechanical Fragility Can be Compromised in Long COVID-19 Patients with Sickle Cell Disease Michael Tarasev, Marta Ferranti, Cidney Allen, Xiufeng Gao, Kayla Topping, Marta Ferranti, et al. (+3)
404 [GO] 2021―Nov―23 Treatment of COVID-19 Patients: Insights into the Use of Bone Marrow-Derived Mesenchymal Stem Cells Heitor Duarte Andrade, Andrea Tiemi Kondo, Lucila Kerbauy, Raquel de Melo Alves Paiva, Denise Cristine Oliveira, Larissa Leggieri Coa, et al. (+7)
405 [GO] 2021―Nov―23 Early Immune Profile Assessment By Flow Cytometry Predicts Severe COVID-19 Pneumonia Abora Rial-Villavecchia, Maria Teresa Asensi, Carme Giménez-Argente, Joan Gómez-Junyent, Juan Jose Rodriguez-Sevilla, Leonor Arenillas, et al. (+5)
406 [GO] 2021―Nov―23 Multi-Arm Trial of Inflammatory Signal Inhibitors (MATIS) for Hospitalised Patients with Mild or Moderate COVID-19 Pneumonia: A Structured Summary of a Study Protocol for a Randomised Controlled Trial Asad Charania, Nikhil Vergis, Rachel Phillips, Victoria Cornelius, Alexia Katsarou, Taryn Youngstein, et al. (+14)
407 [GO] 2021―Nov―23 Use of Defibrotide in Patients with COVID-19 Pneumonia; Results of the Defi-VID19 Phase 2 Trial Annalisa Ruggeri, Antonio Voza, Carmine Liberatore, Gloria Catalano, Francesco Corrado, Luigi Di Filippo, et al. (+16)
408 [GO] 2021―Nov―23 An Inpatient COVID-19 Prophylaxis Protocol and Its Outcomes: Adherence and Efficacy Adrienne Kaufman, Yael Kusne, Molly Klanderman, Heidi E. Kosiorek, Thomas Oliver, Miguel Gonzalez-Velez, et al. (+4)
409 [GO] 2021―Nov―23 Online Patient-Reported Platform Detects Trend of Increased COVID-19 Risk and Severity for Multiple Myeloma Patients on Active Lenalidomide-Based Therapy Emily I. Liu, Nathan W. Sweeney, Jennifer M. Ahlstrom
410 [GO] 2021―Nov―23 Multiple Myeloma, Clinical Characteristics, and Increased COVID-19 Risk Using Real-World Data Emily I. Liu, Nathan W. Sweeney, Jennifer M. Ahlstrom
411 [GO] 2021―Nov―23 Meta-Analysis of D-Dimer, hsCRP and Cytokines in COVID-19 Severe/Critical Patients in China Jie Zhang, Lidong Zhao, Gang Wang, Linhua Yang
412 [GO] 2021―Nov―23 Acute and Post-Acute COVID-19 Severity and Mortality in Patients with Hematologic Malignancies: A Population-Based Registry Study Joaquin Martinez-Lopez, Javier De La Cruz, Rodrigo Gil-Manso, Angel Cedillo, Adrian Alegre, Maria Pilar Llamas Sillero, et al. (+24)
413 [GO] 2021―Nov―23 Identification of Complement-Related Missense Variants in Pediatric Patients with Acute and Post COVID-19 Syndromes Eleni Gavriilaki, Tasoula Touloumenidou, Stefanos Tsiftsoglou, Athanasios Tragiannidis, Evangelia Farmaki, Paraskevi Panagopoulou, et al. (+15)
414 [GO] 2021―Nov―23 CAR-NK Cells Targeting Sars-Cov-2 Glycosites As COVID-19 Treatment Ilias Christodoulou, Ruyan Rahnama, Wesley J. Ravich, Jaesung Seo, Sergey Zolov, Andrew Marple, et al. (+2)
415 [GO] 2021―Nov―23 Thrombocytopenia with and without Thrombosis Following COVID-19 Vaccination Melissa Ge, Danyal Ladha, Jennifer Lymer, Stefana Pancic, Marc Carrier, Gregoire Le Gal, Lana A Castellucci
416 [GO] 2021―Nov―23 Relapsed Refractory Acquired Thrombotic Thrombocytopenic Purpura (aTTP) Following COVID-19 Vaccination Michael T. Francisco, Adrienne E. Kaufman, Donald Northfelt, Leslie Padrnos, Allison C. Rosenthal, Jennifer Andres, et al. (+3)
417 [GO] 2021―Nov―23 Patients with Multiple Myeloma on Anti-CD38 or Anti-BCMA Based Regimens and Patients with Waldenstrom's Macroglobulinemia Under Rituximab or BTK Inhibitors Have a Poor Humoral Response Following COVID-19 Vaccination Evangelos Terpos, Maria Gavriatopoulou, Ioannis Ntanasis-Stathopoulos, Alexandros Briasoulis, Sentiljana Gumeni, Panagiotis Malandrakis, et al. (+10)
418 [GO] 2021―Nov―23 COVID-19 Vaccination after Allogeneic Stem Cell Transplantation: Real Word Data on Safety and Efficacy. a Single Center Experience. Adela Neagoie, Charlotte Sommer, Andrea Gantner, Verena Wais, Jacqueline Schnell, Hannah Simon, et al. (+4)
419 [GO] 2021―Nov―23 Anti-Spike (S) Antibody Production Post Covid-19 Vaccination after B Cell Depleting Therapy (BCDT) for Non-Hodgkin Lymphoma (NHL) Josselyn Glamyr Molina
420 [GO] 2021―Nov―23 Seroconversion Rates after COVID-19 Vaccination Amongst Patients with Hematologic Malignancies: Results of a Rapid Vaccination and Evaluation Program in a Minority Rich, Ethnically Diverse Inner City Cohort Lauren C Shapiro, Radhika Gali, Astha Thakkar, Jesus D Gonzalez-Lugo, Abdul Hamid Bazarbachi, Shafia Rahman, et al. (+14)
421 [GO] 2021―Nov―23 BNT162b2 mRNA COVID-19 Vaccination (BNTCV) in Patients (Pts) Having Hematological Malignancies (HM): Early tolerance with telemedicine application connecting and antibody anti-Spike IgG response (AcAS) Jean-Francois Rossi, Emmanuel Bonnet, Marion Velensek, Emma Wisniewski, Sophie Heraud, Rania Boustany, et al. (+7)
422 [GO] 2021―Nov―23 For Better or for Worse: COVID-19 Vaccination during or Early after (Immuno-) Chemotherapy or Hematopoietic Progenitor Cell Transplantation Sabine Haggenburg, Birgit I. Lissenberg-Witte, Robert S. Van Binnendijk, Gerco Den Hartog, Bhoekhan S. Michel, Nienke J.E. Haverkate, et al. (+12)
423 [GO] 2021―Nov―23 COVID-19 Vaccination in Adults with Immune Thrombocytopenia (ITP): Data from the Platelet Disorder Support Association (PDSA) Patient Registry Jennifer MacWhirter - DiRaimo, Caroline Kruse, James B Bussel, Alexandra Kruse
424 [GO] 2021―Nov―23 Factors Associated with Seroconversion after COVID-19 Vaccination in Patients with Hematologic Malignancies Thomas A. Ollila, Rebecca Masel, John L Reagan, Kimberly Paiva, Shaolei Lu, Ralph Rogers, et al. (+6)
425 [GO] 2021―Nov―23 Immunogenicity of Covid-19 Vaccination in Subjects with Myelodysplastic Syndromes Jennifer Vidler, Thanussuyah Alaguthurai, Sultan Abdul-Jawad, Sivalekha Viramuthu, Richard Beatson, Rosalind Graham, et al. (+3)
426 [GO] 2021―Nov―23 Adverse Events Following COVID-19 Vaccination in Transfusion-Dependent -Thalassemia Patients Polyxeni Delaporta, Eugenia Lampropoulou, Anastasia Moschoviti, Ilona Binenbaum, Dimitra Kyriakopoulou, Natalia Ioakeimidou, et al. (+3)
427 [GO] 2021―Nov―23 The Immediate Effect of COVID-19 Vaccination on Anticoagulation Control in Patients Using Vitamin K Antagonists Chantal Visser, Joseph S. Biedermann, Melchior C. Nierman, Felix J. M. Van der Meer, Anouk J. W. Gulpen, Yvonne C. F. Moors, et al. (+4)
428 [GO] 2021―Nov―23 Response to COVID-19 Vaccination Post-CAR T Therapy in Patients with Non-Hodgkin Lymphoma and Multiple Myeloma Julia E. Wiedmeier, Madiha Iqbal, Javier Munoz, Evandro D. Bezerra, Juan Esteban Garcia Robledo, Radhika Bansal, et al. (+26)
429 [GO] 2021―Nov―23 Autoimmune Cytopenias and Covid-19 Vaccination: Relapse and Suggested Treatment Gregorio Campos-Cabrera, Francisco-Gerardo Torres-Salgado, Salvador Campos-Cabrera, Jose-Luis Campos-Villagomez, Virginia Campos-Cabrera
430 [GO] 2021―Nov―23 Deep Vein Thrombosis after COVID-19 Vaccinations Damon E. Houghton, Anand Padmanabhan, Aneel A. Ashrani, Ewa Wysokinska, Rahul Chaudhary, Leslie Padrnos, et al. (+4)
431 [GO] 2021―Nov―23 Humoral and Cellular Immunogenicity of COVID-19 Vaccinations in Patients with CLL Clare Sun, Erika M Gaglione, Lauren T Vaughn, Rui Mu, Chingiz Underbayev, Jonathan Chen, et al. (+2)
432 [GO] 2021―Nov―23 A Clue to Better Select Chronic Lymphocytic Leukemia Patients with Optimal Response to BNT162b2 mRNA COVID-19 Vaccine Stefano Molica, Diana Giannarelli, Mirella Lentini, Daniela Zappala, Daniela Loiacono, Valentina Gianfelici, et al. (+4)
433 [GO] 2021―Nov―23 Serological Response to the BNT162b2 mRNA or Chadox-Ncov-19 COVID-19 Vaccine after First and Second Doses in Plasma Cell Disorder Patients: Influence of Host and Disease Factors Wei Yee Chan, Lara Howells, William Wilson, Emilie Sanchez, Louise Ainley, Selina J Chavda, et al. (+16)
434 [GO] 2021―Nov―23 Social and Demographic Factors Contributing to COVID-19 Vaccine Hesitancy in Patients with Hematologic Malignancies Karen Sweiss, Meredith Russell, Gregory S Calip, Ryan Nguyen, Meshaal Khan, Eshana Shah, et al. (+9)
435 [GO] 2021―Nov―23 Cellular Immune Responses to BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia Gilad Itchaki, Lior Rokach, Ohad Benjamini, Osnat Bairey, Adi Sabag, Helly Vernitsky, et al. (+6)
436 [GO] 2021―Nov―23 The Effect of COVID-19 Vaccine in Patients with Immune Thrombocytopenia Chantal Visser, Maurice Swinkels, Erik D. van Werkhoven, F. Nanne Croles, Heike Noordzij, Matthijs Eefting, et al. (+10)
437 [GO] 2021―Nov―23 Oral Ixazomib in Untreated Follicular Lymphoma Permits COVID-19 Vaccine Response and Its Efficacy Is Associated with Clinical Factors and Gene Expression Signatures Solomon A. Graf, Ryan C. Lynch, Chaitra S. Ujjani, Ted A Gooley, David G. Coffey, Andrew J. Cowan, et al. (+8)
438 [GO] 2021―Nov―23 Impaired mRNA Based COVID-19 Vaccine Response in Patients with B-Cell Malignancies after CD19 Directed CAR-T Cell Therapy Saurabh Dahiya, Tim Luetkens, Stephanie Avila, Saurabh Dahiya, Philip Margiotta, Kim Hankey, et al. (+12)
439 [GO] 2021―Nov―23 COVID-19 Vaccine Response in Patients with Hematologic Malignancy: A Systematic Review and Meta-Analysis Inna Gong, Abi Vijenthira, Stephen Betschel, Lisa K. Hicks, Matthew Cheung
440 [GO] 2021―Nov―23 Determinants of COVID-19 Vaccine Response in Patients with Lymphoma on B Cell Directed Therapy Shipra Goel, Juan J. Gu, Pallawi Torka, Cory Mavis, Suchitra Sundaram, Mirdza Neiders, et al. (+7)
441 [GO] 2021―Nov―23 COVID-19 Vaccine Responsiveness in Patients with Multiple Myeloma and Waldenström Macroglobulinemia Andrew R. Branagan, Matthew M Lei, Jenny S Maron, Andrew J Yee, Elizabeth O'Donnell, Jorge J. Castillo, et al. (+20)
442 [GO] 2021―Nov―23 Timing and Immune Status after Cellular Therapies Predict Response to COVID-19 Vaccines Roni Tamari, Ioannis Politikos, David Knorr, Santosha Vardhana, Jennifer Young, Leeann Marcello, et al. (+12)
443 [GO] 2021―Nov―23 Biomarkers for Thrombosis in COVID-19: A Role for High Sensitivity Troponin-I and Immature Platelet Fraction? Bilal Ashraf, Haekyung Jeon-slaughter, Christopher Webb, Nicholas C.J. Lee, Weina Chen, Sung-Hee Choi, et al. (+2)
444 [GO] 2021―Nov―23 Loss of an Immunodominant HLA-Α *01:01 Restricted Epitope for CD8+ Cytotoxic T Lymphocytes (CTLs) in the Delta Variant of COVID-19: An Example of Immunologic Escape and Implications for Immunologic Treatment Neal Flomenberg, Dolores Grosso, Yuri Sykulev, Nadezhda Anikeyeva, Yanping Huang, Michael Sun, et al. (+13)
445 [GO] 2021―Nov―23 Outcomes of Patients with Hematologic Malignancies and COVID-19: Perspective of a Large Hematology Center in Greece Nikolaos Spyridis, Georgios Karavalakis, Despina Mallouri, Ioannis Eftychidis, Panagiotis Dolgyras, Niki Stavroyianni, et al. (+5)
446 [GO] 2021―Nov―23 Acute Leukemia and COVID-19: The Johns Hopkins Experience Karin Paige Miller, Patrick A. Brown, B. Douglas Smith, Jonathan Webster, Helen Powell, Amy S. Duffield
447 [GO] 2021―Nov―23 The Experience of the Cooperation in Science and Technology European Network for Innovative Diagnosis and Treatment of Chronic Neutropenias (COST EuNet-INNOCHRON) Action and the Sweden Experience in the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Era Michail Spanoudakis, David C. Dale, Emily Tran, Marije Bartels, Suncica Kapor, Daniela Guardo, et al. (+6)
448 [GO] 2021―Nov―23 Evaluation of Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Immunizations in Patients with B-Cell Malignancies Mukul Singal, Sanjana Kalvehalli Kashinath, S Shahzad Mustafa, Edward Walsh, Karthik Vadamalai, Saad Jamshed
449 [GO] 2021―Nov―23 Rapid Disappearance of Lupus Anticoagulant in Novel Coronavirus 2019 Patients; Is It the Key to Pandora's Box? Hyunji Kim, Seongsoo Jang
450 [GO] 2021―Nov―23 A Phase I/II Dose-Escalation Multi-Center Study to Evaluate the Safety of Infusion of Natural Killer Cells or Memory T Cells As Adoptive Therapy in Coronavirus Pneumonia and/or Lymphopenia: (RELEASE NCT04578210) Antonio Pérez-Martínez, Alejandro Martín-Quirós, Cristina Ferreras, Karima Al-Akioui, Marta Mora-Rillo, Rosa Goterris, et al. (+17)
451 [GO] 2021―Nov―23 Sars-Cov-2 Antibody Levels in Blood Cancer Patients after a Third Sars-Cov-2 "Booster" Vaccination - Observational Data from the LLS National Registry Lee M Greenberger, Larry A Saltzman, Jonathon W Senefeld, Patrick W Johnson, Louis J DeGennaro, Gwen L Nichols
452 [GO] 2021―Nov―23 Sars-Cov-2 Antibody Decay Monitoring in mRNA Vaccinated Multiple Myeloma Patients Samuel D. Stampfer, Marissa-Skye Goldwater, Bernard Sean S. Regidor, Scott Kristian Jew, Sean Elliott Bujarski, Haiming Chen, et al. (+10)
453 [GO] 2021―Nov―23 Chronic Graft-Versus-Host Disease (cGVHD) Exacerbation after Sars-Cov-2 Covid Vaccination Andrew D. Trunk, Samuel Shewan, Catherine J. Lee, Daniel R. Couriel
454 [GO] 2021―Nov―23 Low Frequency of T Cell and Antibody Responses to Vaccination Against Sars-Cov-2 in Patients Post Allogeneic Stem Cell Transplantation in Comparison with Chronic Myeloid Malignancy Patients Patrick Harrington, Katie Doores, Chandan Saha, Jamie Saunders, Deepti H. Radia, Shahram Kordasti, et al. (+14)
455 [GO] 2021―Nov―23 Antibody Response after Vaccination for Sars-Cov-2 in Patients with AL Amyloidosis and the Impact of Therapy Efstathios Kastritis, Evangelos Terpos, Aimilia D. Sklirou, Foteini Theodorakakou, Despina Fotiou, Eleni-Dimitra Papanagnou, et al. (+9)
456 [GO] 2021―Nov―23 Neutralizing Antibody Responses Against Sars-Cov-2 in Patients with Plasma Cell Disorders Who Are on Active Treatment after Two Doses of mRNA Vaccination Al-Ola Abdallah, Zahra Mahmoudjafari, Meera Mohan, Joseph P. McGuirk, Cassie Remker, Margaret Foss, et al. (+4)
457 [GO] 2021―Nov―23 Sars-Cov-2 Induced Endotheliopathy and the Impact on Clinical Outcomes in Critically Ill Pediatric Patients Shreya Agarwal, Mark Zobeck, Clay T Cohen, Sarah E Sartain
458 [GO] 2021―Nov―23 Incidence of Sars-COV-2 Infection in Sickle Cell Patients Presenting with a Painful Crisis, a 12 Month Prospective Cohort Study Kadère Konté, Erfan Nur, Man Wai Tang, Jarom Heijmans, Charlotte F.J. Van Tuijn, Bart J. Biemond
459 [GO] 2021―Nov―23 The Role of PF4 Antibodies in Pediatric Sars-Cov-2 Infections Meady Chiem, Lubica Rauova, Caroline Diorio, Kevin O McNerney, Hamid Bassiri, Kathleen Sullivan, et al. (+3)
460 [GO] 2021―Nov―23 Clinical and Immunological Assessment of Patients with Sars-Cov-2 Infections Aditi Singh, Natali Salaytah, Daniel Lebovic, Zeyad Sako, Zachary Pounders, Laura Kohler, et al. (+4)
461 [GO] 2021―Nov―23 Interest of a Third Dose of BNT162b2 Anti- Sars-Cov-2 mRNA Vaccine in Allogeneic Hematopoietic Stem-Cells Recipients Amandine Le Bourgeois, Marianne Coste-Burel, Thierry Guillaume, Pierre Peterlin, Alice Garnier, Berthe-Marie Imbert, et al. (+14)
462 [GO] 2021―Nov―23 Suboptimal Humoral and Cellular Immune Response to SARS-CoV-2 RNA Vaccination in Myeloma Patients Is Associated with Anti-CD38 and BCMA-Targeted Treatment Oliver Van Oekelen, Sarita Agte, Adolfo Aleman, Bhaskar Upadhyaya, Charles R. Gleason, Komal Srivastava, et al. (+17)
463 [GO] 2021―Nov―23 Serologic Responses Following Sars-Cov-2 Vaccination and Factors Influencing It in Patients with Hematological Malignant and Non-Malignant Diseases - a Prospective Multicentric Study Zrinka Sertić, Marko Lucijanic, Sandra Bašić-Kinda, Ranka Serventi Seiwerth, Vlatka Periša, Dubravka Sertić, et al. (+7)
464 [GO] 2021―Nov―23 Monitoring of Patients with Autoimmune Cytopenias during Sars-Cov-2 Vaccination Campaign: The Experience of a Reference Center Bruno Fattizzo, Juri Alessandro Giannotta, Nicola Cecchi, Paola Bianchi, Wilma Barcellini
465 [GO] 2021―Nov―23 Antibody Response to Sars-Cov-2 Vaccination in Patients Following Allogeneic Hematopoietic Cell Transplantation Caroline Cicin-Sain, Alice Huang, Chloe Pasin, Selina Epp, Nicolas J Mueller, Jakob Nilsson, et al. (+12)
466 [GO] 2021―Nov―23 Sars-Cov-2 Vaccination in Patients with Pre-Existing Immune Thrombocytopenia Eun-Ju Lee, Marina Beltrami Moreira, Hanny Al-Samkari, Adam Cuker, Jennifer MacWhirter - DiRaimo, Terry B. Gernsheimer, et al. (+13)
467 [GO] 2021―Nov―23 Increase in Antibody Titers Following Sars-Cov-2 Vaccination Remains Limited for More Than 3 Years after Final Dose of Anti-CD20 Antibody Yohei Funakoshi, Kimikazu Yakushijin, Goh Ohji, Hironori Sakai, Wataru Hojo, Marika Watanabe, et al. (+17)
468 [GO] 2021―Nov―23 Response to BNT162b2 Sars-Cov-2 Vaccine in Recipients of Allogeneic Hematopoietic Stem Cell Transplant Francesco Saraceni, Alessandro Fiorentini, Sonia Morè, Selene Guerzoni, Bruna Puglisi, Benedetta Corvaro, et al. (+25)
469 [GO] 2021―Nov―23 Profound B-Cell Lymphopenia Is a Major Factor Predicting Poor Humoral Response after BNT162b2 mRNA Sars-Cov-2 Vaccines in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation Maxime Jullien, Amandine Le Bourgeois, Marianne Coste-Burel, Pierre Peterlin, Alice Garnier, Marie Audrain, et al. (+16)
470 [GO] 2021―Nov―23 Inhibition of Sars-Cov-2 Viral Replication and In Vivo Thrombus Formation By a Novel Plant Flavonoid Moua Yang, Lin Lin, Christina Scartelli, Da-Yuan Chen, Anika Patel, Roelof Bekendam, et al. (+3)
471 [GO] 2021―Nov―23 Prospective Assessment of Biomarkers of Hypercoagulability in Oncological Patients and Healthcare Workers Following Vaccination Against Sars-Cov-2 with the mRNA Vaccine. the Roadmap-COVID-19-Vaccin Study Patrick Van Dreden, Joseph Gligorov, Evangelos Terpos, Mathieu Jamelot, Michele Sabbah, Despina Fotiou, et al. (+8)
472 [GO] 2021―Nov―23 Comparison of Clinical and Thrombotic Outcomes in Sars-Cov-2- Pneumonia Versus Other Viral Pneumonia in an Urban Academic Medical Center Rachel N. Goldberg, Kevin Johns, William Ye, Jeff J. Mucksavage, John G. Quigley, Nancy L. Shapiro, et al. (+4)
473 [GO] 2021―Nov―23 Poor Neutralizing Antibody Responses in Patients with CLL, NHL and HL after Vaccination Against Sars-Cov-2; A Prospective Study in 132 Patients Evangelos Terpos, Maria Gavriatopoulou, Despina Fotiou, Chara Giatra, John V. Asimakopoulos, Maria Dimou, et al. (+12)
474 [GO] 2021―Nov―23 Sars-CoV2 Antibody Responses in Patients with Hematological Malignancies Following Anti-CD20 Therapy Veronica A Guerra, Marisol Ocampo, Mike Cusnir
475 [GO] 2021―Nov―23 Adoptive Immune Responses to Sars-Cov2 Vaccination in CART19 Treated Patients Kalpana Parvathaneni, Kyabeth Toress-Rodriguez, Wenzhao Meng, James Knox, Xiaoming Xu, Daniela Weiskopf, et al. (+9)
476 [GO] 2021―Nov―23 A Case Series of Acquired Factor Inhibitor Following Sars-COV2-Vaccination Sriraksha Jayananda
477 [GO] 2021―Nov―23 Optimizing Viable CD34 + Enumeration in Cryopreserved HPC Samples for Implementation of an External QA Program - Relevance to the Current Pandemic Scott J Ragg, Annabella Chang, David Ma
478 [GO] 2021―Nov―23 Impact of COVID 19 Pandemic on Health Care Utilization for Patients with Sickle Cell Disease - a Specialty Treatment Center Experience Akshat Jain, Amie Patel, Udochukwo Oyoyo, Seth Wiafe
479 [GO] 2021―Nov―23 Updated Outcomes during the Pandemic: Relationship between CD34and CD3 Cell Doses, One-Year Graft-Versus-Relapse-Free-Survival, Graft-Versus-Host Disease, and Overall Survival in Haploidentical Hematopoietic Stem Cell Transplantation Using Post Transplant Cytoxan: A Single Center Experience Anastasia Martynova, Krithika Chennapan, Jack Rodman, Mindy Hsiao, Abdullah Ladha, Eric Tam, et al. (+3)
480 [GO] 2021―Nov―23 Determining the Rate of Anti-PF4 Antibody Positive Results in Patients Presenting with Venous Thrombosis but a Normal Platelet Count Following ChAdOx1 Ncov-19 Astrazeneca Vaccination: An Australian Combined State Testing Centre Experience Emma J Leitinger, Joanne Clifford, Michael Parker, Amanda Iacobelli, Pauline Sung, Vivien Chen, et al. (+10)
481 [GO] 2021―Nov―08 COVID-19 in vaccinated adult patients with hematological malignancies. Preliminary results from EPICOVIDEHA Livio Pagano, Jon Salmanton-García, Francesco Marchesi, Alberto Lopez-Garcia, Sylvain Lamure, Federico Itri, et al. (+30)
482 [GO] 2021―Nov―04 COVID-19 in patients with CLL: how can we change the odds? Yair Herishanu, Chava Perry
483 [GO] 2021―Oct―25 COVID-19 Convalescent plasma Aaron Tobian, Claudia S Cohn, Beth Shaz
484 [GO] 2021―Oct―20 Effectiveness of the BNT162b2mRNA Covid-19 Vaccine in Patients with Hematological Neoplasms Moshe Mittelman, Ori Magen, Noam Barda, Noa Dagan, Howard S Oster, Avi Leader, Ran Balicer
485 [GO] 2021―Oct―07 COVID-19 and VITT: same or different? Gowthami M. Arepally
486 [GO] 2021―Sep―29 SARS-CoV-2 Vaccination and Immune Thrombocytopenia in de novo and pre-existing ITP patients Eun-Ju Lee, Marina Beltrami Moreira, Hanny Al-Samkari, Adam Cuker, Jennifer DiRaimo, Terry Gernsheimer, et al. (+13)
487 [GO] 2021―Sep―29 Insights in ChAdOx1 nCov-19 Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT) Andreas Greinacher, Kathleen Selleng, Raghavendra Palankar, Jan Wesche, Stefan Handtke, Martina Wolff, et al. (+25)
488 [GO] 2021―Sep―06 COVID-19 as a potential trigger of complement-mediated atypical HUS. Carine El-Sissy, Antonin Saldman, Gilbert zanetta, Paula Vieira-Martins, Coralie Poulain, Raphaël Cauchois, et al. (+12)
489 [GO] 2021―Aug―02 Response to SARS-CoV-2 vaccination in patients after hematopoietic cell transplantation and CAR-T cell therapy Binod Dhakal, Sameem M Abedin, Timothy S. Fenske, Saurabh Chhabra, Nathan Ledeboer, Parameswaran Hari, Mehdi Hamadani
490 [GO] 2021―Jul―23 COVID-19 in patients with CLL: improved survival outcomes and update on management strategies Lindsey Elizabeth Roeker, Toby Andrew Eyre, Meghan C. Thompson, Nicole Lamanna, Alexander Coltoff, Matthew S. Davids, et al. (+45)
491 [GO] 2021―Jul―23 Immune Thrombocytopenic Purpura after vaccination with COVID-19 Vaccine (ChAdOx1 nCov-19) Finn-Ole Paulsen, Christoph Schaefers, Florian Langer, Christian Frenzel, Ulrich Wenzel, Felicitas E. Hengel, et al. (+2)
492 [GO] 2021―Jul―19 Anti-Platelet Factor 4 Antibodies Causing VITT do not Cross-React with SARS-CoV-2 Spike Protein Andreas Greinacher, Kathleen Selleng, Julia Mayerle, Raghavendra Palankar, Jan Wesche, Sven Reiche, et al. (+20)
493 [GO] 2021―Jul―15 Thrombosis with COVID-19: kids get it too Cliff Takemoto
494 [GO] 2021―Jul―01 Impaired humoral responses to COVID-19 vaccination in patients with lymphoma receiving B-cell directed therapies Paola Ghione, Juan J Gu, Kristopher Attwood, Pallawi Torka, Shipra Goel, Suchitra Sundaram, et al. (+16)
495 [GO] 2021―Jun―10 Efficacy of COVID-19 vaccine in patients with CLL
496 [GO] 2021―Jun―10 Vaccination against COVID-19: a challenge in CLL Barbara Eichhorst
497 [GO] 2021―Jun―02 SARS-CoV-2 infection induces the activation of tissue factor-mediated coagulation by activation of acid sphingomyelinase Jue Wang, Usha R. Pendurthi, Guohua Yi, L. Vijaya Mohan Rao
498 [GO] 2021―May―20 Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry Dimitrios Giannis, Steven L. Allen, James Tsang, Sarah Flint, Tamir Pinhasov, Stephanie Williams, et al. (+22)
499 [GO] 2021―May―14 Frequency of positive anti-PF4/polyanion antibody tests after COVID-19 vaccination with ChAdOx1 nCoV-19 and BNT162b2 Thomas Thiele, Lena Ulm, Silva Holtfreter, Linda Schönborn, Sven Olaf Kuhn, Christian Scheer, et al. (+7)
500 [GO] 2021―May―05 COVID-19 Vaccines Induce Severe Hemolysis in Paroxysmal Nocturnal Hemoglobinuria Gloria Frances Gerber, Xuan Yuan, Jia Yu, Benjamin A.Y. Cher, Evan M. Braunstein, Shruti Chaturvedi, Robert A. Brodsky
501 [GO] 2021―May―05 A Flow cytometric assay to detect platelet activating antibodies in VITT after ChAdOx1 nCov-19 vaccination Stefan Handtke, Martina Wolff, Carlo Zaninetti, Jan Wesche, Linda Schönborn, Konstanze Aurich, et al. (+5)
502 [GO] 2021―Apr―28 Prothrombotic immune thrombocytopenia after COVID-19 vaccine Andreas Tiede, Ulrich J Sachs, Andreas Czwalinna, Sonja Werwitzke, Rolf Bikker, Joachim K Krauss, et al. (+6)
503 [GO] 2021―Apr―25 Rate of thrombosis in children and adolescents hospitalized with COVID-19 or MIS-C Hilary Baker Whitworth, Sarah E Sartain, Riten Kumar, Katherine Armstrong, Lance Ballester, Marisol Betensky, et al. (+14)
504 [GO] 2021―Apr―17 Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia Yair Herishanu, Irit Avivi, Anat Aharon, Gabi Shefer, Shai Levi, Yotam Bronstein, et al. (+7)
505 [GO] 2021―Apr―17 Low Neutralizing Antibody Responses Against SARS-CoV-2 in Elderly Myeloma Patients After the First BNT162b2 Vaccine Dose Evangelos Terpos, Ioannis P Trougakos, Maria Gavriatopoulou, Ioannis Papassotiriou, Aimilia D Sklirou, Ioannis Ntanasis-Stathopoulos, et al. (+4)
506 [GO] 2021―Mar―18 Treon SP, Castillo JJ, Skarbnik AP, et al. The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19-infected patients. Blood. 2020;135(21):1912-1915.
507 [GO] 2021―Feb―25 Another front in COVID-19’s perfect storm Shawn M. Jobe, Renren Wen
508 [GO] 2021―Feb―08 COVID-19 and Hematologic Malignancies: Single Institution Analysis Nwabundo Anusim, Melanie Smalley, Markie Sue Zimmer, Doyle Lang, Vishal Jindal, Hycienth O Ahaneku, et al. (+3)
509 [GO] 2021―Feb―08 Association of Anticoagulant Use with COVID-19 Diagnosis Juraj Kavecansky, Jennifer R Dusendang, Jahan Tavakoli, Julie Schmittdiel, Gwendolyn Ho, Jodi Loyles, Ashok Pai
510 [GO] 2021―Feb―08 Covid-19 Disease Is Not Associated with Venous Thromboembolism in a Cohort of Patients in Jeddah, Saudi Arabia Fatemah Kamel, Rania Magadmi, Sulafa Alqutub, Maha A. Badawi, Fatin Al-Sayes, Mazen Badawi, et al. (+2)
511 [GO] 2021―Feb―08 Patient-Focused Benefits of at-Home Versus in-Clinic Administration of Cancer Therapy: New Considerations for the COVID-19 Era Karen E. Sandman, Timothy J. Bell
512 [GO] 2021―Feb―08 Reduction in Transplantation Activity without Impairment in Outcomes in the Covid-19 Era- Data from the Sarah Cannon Blood Cancer Network (SCBCN) Minoo Battiwalla, Carlos Bachier, Vikas Bhushan, Michael J. Eckrich, Alireza Eghtedar, Haydar Frangoul, et al. (+11)
513 [GO] 2021―Feb―08 Delivering Systemic Anti-Cancer Treatment Via Another Route of Administration As an Option to Reduce Exposure to COVID-19 in Patients with Multiple Myeloma in the UK Holly Cranmer, Tanja Podkonjak, Eugene Benson, Jonathon Dabora, Graham H Jackson
514 [GO] 2021―Feb―08 ABO Blood Type and Outcomes in a Diverse COVID-19 Infected Population Sonal Paul, Nisha Patel, Chathula Kumarasinghe, Neil Nimkar, Angelica Singh, Nivetha Vishnuvardhan, et al. (+10)
515 [GO] 2021―Feb―08 Association of Blood Type on Clinical Outcomes in Black/African Americans Hospitalized for COVID-19 Infection Yan Cheng, Sharif Mohammed, Alexis Okoh, Ki (Steve) Lee, Corinne Raczek, Amin Krushna, et al. (+2)
516 [GO] 2021―Feb―08 Outcomes in Patients with Hematological Malignancies Receiving Anti-CD20 Therapy in the Setting of COVID-19 Infection Carlos A Lopez, David Chitty, Jeffrey Chi, Wasif Saif, Bradley Goldberg
517 [GO] 2021―Feb―08 Outcomes of COVID-19 Infection in Patients with Hematologic Malignancies Elizabeth Behrens, Anne Timmermann, Alexander Yerkan, Deborah A. Katz, Agne Paner, Melissa C. Larson, et al. (+9)
518 [GO] 2021―Feb―08 Prediction of COVID-19 Mortality in Patients with Cancer Simon Mantha, Justin Jee, Gerald A. Soff, Melissa S. Pessin
519 [GO] 2021―Feb―08 Clinical Impact of COVID-19 on Anticoagulation Management at the William S. Middleton Memorial Veterans Hospital Hannah Hecht, Allison B Riendeau, Jillian Kolasinski, Cheryl Ray, Moniba Nazeef
520 [GO] 2021―Feb―08 Increased Productivity and Efficiency Among Cancer Center Clinical Trials Workforce during the COVID-19 Pandemic Kimberly C Jenkins, Emily C Zabor, Lindsey A. R. Mooney, Aaron T. Gerds, Kerry O'Hop, Makenzie Guy, et al. (+3)
521 [GO] 2021―Feb―08 A Shared Electronic Health Record in a Rural Setting Maintains Hematological Cancer Services Remotely during the COVID-19 Pandemic Helen Cashman, Eleni Mayson, David Kliman, Sue Vachalec, Jennifer Bell, Sam Milliken, et al. (+4)
522 [GO] 2021―Feb―08 Utilization of Telemedicine for Comprehensive Visits in Patients with Inherited Bleeding Disorders during the COVID-19 Pandemic Cassandra P Wang, Kelly Ann Bush, Rosalie Brooks, Katharine Farrow, Lizandra Gilsdorf, Fernanda Cortez, Courtney D Thornburg
523 [GO] 2021―Feb―08 Home Care Program for Managing Oncology Patients during COVID-19 Pandemic. a Tertiary Referral Center Experience Giamal Edin Gmati, Nadine Mabsut, Zainab Matar, Mona Alshami, Husam Shahata, Areej Alkhesaifi, et al. (+9)
524 [GO] 2021―Feb―08 COVID-19 Pandemic Highlights Health Disparities in Latinos in San Diego Elisa Quiroz, David J Hermel, Samantha R Bagsic, Carrie L. Costantini, Anuj Mahindra, Alan Saven, et al. (+2)
525 [GO] 2021―Feb―08 Older Age and Increased Neutrophil-to-Lymphocyte Ratio (NLR) Are Predictors of Mortality in a Multiethnic Urban Cohort of Hematologic Neoplasms and COVID-19 Patients Angelica D'Aiello, Sumaira Zareef, Kith Pradhan, Amanda Lombardo, Fariha Khatun, Jennat Mustafa, et al. (+39)
526 [GO] 2021―Feb―08 Thrombotic Complications in COVID-19 Patients: Low Incidence of Thrombotic Complications Among Critically Ill COVID-19 Patients in Singapore Cheryl XQ Lim, Chuen Wen Tan, Bingwen Eugene Fan, Winnie Teo, Moon Ley Tung, Humaira Shafi, et al. (+21)
527 [GO] 2021―Feb―08 COVID-19 Prognostic Score Utilizing Hematological and Inflammatory Markers to Determine Outcomes of Hospitalized Patients Amardeep Kalsi, Sana Irfan Khan, Asad Rehman, Neil Nimkar, Angelica Singh, Nivetha Vishnuvardhan, et al. (+11)
528 [GO] 2021―Feb―08 Improvement in Clinic Efficiency, Patient Satisfaction, and Overcoming Unique Challenges in the Era of COVID-19 with Implementation of Subcutaneous Daratumumab in Patients with Multiple Myeloma (MM) and Light Chain (AL) Amyloidosis David Hughes, Radhika Jhaveri, Bhavesh Shah, Frances Blevins, Alexamil Rodriguez, Shayna Sarosiek, et al. (+3)
529 [GO] 2021―Feb―08 Assessment of Hematologic and Coagulation Parameters As Predictive Value in COVID-19 with Unfavourable Evolution Viola Maria Popov, Lelia Iliescu, Marius Ioan Balea, Daniela Georgeta Georgescu, Mihaela Andreescu, Horia Bumbea, et al. (+21)
530 [GO] 2021―Feb―08 Estimating Mortality in Patients with Hematological Malignancy and COVID-19: A Pooled Analysis of 10 Studies Kamal S. Saini, Marco Tagliamento, Matteo Lambertini, Richard McNally, Adrianne Kelly, Marco Romano, et al. (+5)
531 [GO] 2021―Feb―08 Excellent Outcomes of Patients of Middle Eastern Ethnic Origin with Autologous Haemopoietic Stem Cell Transplantation and COVID-19: Does a Dampened Immune System Protect Against Severe COVID-19? Imran K Tailor, Syed Y Altaf, Nawal F Alshehry, Alaa M Alser, Mohammed Marei, Mansour Alfayez, et al. (+2)
532 [GO] 2021―Feb―08 A Machine Learning Approach for the Differential Diagnosis between Sars-COV19 Infection and Influenza Viruses with Hematological Morphologic DATA (CELL MORPHOLOGIC DATA) Fernando Calvo Boyero, Sandra Gomez Gomez Rojas, Gloria Perez Segura, Ana Lopez Jimenez, Miguel Pedrera Jimenez, Gonzalo Carreño Gomez-Tarragona, et al. (+2)
533 [GO] 2021―Feb―08 Prospective Pilot Study of Telehealth As Domiciliary Follow-up after Hematopoietic Cell Transplantation during the COVID19 Pandemic Alberto Mussetti, Maria Queralt Salas Gay, Maria Condom, Maite Antonio, Cristian Ochoa, Iulia Ivan, et al. (+6)
534 [GO] 2021―Feb―08 Critical Care Support Improves Outcome of Haematology Admissions: A Retrospective Analysis during Covid Pandemic from UK Richard Whitmill, Supratik Basu, Anandadeep Mandal, Ubon Usung, Arwa Babai, Mustafa Mohamed
535 [GO] 2021―Feb―08 Perception and Psychological Help Seeking Behaviour Among Hematology Healthcare Workers during the COVID19 Pandemic in India Lakshmi Prabha, Kishore Kumar
536 [GO] 2021―Feb―08 COVID-19 Associated Coagulopathy: Thrombosis, Hemorrhage and Mortality Rates with an Escalated-Thromboprophylaxis Strategy Molly Daughety, Thomas L. Ortel, Erin Frost, Andrew Morgan, Chester Kao, Joyce Hwang, et al. (+2)
537 [GO] 2021―Feb―08 Edoxaban Vs. Low Molecular Weight Heparin As Anticoagulant Therapy in Hospitalized Patients with Atrial Fibrillation and COVID-19 Infection Pável E Olivera, Desiree Campoy, César A Velasquez, Katia Flores, Tania Canals, Erik A Johansson, et al. (+4)
538 [GO] 2021―Feb―08 Leveraging the Power of a Healthcare System to Fulfill the COVID Convalescent Plasma Needs Early in the COVID-19 Pandemic Valentina Baez Sosa, Cathy Conry-Cantilena, Glenn Wortmann, Emily R Fischer, Brandon G Clark, Lorraine Wyne, Aarthi Shenoy
539 [GO] 2021―Feb―08 Clonal Hematopoiesis and COVID-19 Severity in Cancer Patients Kelly L. Bolton, Michael Foote, Justin Jee, Anton Safonov, Ryan Ptashkin, Sean Devlin, et al. (+13)
540 [GO] 2021―Feb―08 Myelodysplastic Syndromes (MDS) & COVID-19: Clinical Experience from the US Epicenter of the Pandemic Jonathan Feld, Erin P. Demakos, Rosalie Odchimar-Reissig, Douglas Tremblay, Saudia Alli, Darshanie Sewah, et al. (+2)
541 [GO] 2021―Feb―08 Prevalence of Sars-Cov-2 Infection in Patients with Chronic Myeloid Leukemia Simone Claudiani, Carolina Rosadas, Myra McClure, Maryam Khan, Richard S. Tedder, Andrew J. Innes, et al. (+2)
542 [GO] 2021―Feb―08 COVID-19 in Patients with Lymphoma: A Grupo De Estudio Latinoamericano En Linfoproliferativos (GELL) Retrospective Study Guilherme Fleury Perini, Juan Alejandro Ospina Idarraga, Maria Alejandra Torres Viera, Brady E Beltran, Denisse A. Castro, Victoria Otero, et al. (+34)
543 [GO] 2021―Feb―08 Incidence of Venous Thromboembolic Events in Hospitalized COVID-19 Patients: A Systematic Review Nicolas Galllastegui Crestani, Jenny Y Zhou, Annette von Drygalski, Timothy A Morris
544 [GO] 2021―Feb―08 Sars-Cov-2 Spike Protein Induces Cellular Changes in Primitive and Mature Hematopoietic Cells James Ropa, Scott Cooper, Maegan L. Capitano, Hal E. Broxmeyer
545 [GO] 2021―Feb―08 Impact of COVID19 Pandemic on an International MPN Patient Population: Survey Results from 1560 MPN Patients Jeanne M. Palmer, Carolyn Mead-Harvey, Claire Harrison, Amylou C. Dueck, Ryan Eckert, Heidi E. Kosiorek, et al. (+25)
546 [GO] 2021―Feb―08 Outpatient Transplantation during the COVID19 Pandemic: Stretching the Limits for Continuing Care Perla R. Colunga Pedraza, Julia Esther Colunga Pedraza, Andres Gomez-De Leon, Mónica Bustillos Muñoz, Karen Lorena Osorno-Rodriguez, Jose Angel Hawing, et al. (+5)
547 [GO] 2021―Feb―07 COVID-19 Infection in Patients with Paroxysmal Nocturnal Hemoglobinuria in Italy Wilma Barcellini, Bruno Fattizzo, Luisa Quattrocchi, Juri Alessandro Giannotta, Semra Aydin, Federica Barone, et al. (+6)
548 [GO] 2021―Feb―07 Healthcare Utilization Among Children and Adolescents with Sickle Cell Disease during the COVID-19 Pandemic Andrea Nowlin, Kristina Lai, Alexander Maillis, Patricia Waters, Beatrice Gee, Peter A. Lane
549 [GO] 2021―Feb―07 Venous Thromboembolism Prophylaxis Practices for Patients with Sickle Cell Disease Pre and during the COVID-19 Pandemic Jennifer G. Davila, W. Beau Mitchell, Kerry A Morrone, Ellen J Silver, Caterina P Minniti, Henny H. Billett, et al. (+3)
550 [GO] 2021―Feb―07 COVID-19: B-Cell Depletion and Sepsis Related Changes in Bone Marrow and Spleen Jana Ihlow, Ann-Christin von-Bruenneck, Edward Georg Michaelis, Selina Greuel, Verena Heynol, Annika Lehmann, et al. (+9)
551 [GO] 2021―Feb―07 Impact of Sickle Cell Trait on Morbidity and Mortality from Sars-Cov-2 Infection Lauren E. Merz, Kavita Mistry, Revital Freedman, Katherine L Jolley, Hae Soo Park, David M. Dorfman, et al. (+2)
552 [GO] 2021―Feb―07 Thrombosis and Risk Management in Paediatric Inflammatory Multisystem Syndrome - Temporally Associated with Sars-CoV2 (PIMS-TS) Ho Pui Jeff Lam, Jayanthi Alamelu, James Brighouse, Owen Miller, Jonathan Lillie, Baba PD Inusa
553 [GO] 2021―Feb―06 Evaluation of the Prothrombin Fragment 1.2 in Patients with COVID-19 Hanny Al-Samkari, Fei Song, Elizabeth M. Van Cott, David J. Kuter, Rachel P. Rosovsky
554 [GO] 2021―Feb―06 Filter Clotting with Continuous Renal Replacement Therapy in COVID-19 Rachel P. Rosovsky, Paul Endres, Soophia H Zhao, Scott Krinsky, Shananssa G Percy, Omer Kamal, et al. (+13)
555 [GO] 2021―Feb―06 Using Allogeneic, Off-the-Shelf, Sars-Cov-2-Specific T Cells to Treat High Risk Patients with COVID-19 Spyridoula Vasileiou, Manik Kuvalekar, Aster Workineh, Ayumi Watanabe, Yovana Velazquez, Suhasini Lulla, et al. (+7)
556 [GO] 2021―Feb―06 Worldwide Examination of Patients with CLL Hospitalized for COVID-19 Lindsey E Roeker, Lydia Scarfo, Thomas Chatzikonstantinou, Pau Abrisqueta, Toby A. Eyre, Raul Cordoba, et al. (+147)
557 [GO] 2021―Feb―06 Clinical Outcomes in Patients with Hematologic Malignancy (HM) and COVID-19 Michael Roderick Cook, Kaitlyn C Dykes, Katherine White, Jaeil Ahn, Nathan Cobb, Catherine Lai
558 [GO] 2021―Feb―06 Severity of Sars-Cov-2 Infection in Patients with Hematologic Malignancies: A COVID-19 and Cancer Consortium (CCC19) Registry Analysis Samuel Rubinstein, Ryan C. Lynch, Aakash Desai, Catherine Stratton, Alokkumar Jha, Ziad Bakouny, et al. (+12)
559 [GO] 2021―Feb―06 Clinical Course and Outcomes of Sickle Cell Disease Patients with COVID-19 at a New York Hospital Anita Mazloom, Neil Nimkar, Sonal Paul, Ayanna Baptiste
560 [GO] 2021―Feb―06 COVID-19 in Patients (pts) with Chronic Myeloid Leukemia (CML): Results from the International CML Foundation (iCMLf) CML and COVID-19 (CANDID) Study Delphine Rea, Michael J. Mauro, Jorge E. Cortes, Qian Jiang, Katia B Pagnano, Matilda Ongondi, et al. (+4)
561 [GO] 2021―Feb―06 Critical Telehealth and Healthcare Utilization during COVID-19 in Sickle Cell Disease: CBO Reach in Understanding the Patient Experience Jennifer Fields, Mary Brown, Chanell Grismore, Yadira Badwan, Susan Claster, Diane J. Nugent
562 [GO] 2021―Feb―06 The Impact of COVID-19 on Hematology-Oncology Fellowship Programs: Program Director Perspectives Ana I. Velazquez Manana, Urshila Durani, Robby Reynolds, Ashok Kumbamu, Devika G. Das, Martina C. Murphy, et al. (+3)
563 [GO] 2021―Feb―06 Impact on Mental Health, Disease Management and Socioeconomic Modifications in Hematological Patients during COVID-19 Pandemia in Italy Marianna De Muro, Sergio Amadori, Nicolina Rita Ardu, Elisabetta Cerchiara, Paolo De Fabritiis, Pasquale Niscola, et al. (+5)
564 [GO] 2021―Feb―06 Drepadom - Home Care Services and Hospitalizations for Sickle Cell Disease Patients during the Covid-19 Pandemic Gonzalo De Luna, Nicolas Lemonier, Alexis Aidan, Lea Bontemps, Manuel Hautefaye, Hadrien Diakonoff, et al. (+7)
565 [GO] 2021―Feb―06 Mental Health Assessment of Youth with Sickle Cell Disease and Their Primary Caretakers: Baseline Depression and COVID-19 Pandemic-Associated Psychosocial Stress in a Multi-Site Study Nancy S. Green, Deepa Manwani, Kim Smith-Whitley, Banu Aygun, Abena Appiah-Kubi, Arlene Smaldone
566 [GO] 2021―Feb―06 Treating Acute Leukemia during the COVID-19 Pandemic: A Multicenter Latin American Registry Roberta Demichelis, Martha Alvarado, Jule F Vasquez, Nancy Delgado, Cynthia Gómez, Karla Adriana Espinosa, et al. (+26)
567 [GO] 2021―Feb―06 Impact of Treatment and Anticoagulation on Thrombosis in COVID-19 Patients Surbhi Warrior, Elizabeth Behrens, Joshua Thomas, Priya Rajakumar, Sefer Gezer, Parameswaran Venugopal, Shivi Jain
568 [GO] 2021―Feb―06 Increasing Doses of Anticoagulation Are Associated with Improved Survival in Hospitalized COVID-19 Patients Filip Ionescu, Girish B Nair, Ioana Petrescu, Anish S Konde, Markie Sue Zimmer, Nwabundo Anusim, et al. (+6)
569 [GO] 2021―Feb―06 Hematologic Characteristics of Surviving Versus Non-Surviving COVID-19 Patients in Critical Care Units: Inner-City Hospital Experience, Detroit, MI Nino Balanchivadze, Raef Fadel, Jawad Sheqwara, Philip Kuriakose
570 [GO] 2021―Feb―06 Admission Rothman Index, Aspirin, and Intermediate Dose Anticoagulation Effects on Outcomes in COVID-19: A Multi-Site Propensity Matched Analysis George Goshua, Yiwen Liu, Matthew L. Meizlish, Rebecca Fine, Kejal Amin, Eric Chang, et al. (+9)
571 [GO] 2021―Feb―06 The Impact of ABO Blood Group on Clinical Outcomes and Susceptibility in COVID-19: A Retrospective Population Study of 3305 Patients Waleed Alduaij, Sarah Al-Youha, Ahmad Al-Serri, Sulaiman Almazeedi, Mohannad Al-Haddad, Mohammad H Jamal, Salman Al-Sabah
572 [GO] 2021―Feb―06 Outcomes of Adult and Pediatric Patients with Hematologic Malignancies and COVID-19: A Systematic Review and Meta-Analysis of 1847 Patients Abi Vijenthira, Inna Gong, Thomas A Fox, Stephen Booth, Gordon Cook, Bruno Fattizzo, et al. (+13)
573 [GO] 2021―Feb―06 Influenza Vaccination in Asplenia: Improving Quality of Care in Time of Coronavirus Nicoletta Di Maio, Giovanna Russo, Susanna Barella, Gian Luca Forni, Raffaella Colombatti, Lucia Notarangelo, et al. (+38)
574 [GO] 2021―Feb―06 Leveraging Project Echo Telementoring to Improve Sickle Cell Disease Care in the Midwest: Expanding Provider Education during a Pandemic Lisa M Shook, Christina Bennett Farrell, Cami Mosley, Lori E Crosby, Charles T. Quinn
575 [GO] 2021―Jan―14 Vaccinations in CLL: implications for COVID-19 Mazyar Shadman, Chaitra Ujjani
576 [GO] 2020―Dec―23 Antibody-induced procoagulant platelets in severe COVID-19 infection Karina Althaus, Irene Marini, Jan Zlamal, Lisann Pelzl, Anurag Singh, Helene Häberle, et al. (+11)
577 [GO] 2020―Dec―19 Severe transient pancytopenia with dyserythropoiesis and dysmegakaryopoiesis in COVID-19-associated MIS-C Rachel Mariani, Huifei Liu
578 [GO] 2020―Dec―19 Expanding the toolbox to combat a pandemic Susan E. Prockop
579 [GO] 2020―Dec―03 COVID-19, plasma, and hypogammaglobulinemia Michael F. Murphy, Sunny Dzik
580 [GO] 2020―Dec―03 Waning of SARS-CoV-2 RBD antibodies in longitudinal convalescent plasma samples within 4 months after symptom onset Josée Perreault, Tony Tremblay, Marie-Josée Fournier, Mathieu Drouin, Guillaume Beaudoin-Bussières, Jérémie Prévost, et al. (+4)
581 [GO] 2020―Nov―17 How should we use convalescent plasma therapies for COVID-19? Erica Michelle Wood, Lise J Estcourt, Zoe McQuilten
582 [GO] 2020―Nov―06 Clinical Features Associated with COVID-19 Outcome in MM: First Results from International Myeloma Society Dataset Ajai Chari, Mehmet Kemal Samur, Joaquin Martinez-Lopez, Gordon Cook, Noa Biran, Kwee L. Yong, et al. (+19)
583 [GO] 2020―Nov―05 COVID-19-induced atypical pulmonary lymphocytes Véronique Vergé, Ranya Soufan
584 [GO] 2020―Nov―04 Coagulation Dysfunction and Hematological Changes in 633 Patients with COVID-19 Mo Yang, Huixia Deng, Liuming Yang, Liang Li, Jieyu Ye, Yucai Cheng, et al. (+3)
585 [GO] 2020―Nov―04 Thrombotic Complications in a Canadian Population of Critically Ill Patients with COVID-19 Simard Camille, Maral Koolian, Diana Escobar, Mark Blostein, Jed Lipes, Adelina Teona Avram, et al. (+4)
586 [GO] 2020―Nov―04 Derivation and Validation of a Predictive Score for Disease Worsening Inpatients with COVID-19 Grigoris Gerotziafas, Patrick Van Dreden, Loula Papageorgiou, Theodoros N Sergentanis, Meletios-Athanasios Dimopoulos, Ismail Elalamy
587 [GO] 2020―Nov―04 The Role of D-Dimer for Optimal Thromboprophylaxis Strategy in Patients with COVID-19 Lantarima Bhoopat, Anastasia Martynova, April Choi, Pattharawin Pattharanitima, Semi Han, Senxi Du, et al. (+5)
588 [GO] 2020―Nov―04 Thrombosis and Mortality in Pregnant Patients with COVID-19 Elizabeth Behrens, Surbhi Warrior, Joshua Thomas, Xavier Pombar, Sefer Gezer, Parameswaran Venugopal, Shivi Jain
589 [GO] 2020―Nov―04 COVID-19-Associated Coagulopathy: Safety and Efficacy of Prophylactic Anticoagulation Therapy in Hospitalized Adults with COVID-19 Isaac Chambers, Sanjana Dayal, Patrick Ten Eyck, Alicia Eustes, Grerk Sutamtewagul, Lori Rosenstein, et al. (+3)
590 [GO] 2020―Nov―04 The Impact of Different Prophylactic Anticoagulation Doses on the Outcomes of Patients with COVID-19 Rodolfo Jiménez-Soto, Mercedes Aguilar-Soto, Roberta Demichelis
591 [GO] 2020―Nov―04 Incidence of Vascular Thromboembolic Events in Outpatients with Mild COVID-19 Harish Eswaran, Jamie Jarmul, Amy Shaheen, David Meaux, Tristan Long, Derek Saccoccio, Stephan Moll
592 [GO] 2020―Nov―04 Mild Anemia As a Single Independent Predictor of Mortality in Patients with COVID-19 Douglas Tremblay, Joseph Rapp, Naomi Alpert, William Lieberman-Cribbin, John Mascarenhas, Emanuela Taioli, Saghi Ghaffari
593 [GO] 2020―Nov―04 Heparin Induced Thrombocytopenia in Patients with COVID-19 Surbhi Warrior, Elizabeth Behrens, Sefer Gezer, Parameswaran Venugopal, Shivi Jain
594 [GO] 2020―Nov―04 Venous Thromboembolic Disease in Children Associated with COVID-19 Shalu Narang, Kavita Morparia, Prachi Sharma
595 [GO] 2020―Nov―04 Immune Thrombocytopenia Associated with COVID-19 - Case Series Ramil Fatkhullin, Vasily Shuvaev
596 [GO] 2020―Nov―04 Biomarkers of Hypercoagulability and Endothelial Cell Activation in Patients with Severe COVID-19 Admitted at the Intensive Care Unit. the Roadmap-COVID-19 Prospective Observational Study Patrick Van Dreden, Guillaume Voiriot, Alexandre Alabbadi, Ismail Elalamy, Loula Papageorgiou, Hélène Cost, et al. (+4)
597 [GO] 2020―Nov―04 Risk Factors for Severe Form of COVID-19 after Allogeneic Hematopoietic Stem Cell Transplantation: A SFGM-TC Multicentre Cohort Study Alienor Xhaard, Constance Xhaard, Maud D'Aveni, Hélène Salvator, Marie-Laure Chabi-Charvillat, Tereza Coman, et al. (+13)
598 [GO] 2020―Nov―04 Incidence of and Risk Factors for Venous Thromboembolism Among Hospitalized Patients with Cancer and COVID-19: Report from the COVID-19 and Cancer Consortium (CCC19) Registry Ang Li, Nicole M. Kuderer, Jeremy L. Warner, Aakash Desai, Dimpy P. Shah, Julie Fu, et al. (+25)
599 [GO] 2020―Nov―04 Clinical Characterization and Risk Factors Associated with Cytokine Release Syndrome Induced By COVID-19 and Chimeric Antigen Receptor T-Cell Therapy Ruimin Hong, Houli Zhao, Yiyun Wang, Yu Chen, Hongliu Cai, Yongxian Hu, et al. (+2)
600 [GO] 2020―Nov―04 COVID-19 and Stem Cell Transplantation; Results from the Prospective Survey By the Infectious Diseases Working Party of the European Society for Blood and Marrow Transplantation (EBMT) and the Spanish Hematopoietic Stem Cell Transplantation and Cell Therapy Group (GETH) Per Ljungman, Rafael De La Camara, Malgorzata Mikulska, Gloria Tridello, Beatriz Aguado, Yves Beguin, et al. (+32)
601 [GO] 2020―Nov―04 Circulating Histone Levels Correlate with the Severity of COVID-19 and the Extent of Coagulation Activation and Inflammation Rebecca Jane Shaw, James Austin, Joseph Taylor, Tina Dutt, Guozheng Wang, Simon Timothy Abrams, Cheng Hock Toh
602 [GO] 2020―Nov―04 COVID-19 Associated Coagulopathy: A Comprehensive Assessment of the Coagulation Profile in Critically and Non-Critically Ill Patients Reyes María Martín-Rojas, Maite Chasco, Sara Casanova, Valeria Estefanía Delgado-Pinos, Gloria Perez-Rus, Patricia Duque, et al. (+3)
603 [GO] 2020―Nov―04 Children and Young Adults Admitted to a NYC Children's Hospital Had a Similar Rate of Severe COVID-19 Coagulopathy As That Reported in Older Adults William Beau Mitchell, Jennifer G. Davila, Janine Keenan, Jenai Jackson, Adit Tal, Kerry A Morrone, et al. (+3)
604 [GO] 2020―Nov―04 Newly Diagnosed Acute Lymphoblastic Leukemia in a Child with COVID-19 Complicated By MIS-C: A Case Report from Kuwait Fatemah Al-Haddad, Abdullah Ali, Danah Al-Sharrah, Suha Atyani, Hadeel Saleh, Ali M.A. Mullah-Ali
605 [GO] 2020―Nov―04 COVID-19 Convalescent Plasma Decreased Oxygen Requirement and Hospital Stay in COVID-19 Hospitalized Patients Including Those with Hematological Malignancies: A Report of 16 Patients Moayed Ibrahim, Priya Pal, Alex Niu, Kevin Zwezdaryk, Elise Tatje, Leta Ko, et al. (+19)
606 [GO] 2020―Nov―04 Whimsical (Waldenstrom's Macroglobulinemia Study Involving CArt-wheeL): A Global Patient-Derived Data Registry Capturing Treatment, Quality of Life and COVID-19 Data Ibrahim Tohidi-Esfahani, Andrew Warden, Elena Malunis, Peter Liburdi deNardis, Javier Haurat, Marita Black, et al. (+9)
607 [GO] 2020―Nov―04 Prevalence of Low Limb Venous Thromboembolic Events in Mild and Severe/Critically Ill Patients with COVID-19 Despite Pharmacological Thromboprophylaxis Cong Zhang, Jialan Shi, Changjun WU, Chunxu Wang, Xinyi Zhao, Jinming Zhang, et al. (+9)
608 [GO] 2020―Nov―04 The ACE2 Receptor for COVID-19 Entry Is Expressed on the Surface of Hematopoietic Stem/Progenitor Cells and Endothelial Progenitors As Well As Their Precursor Cells and Becomes Activated in Nlrp3 Inflammasome-Dependent Manner By Virus Spike Protein - a Potential Pathway Leading to a "Cytokine Storm" Magdalena Kucia, Kamila Bujko, Andrzej Ciechanowicz, Monika Cymer, Katarzyna Sielatycka, Janina Ratajczak, Mariusz Z Ratajczak
609 [GO] 2020―Nov―04 COVID-19 Impact on Lymphoma Patients' Clinical Outcomes - an Observational Cohort Study Andrew Ip, Anthony Mato, Jordan Intrator, Nicholas P Howard, Alessandra Petrillo, Rosalba Vicioso, et al. (+6)
610 [GO] 2020―Nov―04 COVID-19 in Chronic Myeloid Leukemia Patients - Brazilian Experience Katia B Pagnano, Ana Carolina Mourão Toreli, Leila Martins Perobelli, Acy TS Quixada, Fernanda S Seguro, Israel Bendit, et al. (+19)
611 [GO] 2020―Nov―04 Clinical Characteristics and Outcomes of COVID-19 in HSCT Recipients Clarisse MARTINS Machado, Mariana Nassif Kerbauy, Iago Colturato, Leonardo Javier Arcuri, Ana Cláudia Ferrari dos Santos, Fernanda Rodrigues Silva, et al. (+5)
612 [GO] 2020―Nov―04 COVID-19 in Patients with Hematologic Malignancies: A Single-Center Experience Lindsay Wilde, Adam F. Binder, Matthew Carabasi, Joanne Filicko-O'Hara, John L. Wagner, Onder Alpdogan, et al. (+12)
613 [GO] 2020―Nov―04 COVID-19 in Patients with Hematological Malignancies: High False Negative Rate with High Mortality Alex Niu, Bo Ning, Francisco Socola, Hana Safah, Tim Reynolds, Moayed Ibrahim, et al. (+6)
614 [GO] 2020―Nov―04 COVID-19 in Relation to Hematological Events (Thrombosis/Bleeding) and Mortality in Inpatient Setting Saikrishna Gadde, Nikhil Manjunath, Ambuga Badari, John T. Cole, Rula Saeed
615 [GO] 2020―Nov―04 Outcomes in Patients with Hematologic Disease and COVID-19 in Russia: Interim Analysis of CHRONOS19 Registry Olga A. Gavrilina, Kristina Zakurdaeva, Vladimir I. Vorobyev, Anastasia N. Vasileva, Lev S. Butaev, Alena Sukhareva, et al. (+15)
616 [GO] 2020―Nov―04 Hepatobiliary Manifistations of COVID-19 in Sickle Cell Disease: A Case Report Badria M. Alghamdi, Ohoud F. Kashari
617 [GO] 2020―Nov―04 Frequency, Clinical Characteristics and Outcome of Adult Patients with Acute Lymphoblastic Leukemia (ALL) and COVID-19 in Spain: Results of a Survey from Pethema and Geth Groups Josep-Maria Ribera, Mireia Morgades, Rosa Coll, Jose Luis Lopez Lorenzo, Pau Montesinos, Rosario Varela, et al. (+15)
618 [GO] 2020―Nov―04 Hospitalization and Case Fatality in Individuals with Sickle Cell Disease and COVID-19 Infection Lana Mucalo, Amanda M. Brandow, Sadie F. Mason, Ashima Singh, Bradley W. Taylor, Katherine J. Woods, et al. (+2)
619 [GO] 2020―Nov―04 Elderly Hemopoietic and Inflammatory Signature for Life-Threatening COVID-19 Infection Jesus Romero, Jorge Mazzini, Sarvari Venkata Yellapragada, Iberia R. Sosa, Gustavo A. Rivero
620 [GO] 2020―Nov―04 Autoimmune Hemolytic Anemia As Initial Presentation of COVID-19 Infection Gregorio Campos-Cabrera, Esther Mendez-Garcia, Maria Mora-Torres, Salvador Campos-Cabrera, Virgina Campos-Cabrera, Gabriel Garcia-Rubio, Jose-Luis Campos-Villagomez
621 [GO] 2020―Nov―04 Atypical Presentation of COVID-19 Infection Cory Mellon, Salma Ferouz, Tariq Mubarak, Isoken Koko
622 [GO] 2020―Nov―04 Evaluation of Soluble Fibrin Monomer Complex in Patients with Sars-Cov-2 COVID-19 Infection Meera Sridharan, Aneel A. Ashrani, Dong Chen, Nahla M. Heikal, Ariela L. Marshall, Rajiv K. Pruthi
623 [GO] 2020―Nov―04 Low Rate of Thrombosis in Mexican Patients with COVID-19 Infection. a Benefit of Higher Doses Anticoagulants or a Sub Diagnosis? Félix Gibrant Marquez, Santiago Riviello-Goya, Angel Gabriel Vargas Ruiz, Edgar Ortíz Brizuela, Fernando Gil López, Alfredo Gutierrez Marín, et al. (+4)
624 [GO] 2020―Nov―04 Outcomes of COVID-19 Infection in Patients Receiving Ruxolitinib and Hypomethylating Agent Therapy Daniel I. Nathan, Douglas Tremblay, Santiago Thibaud, John Mascarenhas, Janice L. Gabrilove
625 [GO] 2020―Nov―04 ABO/Rh Blood Group and COVID-19 Infection Severity David J Hermel, Elisa Quiroz, Samantha R Bagsic, Carrie L. Costantini, Alan Saven, James R. Mason, et al. (+3)
626 [GO] 2020―Nov―04 Outcomes of Patients with Hematologic Malignancies and COVID-19 Infection: A Report from the ASH Research Collaborative Data Hub William A. Wood, Donna S. Neuberg, John Colton Thompson, Martin S. Tallman, Mikkael A. Sekeres, Laurie H. Sehn, et al. (+8)
627 [GO] 2020―Nov―04 Outcomes of Sickle Cell Disorders in COVID-19 Infection: An Institutional Experience Sarah Sewaralthahab, Hedy Smith
628 [GO] 2020―Nov―04 Sickle Cell Disease Related Outcomes in Patients Evaluated for COVID-19 Infections in South Carolina Laurence Noisette, Mamatha Mandava, Mathew Gregoski, Shayla Bergmann
629 [GO] 2020―Nov―04 The Elevation of LIVER Enzymes in Patients with Atrial Fibrillation and COVID-19 Is a Marker of Bad Evolution and Mortality Juan Jose Cerezo Manchado, Pável E Olivera, María Dolores Lopez Abellan, Desiree Campoy Castaño, César A Velasquez, Carlos Rodriguez Rojas, et al. (+7)
630 [GO] 2020―Nov―04 Measuring the Impact of COVID-19 on Hematology-Oncology Trainees: A Quantitative and Qualitative Assessment Urshila Durani, Ana I. Velazquez Manana, Jori May, Marquita Nelson, Ze Zheng, Anurekha Gollapudi, et al. (+11)
631 [GO] 2020―Nov―04 Impact of a National Lockdown for COVID-19 on Morbidity and Mortality Among Children with Sickle Cell Anaemia at a Tertiary Care Hospital in Uganda Ruth Namazzi, Robert Opoka, Andrea L Conroy, Dibyadyuti Datta, Micheal Goings, Chandy C. John
632 [GO] 2020―Nov―04 COVID-19 Outcomes in Individuals with Sickle Cell Disease and Sickle Cell Trait Compared to Blacks without Sickle Cell Disease or Trait Ashima Singh, Amanda M. Brandow, Julie Panepinto
633 [GO] 2020―Nov―04 Hematology Consultations during the COVID-19 Pandemic at a University Medical Center Daniel C Choi, Madhav Seshadri, Maria T De Sancho
634 [GO] 2020―Nov―04 Analysis of Free-Text Responses in an International Myeloproliferative Neoplasms Patient Survey to Assess Impact of the COVID-19 Pandemic on Clinical Care Blake T. Langlais, Carolyn Mead-Harvey, Heidi E. Kosiorek, Gina L. Mazza, Ruben Mesa, Jeanne M. Palmer, Amylou C. Dueck
635 [GO] 2020―Nov―04 A Survey of Survival Status of 601 Hemophilia Patients in Guangdong Region during COVID-19 Pandemic: Investigation and Implications Lei Meng, Jing Sun, Yufang Xun, Huiping Li, Zhuqin Liu, Xiaoqin Feng, Xuan Zhou
636 [GO] 2020―Nov―04 The Challenge of Recruiting Convalescent Plasma Donors during the COVID-19 Pandemic: Preliminary Results from a Single Center in Midwest Brazil Maria do Rosario Ferraz Roberti, Tiago Paiva Prudente, Renato Gomes Castro, Marcos Antonio Candido, Roberta Luiza Rodrigues, Maria Cunha Ribeiro Morelli, et al. (+5)
637 [GO] 2020―Nov―04 Efficacy of COVID-19 Pathogen Inactivated Convalescent Plasma for Patients with Moderate to Severe Acute COVID-19: A Case Matched Control Study Nina Khanna, Maja Weisser, Anemone Hedstueck, Sarah Tschudin Sutter, Sandra Roesch, Manuel Battegay, et al. (+15)
638 [GO] 2020―Nov―04 A National Collaborative Multicenter Phase II Study for Potential Safety Efficacy of Convalescent Plasma to Treat Severe COVID-19 Patients Hani Al Hashmi, Deia Alawami, Syed Ziauddin A Zaidi, Nawal F Alshehry, Hazza A. Alzahrani, Abdul Rehman Z Zaidi, et al. (+15)
639 [GO] 2020―Nov―04 Correlation between ABO Blood Groups and Disease Severity and Mortality in Hospitalized COVID-19 Patients Aula Ramo, Harshita Mehrotra, Ifeoma Onwubiko, Jawad Sheqwara, Zaher K. Otrock
640 [GO] 2020―Nov―04 Anticoagulant and Antiplatelet Use Not Associated with Improvement in Severe Outcomes in COVID-19 Patients Gwendolyn Ho, Jennifer R Dusendang, Julie Schmittdiel, Juraj Kavecansky, Jahan Tavakoli, Ashok Pai
641 [GO] 2020―Nov―04 Evaluation of Antiplatelet and Anticoagulation Therapy in High-Risk COVID-19 Patients Farah Ashraf, Anita Mazloom, Neil Nimkar, Nisha Patel, Amardeep Kalsi, Angelica Singh, et al. (+10)
642 [GO] 2020―Nov―04 Hemorrhage Is a Major Cause of Blood Transfusion in COVID-19 Patients Cristina Sanz, Anabel Faundez, Anna García Carulla, Marta Rodriguez Aliberas, Anny Coromoto, Arturo Pereira
643 [GO] 2020―Nov―04 Impact of Blood Group Type on Severity of Disease in COVID-19 Patients Shivani Rao, Surbhi Warrior, Sefer Gezer, Parameswaran Venugopal, Shivi Jain
644 [GO] 2020―Nov―04 Thrombotic Microangiopathy Variants Are Independently Associated with Critical Disease in COVID-19 Patients Eleni Gavriilaki, Styliani Kokoris, Tasoula Touloumenidou, Evdoxia Koravou, Maria Koutra, Vassiliki Karali, et al. (+16)
645 [GO] 2020―Nov―04 The Correlation between Absolute Lymphocyte Counts and Clinical Outcomes in COVID-19 Patients Mayer Goldberg, Madhumati Kalavar, Joseph Giovanetti
646 [GO] 2020―Nov―04 Thrombocytopenia Associated with Increase in Disease Severity and Mortality in COVID-19 Patients Ranjit Banwait, Aya Marachi, Uma G. Iyer
647 [GO] 2020―Nov―04 The Potential Role of Therapeutic Dose of Low Molecular Weight Heparin (LWMH) to Attenuate Hyper-Inflammatory State in Hospitalized COVID-19 Patients Mohsin Sheraz Mughal, Ikwinder Preet Kaur, Ali R. Jaffery, Chang Wang, Muhammad Asif, Anthony J. Ricca, et al. (+3)
648 [GO] 2020―Nov―04 Extensive Characterization of the Hemostatic Derangement Occurring in COVID-19 Patients Admitted to the Bergamo Hospital Patricia Gomez-Rosas, Marina Marchetti, Eleonora Sanga, Sara Gamba, Cristina Verzeroli, Laura Russo, et al. (+7)
649 [GO] 2020―Nov―04 Thrombotic Events in COVID-19 Patients and Its Comparison with Other Non-Sars-Cov-2 Respiratory Viruses Jing Yuan Tan, Chuen Wen Tan, Wan Hui Wong, Edwin Philip Conceicao, Ian Matthias Ng, May Anne Cheong, et al. (+3)
650 [GO] 2020―Nov―04 Incidence of Thrombosis and Associated Risk Factors in Hospitalized COVID-19 Patients in a New York City Hospital System Poy P. Theprungsirikul, Sunil E. Saith
651 [GO] 2020―Nov―04 Thromboembolic Outcomes of Hospitalized COVID-19 Patients in the 90-Day Post-Discharge Period: Early Data from the Northwell CORE-19 Registry Dimitrios Giannis, Steven L. Allen, Anne Davidson, Galina S. Marder, Sarah Flint, David Garrett, et al. (+8)
652 [GO] 2020―Nov―04 Outcomes in COVID-19 Patients on Treatment Dose Anti-Coagulation Compared to Prophylactic Dose Anti-Coagulation Rich Kodama, Amardeep Kalsi, Angelica Singh, Nivetha Vishnuvardhan, Neil Nimkar, Sonal Paul, et al. (+10)
653 [GO] 2020―Nov―04 Association between ROTEM Hypercoagulable Profile and Outcome in a Cohort of Severely Ill COVID-19 Patients Under Mechanical Ventilation Damian Ratano, Caragata Rebecca, Eddy Fan, Ewan C Goligher, Rita Selby, Niall D Ferguson, et al. (+2)
654 [GO] 2020―Nov―04 Immunologic Characterization of Coronavirus Disease 2019 (COVID-19) Patients with Hematological Cancer: Biologic and Clinical Significance Catarina Maia, Esperanza Martín-Sánchez, Juan José Garcés, Ascensión López-Diaz de Cerio, Susana Inogés, Manuel Landecho, et al. (+16)
655 [GO] 2020―Nov―04 Presentation, Management and Outcomes of COVID-19 Patients with Sickle Cell Disease Nwabundo Anusim, Ruby Gupta, Hycienth O Ahaneku, Candace Franklin, Savitha Balaraman, Marianne Terese Huben, Ishmael Jaiyesimi
656 [GO] 2020―Nov―04 Use of Convalescent Plasma in COVID-19 Patients: Guayaquil, Ecuador Experience. Carlos Plaza, Brener Sabando, Yaira Loor Morán, Maria Alejandra Posligua, Luis Layedra, Jorge William Oliveros-Alvear
657 [GO] 2020―Nov―04 Anticoagulation Management and Outcomes in Covid-19 Patients:a Multi-Center Retrospective Cohort Study Jasmeet Kaur, Anupam A Sule, Tracy Koehler, Geetha Krishnamoorthy, Jennifer DeLongpre
658 [GO] 2020―Nov―04 Higher Tissue Factor (TF) Expression in the Lungs of COVID-19 Pneumonia Patients Than Patients with Acute Respiratory Distress Syndrome: Association with Thrombi Formation Sandeep Subrahmanian, Alain Borczuk, Steven P. Salvatore, Jeffrey Laurence, Jasimuddin Ahamed
659 [GO] 2020―Nov―04 Clinical Trial to Evaluate an Approved ITP Therapy Targeting Spleen Tyrosine Kinase (SYK) for Prevention and Treatment of COVID-19 Related Complications Wolfgang Dummer, Vadim V. Markovtsov, Sandra Tong, Esteban Masuda
660 [GO] 2020―Nov―04 Atypical Peripheral Blood Cell Morphology in COVID-19 (Sars-CoV-2) Patients from Mount Sinai Health System in New York City Christian Salib, Pallavi Khattar, Jinjun Cheng, Julie Teruya-Feldstein
661 [GO] 2020―Nov―04 Does Thrombocytopenia Truly Correlate with COVID-19 Severity? Caroline Hana, Samar Aboulenain, Nakeya Dewaswala, Vijay Narendran
662 [GO] 2020―Nov―04 Actions of L-Glutamine vs. COVID-19 Suggest Additional Benefit in Sickle Cell Disease Mahmoud A.Z. Abdelaal, Dyala Abdelrahman, Mahir Cengiz, Hakan Yavuzer, Serap Yavuzer, Ivy Bien, et al. (+9)
663 [GO] 2020―Nov―04 Plasma Exchange for COVID-19 Thrombo-Inflammatory Disease Mari Thomas, Nishkantha Arulkumaran, David Brearley, Ferras Alwan, Deepak Singh, Michael P Lunn, et al. (+8)
664 [GO] 2020―Nov―04 COVID-19 Thrombosis: Understanding the Negative Predictive Value in a Pandemic Talat Almukhtar, Julio Hajdenberg, Gurjot Garcha
665 [GO] 2020―Nov―04 Serological Prevalence of Sars-Cov-2 Infection Among Chronic Myeloid Leukemia Patients Undergoing Tyrosine Kinase Inhibitor Treatment in Italy (COVID-19-HEM Study) Massimiliano Bonifacio, Gianni Binotto, Mario Tiribelli, Maria Cristina Miggiano, Malgorzata Monika Trawinska, Luigi Scaffidi, et al. (+14)
666 [GO] 2020―Nov―04 Circulating Biomarkers of COVID-19-Triggered Endotheliopathy: From Conjecture to Certainty Ana Belen Moreno-Castaño, Sara Fernandez, Marta Palomo, Patricia Molina, Julia Martinez-Sanchez, Sergi Torramade-Moix, et al. (+12)
667 [GO] 2020―Nov―04 Outcomes of Patients of Eastern Mediterranean Region with Lymphoma and COVID-19.Does Recent Chemo Immunotherapy Have a Role on Severity? Imran K Tailor, Nawal F Alshehry, Kamran Sabir, Abdul Rehman Z Zaidi, Mohammed Marei, Ibraheem Motabi, et al. (+3)
668 [GO] 2020―Nov―04 CD28 Expression Distinguishes Plasma Cell Fate in Pediatric Patients Suffering from COVID-19/Kawasaki's Disease Vs MIS-C Adam Utley, Kelvin P. Lee, Mark Hicar
669 [GO] 2020―Nov―04 VWF/ADAMTS13 Ratios Are Potential Markers of Immunothrombotic Complications in Patients with COVID-19: A Cross-Sectional Study Daria V Madeeva, Jana Christian, George Goshua, Hyung J. Chun, Alfred Ian Lee, Alexander B Pine
670 [GO] 2020―Nov―04 Frequency of Venous Thromboembolism in 6513 Patients with COVID-19: A Retrospective Study Mark Crowther, David A. Garcia, Jason Hill, Bryan Savage, Shira Peress, Kevin Chang, Steven Deitelzweig
671 [GO] 2020―Nov―04 Successful Outcomes of Children Simultaneously Diagnosed with Acute Myeloid Leukemia and Covid-19: The Role of a Mild Chemotherapeutic Induction Regimen Mecneide Mendes Lins, Juliana Teixeira Costa, Alayde Vieira Wanderley, Adriana Seber, Cinthya Rocha, Luciana Nunes Silva, et al. (+4)
672 [GO] 2020―Nov―04 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Hematologic Patients: Experience at the Hospital Attending More Patients in Spain Alba Cabirta, Macarena Izuzquiza, Isabel Ruiz-Camps, David Valcarcel, Eva Catala, M Moraima Jimenez, et al. (+11)
673 [GO] 2020―Nov―04 Use of Convalescent Plasma Therapy in Severe Coronavirus Disease 2019: The Yale-New Haven Health System Experience Sabrina L. Browning, Michael Gormally, Neima Briggs, Muyi Li, Alan Zakko, Maudry Laurent-Rolle, et al. (+11)
674 [GO] 2020―Nov―04 Phase I and Preliminary Results of a Phase II Study (TERAPLASCoV2) of Convalescent Plasma in Patients with Severe and Life-Threatening Pneumonia Caused By Sars-Cov-2 Fernando Pérez-Jacobo, Luis Villela Villela, Edgar Velásquez-Vega, Jesús Hernández, Melani Otañez, Mónica Arellano-Mendoza, et al. (+23)
675 [GO] 2020―Nov―04 Antibody Response Against Sars-Cov-2 in Convalescent Plasma Donors: Preliminary Results from a Single Center in Midwest Brazil Maria do Rosario Ferraz Roberti, Tiago Paiva Prudente, Renato Gomes Castro, Marcos Antonio Candido, Roberta Luiza Rodrigues, Francielle Barreto Machado Candido, et al. (+4)
676 [GO] 2020―Nov―04 Longitudinal Serological Response to Sars-COV-2 in Patients Affected By Hematologic Diseases Chiara Cattaneo, Valeria Cancelli, Chiara Pagani, Alessandra Tucci, Giuseppe Rossi, Luisa Imberti, et al. (+6)
677 [GO] 2020―Nov―04 Detailed Immunophenotypic Profiling of Peripheral Blood Immune Cells in Patients with Hematologic Malignancies after Sars-Cov-2 Infection Forat Lutfi, Jonathan Siglin, Gabriela Sanchez-Petitto, Ali Bukhari, David Gottlieb, Dong Won Kim, et al. (+8)
678 [GO] 2020―Nov―04 Sars-Cov-2 Infection and Systemic Light Chain Amyloidosis: The International Society of Amyloidosis' Survey Paolo Milani, Vaishali Sanchorawala, Ramon Lecumberri, Sunil Saith, Mathew S. Maurer, M. Teresa Cibeira, et al. (+3)
679 [GO] 2020―Nov―04 Impact of Sars-Cov-2 Infection in Acute Myeloid Leukemia Patients: Experience of the Pethema Registry Pilar Martínez, Tomás Palanques Pastor, Jose Luiz Lopez Lorenzo, Javier Cornago Navascués, Gabriela Rodriguez-Macías, Isabel Cano, et al. (+36)
680 [GO] 2020―Nov―04 Impact of Sars-Cov-2 Infection in Hematopoietic Transplant Patients: Experience from the Madrid Group Rebeca Bailén, Mi Kwon, Beatriz Aguado, Rafael F. Duarte, Maria Calbacho, Anabelle Chinea, et al. (+12)
681 [GO] 2020―Nov―04 Defibrotide for the Treatment of Endotheliitis Complicating Sars-Cov-2 Infection: Rationale and Ongoing Studies As Part of the International Defacovid Study Group Jose M. Moraleda, Carmelo Carlo-Stella, David Garcia-Bernal, Ruben Jara Rubio, Enriqueta Andreu, Eleonora Calabretta, et al. (+18)
682 [GO] 2020―Nov―04 Inflammation Drives Coagulopathies in Sars-Cov-2 Patients Martha MS Sim, Meenakshi Banerjee, Melissa Hollifield, Hammodah Alfar, Xian Li, Alice Thornton, et al. (+9)
683 [GO] 2020―Nov―04 Evidence of Microangiopathy in Children with Sars-Cov-2 Regardless of Clinical Presentation Caroline Diorio, Kevin O McNerney, Michele P. Lambert, Michele Paessler, Julie Chase, Kandace Gollomp, et al. (+18)
684 [GO] 2020―Nov―04 Impaired Sars-Cov-2 Specific Antibody Responses in Patients Treated with Anti-CD20 Antibodies Alessandra Sottini, Luisa Imberti, Simone Paghera, Vanessa Previcini, Chiara Cattaneo, Eugenia Quiros-Roldan, et al. (+7)
685 [GO] 2020―Nov―04 Environmental Sars-Cov-2 Surface Testing: Low Incidence of Virus Positivity in Outpatient and Inpatient Hematology/Oncology Settings Mansi R Shah, Imraan Jan, Jeremy Johns, Kuldip Singh, Pallavi Kumar, Norma Belarmino, et al. (+7)
686 [GO] 2020―Nov―04 Real World Outcomes of Sars-Cov-2 Thrombosis Rates across Three University Health Systems in the Chicago Metropolitan Area Stephanie Berg, Seo-Hyun Kim, Sonam Patel, Priya Rajakumar, Elizabeth Jane Elliott, Candice Schwartz, et al. (+32)
687 [GO] 2020―Nov―04 Analysis of Sars-Cov-2-Associated Proteins Identify Tank-Binding Kinase-1 As an Immunotherapeutic Target in Multiple Myeloma Arghya Ray, Ting DU, Krishan Chauhan, Yan Song, Dharminder Chauhan, Kenneth Anderson
688 [GO] 2020―Nov―04 Outcomes in Patients with Hematologic Malignancies Infected with Sars-Cov-2: The Northwestern University Experience Carlos Galvez, Imran Nizamuddin, Emily Tuchman, Peter Doukas, Neha Reddy, Jessica K. Altman, et al. (+15)
689 [GO] 2020―Nov―04 Impact of Sars-CoV2 Infection on 491 Hematological Patients: The Ecovidehe Multicenter Study Cristina De Ramón, Jose Angel Hernandez-Rivas, Jose Antonio Rodríguez García, Enrique M. Ocio, María Teresa Gómez-Casares, Javier López Jiménez, et al. (+13)
690 [GO] 2020―Nov―04 How We Did Bone Marrow Transplants amidst the COVID19 Pandemic Kishore Kumar, Durai Prabhu, Dharani Devi, Dilshada Pulikkal, Joshua Daniel, Chezhian Subash
691 [GO] 2020―Nov―04 Impact of the COVID19 Pandemic on Admissions and Emergency Department Visits of Adults with Sickle Cell Disease Alice J. Cohen
692 [GO] 2020―Nov―04 Maximising Capacity and Saving Cost in an Outpatient Chemotherapy Centre during a Pandemic: A Quality Improvement Project Ednajoy Ngo, Cheng Ean Chee, Melinda Khoo, Yee Mei Lee, Belinda Tan, Yen-Lin Chee, Wei-Ying Jen
693 [GO] 2020―Nov―04 Caring for Patients with Sickle Cell Disease during a Pandemic: Continuing to Provide Automated Red Blood Cell Exchange Transfusions in Difficult Times Richard Curtis Godby, Ashton Kornbrust, Denis Noubouossie, Jose Lima, Marisa B. Marques, Rance C Siniard
694 [GO] 2020―Nov―04 Outcome of Severe Aplastic Anemia Treated with Low Dose Immunosuppression in Resource Limited World during Pandemic: Single Center Experience from Myanmar Aye Aye Gyi, Khin Thida Htut, Yin Nwe Han, Mie Mie Khine, Hnin Mya Thandar, Yi Mon Thant
695 [GO] 2020―Oct―29 Targeting complement activation in COVID-19 Hrishikesh S. Kulkarni, John P. Atkinson
696 [GO] 2020―Oct―28 Outcomes of patients with hematologic malignancies and COVID-19: A systematic review and meta-analysis of 3377 patients Abi Vijenthira, Inna Y. Gong, Thomas A Fox, Stephen Booth, Gordon Cook, Bruno Fattizzo, et al. (+13)
697 [GO] 2020―Oct―26 SARS-CoV-2 specific T-cells Are Rapidly Expanded for Therapeutic Use and Target Conserved Regions of Membrane Protein Michael D. Keller, Katherine M. Harris, Mariah A. Jensen-Wachspress, Vaishnavi Kankate, Haili Lang, Christopher Andrew Lazarski, et al. (+27)
698 [GO] 2020―Sep―22 Convalescent plasma therapy for B-cell depleted patients with protracted COVID-19 disease Thomas Hueso, Cécile Pouderoux, Hélène Péré, Anne-Lise Beaumont, Laure-Anne Raillon, Florence Ader, et al. (+31)
699 [GO] 2020―Sep―10 Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19 Eugenio D. Hottz, Isaclaudia G. Azevedo-Quintanilha, Lohanna Palhinha, Lívia Teixeira, Ester A. Barreto, Camila R. R. Pão, et al. (+6)
700 [GO] 2020―Sep―10 COVID-19 concerns aggregate around platelets Elisabeth M. Battinelli
701 [GO] 2020―Sep―03 A NET-thrombosis axis in COVID-19 Andrés Hidalgo
702 [GO] 2020―Sep―03 When CLL meets COVID-19 Emili Montserrat
703 [GO] 2020―Sep―02 Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition Jia Yu, Xuan Yuan, Hang Chen, Shruti Chaturvedi, Evan M. Braunstein, Robert A. Brodsky
704 [GO] 2020―Sep―01 No evidence of SARS-CoV-2 transfusion-transmission despite RNA detection in blood donors showing symptoms after donation Pierre Cappy, Daniel Candotti, Virginie Sauvage, Quentin Lucas, Laure Boizeau, Johanna Gomez, et al. (+6)
705 [GO] 2020―Aug―14 Leukoerythroblastosis and plasmacytoid lymphocytes in a child with SARS-CoV-2-associated multisystem inflammatory syndrome Won Sok Lee, Elizabeth Margolskee
706 [GO] 2020―Aug―14 Ritonavir- and lopinavir-induced eryptosis in a SARS-CoV-2-infected patient Gregoire Stalder, Lorenzo Alberio
707 [GO] 2020―Aug―07 Post-discharge thrombosis and hemorrhage in patients with COVID-19 Rushad Patell, Thomas Bogue, Anita G Koshy, Poorva Bindal, Mwanasha Merrill, William C Aird, et al. (+2)
708 [GO] 2020―Aug―06 Convalescent plasma to treat COVID-19 Evan M. Bloch
709 [GO] 2020―Aug―06 COVID-19 and the Coombs test Jeanne E. Hendrickson, Christopher A. Tormey
710 [GO] 2020―Aug―03 Post-discharge venous thromboembolism following hospital admission with COVID-19 Lara N Roberts, Martin Brunel Whyte, Loizos Georgiou, Gerard Giron, Julia Czuprynska, Catherine Rea, et al. (+4)
711 [GO] 2020―Jul―23 COVID-19 coagulopathy, thrombosis, and bleeding Noel C. Chan, Jeffrey I. Weitz
712 [GO] 2020―Jul―20 Outcomes of COVID-19 in Patients with CLL: A Multicenter, International Experience Anthony R. Mato, Lindsey Elizabeth Roeker, Nicole Lamanna, John Allan, Lori Ann Leslie, John M. Pagel, et al. (+56)
713 [GO] 2020―Jun―29 Neutrophil Extracellular Traps (NETs) Contribute to Immunothrombosis in COVID-19 Acute Respiratory Distress Syndrome Elizabeth A Middleton, Xue-Yan He, Frederik Denorme, Robert A. Campbell, David Ng, Steven P. Salvatore, et al. (+18)
714 [GO] 2020―Jun―23 Platelet Gene Expression and Function in COVID-19 Patients Bhanu Kanth Manne, Frederik Denorme, Elizabeth A Middleton, Irina Portier, Jesse W Rowley, Chris J. Stubben, et al. (+8)
715 [GO] 2020―Jun―23 Improved Clinical Symptoms and Mortality on Severe/Critical COVID-19 Patients Utilizing Convalescent Plasma Transfusion Xinyi Xia, Kening Li, Lingxiang Wu, Zhihua Wang, Mengyan Zhu, Bin Huang, et al. (+19)
716 [GO] 2020―Jun―19 Red cell bound antibodies and transfusion requirements in hospitalized patients with COVID-19 Alessandra Berzuini, Cristiana Bianco, Cinzia Paccapelo, Francesco Bertolini, Giuliana Gregato, Alessandra Cattaneo, et al. (+13)
717 [GO] 2020―Jun―19 Use of Convalescent Plasma in Hospitalized Patients with Covid-19 - Case Series Livia Hegerova, Ted Gooley, Kelly A Sweerus, Cynthia L Maree, Neil Bailey, Megumi Bailey, et al. (+14)
718 [GO] 2020―Jun―19 CHRONIC LYMPHOCYTIC LEUKEMIA MANAGEMENT IN ITALY DURING THE COVID-19 PANDEMIC. A CAMPUS CLL REPORT Antonio Cuneo, Lydia Scarfo, Gianluigi Reda, Marzia Varettoni, Francesca Maria Quaglia, Monia Marchetti, et al. (+12)
719 [GO] 2020―Jun―18 Combination dose-escalated hydroxyurea and transfusion: an approach to conserve blood during the COVID-19 pandemic Robert Sheppard Nickel, Stefanie Margulies, Brittany Frazer, Naomi L. C. Luban, Jennifer Webb
720 [GO] 2020―Jun―18 Hemophagocytic lymphohistiocytosis in SARS-CoV-2 infection Klaas Dewaele, Rowan Claeys
721 [GO] 2020―Jun―18 Morphological changes in a case of SARS-CoV-2 infection John R. Jones, Robin Ireland
722 [GO] 2020―Jun―11 Hypersegmented granulocytes and COVID-19 infection Christian Salib, Julie Teruya-Feldstein
723 [GO] 2020―Jun―03 House Calls for Stem Cell Transplants During the COVID-19 Pandemic. Anthony D Sung, Krista R. Nichols, Nelson J. Chao
724 [GO] 2020―Jun―03 COVID and Coagulation: Bleeding and Thrombotic Manifestations of SARS-CoV2 Infection Hanny Al-Samkari, Rebecca S Karp Leaf, Walter H Dzik, Jonathan CT Carlson, Annemarie E Fogerty, Anem Waheed, et al. (+7)
725 [GO] 2020―May―28 COVID-19 and SCA: an old friend comes to the rescue Enrico M. Novelli
726 [GO] 2020―May―28 Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study Douglas Tremblay, Maaike van Gerwen, Mathilda Alsen, Santiago Thibaud, Alaina Justine Kessler, Sangeetha Venugopal, et al. (+13)
727 [GO] 2020―May―27 Tocilizumab not associated with increased infection risk after CAR T - Implications for COVID-19? Matthew J Frigault, Sarah Nikiforow, Michael Mansour, Zhen-Huan Hu, Mary M Horowitz, Marcie Riches, et al. (+5)
728 [GO] 2020―Apr―27 COVID-19 and its implications for thrombosis and anticoagulation Jean Marie Connors, Jerrold H Levy
729 [GO] 2020―Apr―17 The BTK-inhibitor ibrutinib may protect against pulmonary injury in COVID-19 infected patients Steven P Treon, Jorge Castillo, Alan P Skarbnik, Jacob D Soumerai, Irene M Ghobrial, Maria Luisa Guerrera, et al. (+2)
730 [GO] 2020―Apr―13 Initiating adjunct low dose-hydroxyurea therapy for stroke prevention in children with SCA during the COVID-19 pandemic Michael R DeBaun
731 [GO] 2020―Apr―10 ILROG Emergency Guidelines for Radiation Therapy of Hematological Malignancies During the COVID-19 Pandemic Joachim Yahalom, Bouthaina S. Dabaja, Umberto Ricardi, Andrea Ng, N. George Mikhaeel, Ivan Richter Vogelius, et al. (+4)

731 Results       Page 1


Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.146 sec